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Abstract 
The aim of this study was to investigate the cellular mechanism(s) that underpins 
contractile dysfunction in the streptozotocin (STZ)-induced diabetic rat heart compared to 
age-matched control heart. In some experiments, a clinically relevant concentration of the 
volatile anaesthetic halothane (0.6 mM) was used examine its effect on contractile 
properties of STZ-induced diabetic heart. Diabetes was induced in male Wistar rats by a 
single i.p. injection of STZ (60 nig Kg', body weight) which, resulted in an experimental 
model of type I diabetes that was characterised by hypoinsulinaemia, hyperglycaemia, 
increases in osmolarity and decreases in body and heart weights. Total cation contents 
2+ 	 2+ 	 2+ 	 2+ (Ca , Cu , Zn and Fe ) were significantly (P<0.05) increased in the STZ-induced 
diabetic heart compared to age-matched controls. The majority of experiments were carried 
out on ventricular myocytes following 8-12 weeks of STZ treatment. L-type calcium 
(Ca 2 ) current (JCa,L) was measured in patch clamped ventricular myocytes in whole cell 
mode, using a cesium-based pipette solution and a holding potential of-40 my and test 
potentials between —30 and 50 my. The amplitude of 
'Cal. was significantly (P<0.05) 
decreased in the STZ-induced diabetic myocytes compared to age-matched control. 
Furthermore, halothane further reduced the peak 
'Cal, to levels in both age-matched 
control STZ-induced diabetic myocytes. Contraction was measured in electrically-
stimulated myocytes via a video-edge detector and results showed that the amplitude of 
contraction as a percentage of resting cell length (% RCL) was significantly (P<0.01) 
greater in STZ-induced diabetic myocytes (6.8 ± 0.5 %, n32) compared to that of age-
matched control (4.1 ± 1.04 %, n27). Moreover, the i,,A of contraction was found to be 
significantly (P<0.01) longer in diabetic myocytes (164.1 ± 7.4 ms, n'30 Vs. 132.3 ± 5.9 
ms, n=27) compared to control, respectively. Halothane evoked significant (P<0.05) 
reductions in the amplitude of contraction in control myocytes. The amplitude of 
ix 
contraction was significantly (P<0.01) reduced further in STZ-induced myocytes compared 
to the response in the absence of halothane. In voltage clamped myocytes however, 
contraction was peak amplitude of contraction was greater in control compared to STZ-
induced myocytes. Since contraction is ultimately dependent on cytosolic Ca 24, it was 
relevant to measured free intracellular Ca 2 concentrations ([Ca 24]) using the fluorescent 
dye fura-2. Basal resting Ca 2+ 
 (measure by fluorescence ratio units) was significantly 
(P<0.01) increased in STZ-induced diabetic myocytes following 8 weeks of treatment 
compared to age-matched control (0.599 ± 0.009 ratio units, nr23 f<s. 0.521 ± 0.012 ratio 
units, n=23) , respectively. Electrically stimulated cardiac myocytes (I Hz) induced Ca 2 
transients that had a longer time from the peak (tk) of Ca24 transient to half decay (1 decrn). 
Moreover, in the presence of halothane. the amplitude of electrically stimulated Ca 24 
transient release was significantly (P<0.05) decreased in control and STZ-induced 
myocytes but was not significantly altered between control and STZ-induced myocytes. 
Following a caffeine-induced Ca 2+ 
 release, / 2+ of Ca decay was significantly 
(P<0.01) longer (43%) in myocytes obtained from STZ-induced compared to age-matched 
controls. However, in the presence of 10 mM nickel chloride (NiCl 2), the rate of Ca 2 
efflux out of the cell was similar in both control and diabetic myocyte. Myofilament 
sensitivity was studied by plotting the relationship between contraction and Ca 24 in control 
and STZ-induced diabetic myocytes. The results show that myofilament sensitivity for 
Ca2* is increased in the STZ-induced myocytes but is significantly (P<0.05) reduced 
following the application of halothane. 
In conclusion, the results have shown that in electrically stimulated STZ-induced diabetic 
myocytes, the increase in contraction is primarily caused by an increase in myofilament 
Ca24 sensitivity, and not through an increase in Ca 2 release from the SR. Moreover, in the 
STZ-induced diabetic myocytes an alteration in NatfCa 2texchanger may contribute to a 
x 
prolonged Ca2 transient. It is suggested that prolonged Ap duration in the diabetic heart 
leads to increased Ca 2 influx albeit a reduced 'CLI.  which may overcompensate for a 
decrease in SERCA function (that has been reported in the diabetic heart. Misra el at 
1999) and may lead to similar SR Ca 2 load and release in both diabetic and control 
myocytes. Following. SR Ca 2 release it is suggested that the increased myofilament Ca 24 
sensitivity in STZ-induced myocytes leads to an increase in contraction that has been 
reported in this study. 
In voltage clamped STZ-induced diabetic myocytes, a decrease in 
'Cal.  was mirrored by a 
decrease in the peak amplitude of contraction. It is suggested that in voltage clamped 
myocytes from STZ-induced hearts, that are not influenced by the Ap. decreased 
'CaL, may 
lead to a reduced Ca 24 influx and subsequent SR Ca 2 release. Reduced Ca 2 release from 
the SR, may not be compensated for by the increase in myofilament Ca 2 sensitivity in the 
diabetic heart, and may ultimately lead to a reduction in the amplitude of contraction that 
has been reported in this study. 
It has also been shown that, following the application of halothane. the 
'CO.!., Ca2* transient 
and amplitude of contraction were significantly more decreased in STZ-induced myocytes 
compared to that of control. It is suggested that reduced myofilament Ca 2 sensitivity in the 
presence of halothane contributes to the changes in contraction. However, it is also likely 
that another mechanism such as fractional Ca 2 release and/or SR Ca 2 load may also be 
affected by the actions of halothane in the diabetic heart. 
xi 
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Chapter 1 
General introduction 
I. I 
	 History of diabetes 
Diabetes has been recognised as a disease state since ancient times. The Ebers papyrus 
discovered by a German Egyptologist in 1862, dates from 1550 BC and describes a state of 
polyuria resembling diabetes. For thousands of years, no one knew how to live with, let 
alone correct diabetes. Children with the disease died quickly, often within days of onset, 
and older people struggled with devastating complications (Williams & Pickup, 1999). 
In 1869, Paul Langerhans, a German medical student in his doctoral thesis, was the first to 
describe a small cluster of cells in teased preparation of the pancreas, but he was not able 
to explain their function, and it was Edouard Larguesse in 1893 who named the cells the 
'Islets of Langerhans' and suggested the function of the cells to be endocrine in origin. In 
1889 twenty years after Paul Langerhans discovery, Oscar Minkowski and Josef von 
Mering, using dog experiments showed that if the pancreas was removed from the body, 
the animal displayed typical signs of diabetes, with polydipsia, polyuria and muscle 
wasting, which were associated with glycosuria and hyperglycaemia (Williams & Pickup, 
1999). 
1.1.1 The search for all extract 
The link between the pancreas and diabetes had now been recognised. This led to research 
focusing on treating the disease with pancreatic extracts. It was the discovery of insulin in 
1921 at the University of Toronto, Canada through collaboration of Frederick Banting and 
his assistant Charles Best, the biochemist James Collip and physiologist John Macleod that 
would prove to be one of the greatest breakthroughs in the understanding of diabetes. 
Banting and Best made chilled extracts of dog pancreas (called isletin by Banting and Best 
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but later changed to insulin by the request of Macleod, the name given to the hormone in 
1909 by Belgium researcher Jean de Meyer) and injected them in pancreactectomised, 
diabetic dogs. Following the administration of the pancreas the blood sugar of the dogs 
declined. Macleod and Banting were awarded the Nobel Prize in 1923, which they later 
shared with Best, and Collip (Joslin, 1948). Collip (1922) later developed an improved 
extraction procedure, and the first diabetic patient was treated on 1st  January 1922. A 
commercially viable extraction method was then developed in collaboration with chemists 
at Eli Lilly and Co. and insulin then became widely available in North America and Europe 
from around 1923 (Williams & Pickup, 1999). 
Later developments in insulin research came with the discovery of the primary structure of 
insulin by Frederick Sanger in 1955 and in 1969 when Dorothy Hodgkin and colleagues 
described its three dimensional structure (Williams & Pickup, 1999). 
1.2 	 Diabetes Mel/kits 
Diabetes Mellitus, once considered of minor significance to world health is now ranked 
amongst the main targets of human health in the 21 s' century (Zimmet, 2000). The 
increased attention to diabetes stems from the rising number of people who are diagnosed 
With the disease (King et al. 1998). The disease is recognised as a group of heterogeneous 
population disorders characterised by fasting hyperglycaemia and glucose intolerance, due 
to insulin deficiency, impaired effectiveness of insulin action or both (Harris & Zimmet, 
1997). It is classified on the basis of aetiology, natural history and clinical presentation of 
the disease. In 1997 the American Diabetes Association (ADA) classified diabetes in terms 
of aetiology and not by treatment, and to date, diabetes is classified into two main types; 
type I diabetes mellitus (previously known as insulin-dependent diabetes mellitus (IDDM) 
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orjuvenile onset) and type 2 diabetes mellitus (previously known as non-insulin-dependent 
diabetes mellitus (NIDDM) and maturity onset) (Williams & Pickup, 1999). 
1.21 A worldwide disease 
Diabetes is a major global health problem. in 1997, an estimated 124 million people 
worldwide had diabetes, 97% of these having type 2 diabetes (Amos ci oL 1997). This 
figure has now increased to an estimated 160 million today, and is expected to reach a level 
of 221 million in 2010 (Amos ci aL 1997) and 300 million world-wide by 2025 (King c-
aL 1998). Within the U.K. alone, type 2 diabetes affects in excess of I million people. 
1.2.2 Type I diabetes meffitus 
Type I diabetes can occur at all ages but is predominant in children and young adults, with 
a peak incidence before school age (Williams & Pickup, 1999). The exact cause of the 
disease is multiple in nature and still imperfectively understood, but is thought to be a 
consequence of the cellular mediated autoimmune degeneration of pancreatic islet-beta (j3) 
cells and/or environmental factors (Schaffer. 1991). Much evidence suggests that type I 
diabetes has geographical, ethnic or seasonal differences. The highest world incidence of 
type I diabetes is found in Finland where there is reported to be 35 cases per 100,000 
people (Tuomilehto ci aL 1992a), however, in other Baltic states such as Estonia, the 
incidence is only one third that of Finland, although the country is made up of people of 
similar linguistic and ethnic background (Tuomilehto ci aL 1992b). This would suggest 
that environmental agents have a strong control in the induction of type I diabetes. 
However, despite strong epidemiological evidence it has been difficult to trace particular 
environmental factors that trigger the disease in genetically susceptible individuals 
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(Zimmet etal. 2001). Comparable with other disease states, a growing number of factors 
have reported to be involved in triggering diabetes, which includes exposure of viruses 
(mumps, rubella). Weaning on cows milk and ingestion of smoked meat products have also 
been reported as induction agents (Williams & Pickup, 1999). The difficulty in identifying 
environmental factors comes about because of the time difference between being exposed 
to the triggering agent and the initial onset of hyperglycaemia (Zimmet ci at 2001). One 
new report targets a macrolide antibiotic bafilomycin Al (bafAl) derived form the 
Streptornyces species as an agent that disrupts pancreatic insulin secretion in mice (Myers 
ci at 2001). Streptornyces species are found in soil and some vegetables including, 
potatoes and sugar beet (Myers ci at 2001). Therefore, it has been suggested that everyday 
common food sources or soil derivatives may be the trigger for the disease (Myers ci at 
2001). The interesting thing is that a Sirepionzyces species is also the source of STZ, the 
agent that is widely used to induce pancreatic n-cell necrosis in many experimental rodent 
models of type I diabetes. 
The commonest cause of type I diabetes is the autoimmune destruction of the pancreatic 3-
cells in the islets of Langerhans. The exact aetiology is complex and not thoroughly 
understood. As has been suggested, it is thought that environmental factors may trigger the 
response in people who have an inherent genetic susceptibility for the disease. Inherited 
susceptibility to type I diabetes depends on several genes at different loci. A major 
component of the genetic predisposition is encoded within the human leukocyte antigen 
(HLA) genes lying within the region of the short arm chromosome 6 (Newly called the 
'type I diabetes locus'). HLA antigens are cell surface glycoproteins and certain HLA-DR 
(3 and 4) and DQ alleles encoding antigen-presenting molecules have been established to 
be involved in the susceptibility of type I diabetes (Thorsby ciot 1998). 
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Type I diabetes is characterised by the loss of insulin production, resulting in a decrease in 
circulating plasma insulin. This insulin deficiency in the presence of catabolic counter-
regulatory hormones such as catecholamines, cortisol, glucagon and growth hormones 
increase lipolysis within the adipose tissue. The consequence of this is the release of non-
esterified fatty acids (NEFA) into the circulation. Within the liver the fatty acids (FA) are 
partially oxidised to produce ketone bodies, acetoacetic acid and 3-hydroxybutyric acid. 
All of these contribute to the state of acidosis (Williams & Pickup, 1999). The symptoms 
of ketoacidosis include polydipsia, polyuria, weight loss, leg cramps and weakness and if 
not dealt with, can soon lead to diabetic coma and eventual death (Amos et aL 1997). 
Therefore, type I diabetic patients have an absolute requirement for insulin, to prevent the 
life threatening consequences of hyperglycaemia and ketoacidosis (Schaffer, 1991). 
1.3 Animal model of diabetes 
Most of the experimental data regarding the pathogenesis of diabetic complications have 
been accumulated using animal models of diabetes, which can be characterised into two 
main types: experimentally-induced diabetes and spontaneously, genetically determined 
diabetes (Dhalla et aL 1985). 
1.3.1 Chemically-induced type I model of diabetes mellitus. 
Experimental-induction of diabetes frequently involves the administration of an agent, 
which will induce p-cell necrosis of the pancreas. Two widely used diabetogenic agents are 
alloxan and STZ (2-deoxy-2-[ [(methylnitrosamino)carbonyl]amino]-D-lucopyranose). 
STZ appears to be highly specific to 3-cells whereas alloxan has been shown to elicit non- 
specific necrotic effects. STZ is synthesized by the bacterium Sircp;onyces achrornogencs 
(Szkudelski, 2001). Doses of STZ between 40-60 mg Kg' are used to induce an 
experimental model of type I diabetes (Szkudelski 2001). Following administration, STZ 
is taken up by the pancreatic 13-cells via the glucose transporter GLLJT2. STZ then causes 
alkylation (Eisner et at 2000) of deoxyribonucleic acid (DNA), which in turn leads to the 
activation of poly adenosine 5' diphosphate (ADP)-ribosylation (Sandier & Swenne. 
1983). The consequence of this is the cellular depletion of nicotinamide adenine 
dinucleotide phosphate (NADP) and adenosine tn-phosphate (ATP) (Helier ci at 1994). 
Increased ATP de-phosphorylation following STZ-treatment offers a substrate for xanthine 
oxide and in doing so results in the formation of super oxide radicals, hydrogen peroxide 
and hydroxyl radicals (Nukatsuka ci at 1988). STZ induction also raises nitric oxide (NO), 
an inhibiter of aconitase activity, which also participates in DNA damage (Kroncke ci at 
1995) The outcome of STZ derangement in the 3-cells of the pancreas, is the inhibition of 
insulin synthesis (Nukatsuka ci at 1990), which leads to severe insulinopaenia, 
hyperglycaemia, glycosuria, polydipsia and muscle wasting (features associated with type 
I diabetes) (Bracken ci at 2003). 
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Figure 1.1. Whole blood glucose concentrations in response to an intraperitoneal (i.p.) 
glucose challenge test (2 g glucose (Kg body weight) ') in six-month-old STZ type 2 
treated and control (n6) Wistar rats following a 16 hour fast. Values represent the mean ± 
SEM (** PC 0.01) (unpublished work). 
1.4 	 The normal heart 
The mammalian heart is situated in the thoracic cavity, and is a muscular structure 
encapsulated by a fibrous pericardium layer. It contains four muscular compartments that 
include the right and left atria and ventricles, which are built upon a fibrotendinous, ring 
containing four apertures each with valves (Levick, 1995; Vander ci at 1999). The 
papillary muscles within the heart (see Figure 1.3) anchor the bi and tricuspid valves via 
the chordae tendinae. The purpose of the heart is to deliver oxygenated blood to the cells of 
the body and to pump the waste products of metabolism away from the cells. 
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1.4.1 The mechanical events of the cardiac cycle 
The continuous pumping action of the heart's cardiac cycle is divided into systole 
(contraction) and diastole (relaxation), and these two processes are called the cardiac cycle. 
Ventricular diastole lasts for around 2 thirds of the cardiac cycle at rest. This enables the 
time period needed for ample ventricular filling. At first, the atria are in diastole too. 
Therefore, blood flows passively from the superior and inferior vena cava through the atria, 
atrio-ventricular (AV) valve and into the ventricles. As the ventricles begin to fill up, the 
rate of flow slows down and ventricular pressure begins to rise. The final part of filling is 
associated with atrial contraction, which adds only a small amount of additional blood to 
the ventricles. The volume of blood (130 ml) in the ventricles at the end of ventricular 
filling is called the end diastolic volume (EDV). At this point ventricular systole begins. At 
the beginning of systole, the pressure within the ventricles quickly exceeds that within the 
atria. This causes the closure of the AV valves. At this stage the aortic and pulmonary 
valves are not open and therefore no ejection of blood occurs out of the ventricle. This 
phase is therefore known as isovolumetric ventricular contraction. Ventricular pressure 
then continues to rise until ventricular pressures exceed aortic and pulmonary trunk 
pressures, this causes the opening of the aortic and pulmonary valves, and the rapid 
ejection of blood out of the ventricles (stroke volume (SV) = 70 ml). The ventricles then 
begin to relax at the beginning of diastole, which in turn causes a significant fall in 
ventricular pressure, below those in the aorta and pulmonary trunk. which coincides with 
the closure of the aortic and pulmonary valves. At this stage the AV valves are also still 
closed, therefore no change in ventricular volume occurs. When the pressure within the 
ventricles fall below that of the atrias, the AV valves open and blood enters the ventricles 
again to begin another cycle (Litwin ci al. 1998; Vander ci ol. 1994; Katz, 1977). 
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Figure 1.2. A schematic overview of the mechanical events and the direction of blood flow 
involved in a cardiac cycle of a normal mammalian heart (Taken from Vander et al. 1999). 
1.4.2 Ultra structure of the heart 
The heart wall consists of three distinct layers; the epicardium, endocardium and 
myocardium. The epicardium makes up the outer layer of the heart wall and contains 
mainly connective tissue and forms the inner membrane portion of the pericardium. The 
endocardium, which is the inner most layer of the wall consists of a simple squamous 
epithelial layer overlying a thinner areola tissue. The middle portion, and the thickest 
section of the heart wall, the myocardium contains several types of specialised cells, which 
include ventricular, and atrial cells or myocytes, nodal cells and Purkinje fibres (Litwin ci 
aL 1998). 
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The myocytes form one of the largest portions of cells within the heart. These individual 
contractile cells have a single central nucleus (although some are hi-nucleated). Myocytes 
are attached to other myocytes by end junctions called intercalated discs, which contain 
three different regions known as; I) gap junctions, which provide a low resistance pathway 
for the rapid conductance through, which ionic current can pass from one cell to the next 
(Levick, 1995), 2) intermediate junctions and 3) desmosomes (Sjostrand & Anderson-
Cedergren, 1958), that hold the adjacent myocytes together by means of a proteoglycan 
matrix (Levick, 1995). Myocytes contract when stimulated, however, nodal cells are 
spontaneously active and are located in the sino-atrial (SA) node and AV node regions of 
the heart. These pacemaker cells initiate the contractile response for the working myocytes. 
The spontaneous activity of these cells can be modified by nerve impulses. The Purkinje 
fibres are a set of conducting cells enabling rapid penetration of electrical impulses through 
the heart. They appear very similar to nodal cells but contain only a few contractile 
filaments compared to a myocyte (Litwin ci al. 1998; Vander ci al. 1994; Katz, 1977). 
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Figure 1.3. Electron microscope images of papillary muscle (top) and 
ventricular muscle (bottom), taken from STZ-induced type I diabetic and 
age-matched control rat hearts (Taken from Howarth et at 2001). 
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1.4.3 The working niyocyte 
The working myocyte is full of long contractile bundles called myofibrils. Each myofibril 
is made up of smaller sarcomeres that are orientated across the cell giving a striated 
appearance. The sarcomere contains myofilaments that occupy between 45-60% of the cell 
volume (Bers, 2002a). The myofilaments are made of the thick myosin and thin actin 
filaments, along with other contractile and cytoskeletal components (Bers, 2002a). The 
myofilaments are responsible for contractility and changes in chemical energy to 
mechanical energy in the cardiac myocyte (Bers, 2002a). During contraction, the thin and 
thick filaments slide past each other, causing a change in muscle length. This movement is 
a consequence of cross bridge formation between the thin and thick filaments and is 
historically known as the sliding filament theory (Huxley, 2000). 
The backbone of the thin filament consists of two chains of globular actin molecules (0-
actin) to form a right-handed double stranded helical polymer (F-actin). Each turn of the 
actin molecule incorporates a molecule of tropomyosin that sits in the groove created by 
the double helices. At every seventh actin molecule, tropomyosin is attached to troponin. 
Troponin is a complex of three unidentical subunits; troponin—C, a Ca 2 binding unit, 
troponin-T, a tropomyosin binding unit and troponin-1, an inhibitory unit. Every thick 
filament is made up of around 300 myosin molecules along with other proteins including 
titin and C-protein. The tails of the myosin heavy chain (MUC) form the main core of the 
thick filament and the head region forms two light chains with binding sites for ATP and 
actin. 
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Ca2t regulates the process of contraction brought about by the sliding of thin and thick 
filaments. In the resting state, with low [Ca2t], troponin-1 binds to actin preventing the 
interaction of actin and myosin. Following a Ca 2 transient. [Ca2*]j is raised, which causes 
the interaction of free Ca 2 
 with the troponin-C complex. Troponin-C then binds to 
troponin-1 and causes the dissociation of it from actin. The change in troponin-C and 
troponin-i interaction instigate troponin-T, which causes positional change of the adjacent 
tropomyosin molecule, and in doing so exposes a myosin-binding site on the actin 
molecule. The head region of the myosin then attaches to the actin, which is followed by a 
change in the angle of the head. This causes the sliding of the actin and myosin over each 
other. The head is then disengaged and reattached at a different actin site. The requisite 
energy needed in the reaction comes from the hydrolysis ofa molecule of ATP to ADP and 
a phosphate (Pi) (Huxley, 2000). Therefore the number of cross bridges formed is directly 
related to the Ca 2 
 content and causes a greater or lesser contraction in the presence of 
ATP. 
1.4.4 Cardiac action potential 
An Ap is a recording of the electrical membrane potential (E,) of a cell (Katz, 1977). In a 
resting cardiac cell permeability favours potassium ion (K) entry and is relatively 
impermeable to sodium ions (Na). chloride ions (C1) and Ca 2t . The Na t/KtATPase 
pumps 3 Na out and 2 K into the cell and is responsible for the ionic concentration 
gradients for Na and for Kt but it is the K channels themselves that are responsible for 
the negative Em in cardiac myocytes (Bers, 2002a). This results in a highly negative resting 
Em nearing —90 my. The cardiac action potential is characterised by four phases: 
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Phase (0) initial cardiac myocyte depolarisation is initiated by the spread of current from 
adjacent sarcolemmal membrane regions (Bers, 2002a) which, is associated with a rapid 
transient opening of fast Na channels and slow Ca 2 channels so that inward Na current 
('Na) exceeds outward K current (JK). This results in a large influx of Na into the cell 
through voltage activated 'Na, driving the E. nearer to that of the Na* 
 equilibrium (+70 
my). At the peak Of 'Na the E. lies around +35 to 50 rnV in ventricular myocytes, because 
of a small permeability of K to the cell. The early repolarisation phase, Phase (I) 
coincides with the inactivation and activation of outward I0 and Ca2 activated chloride 
current (ICI(ca))and the slower influx of Ca 2 thus creating a plateau effect (phase 2). Ca 2 
channels then close at this point and K permeability increases resulting in the 
repolarisation of the cell (phase 3). Ionic balance is restored by a number of Na*/K+ 
ATPase pumps. This is also a refractory period, which lasts from phase 0 until about 
halfway into phase 3. Between these points the heart muscle cannot be excited again and is 
absolutely refractory to stimulation. However, for a short period after this (during the 
relative refractory period) a critically timed stimulus may result in ventricular fibrillation 
and death (Litwin et al. 1998; Vander ci aL 1994; Katz, 1977). 
1.4.5 Rat ventricular action potentials 
Action potentials profiles differ greatly according to differences in species and also 
regional variation within species (Oudit ci al. 2001)(see Figure 1.4). In the ventricle of the 
rat, the amplitude of the action potential is shorter and is distinguishable by its "spike like" 
appearance, compared to other species including human (Li ci aL 1998) and rabbits (Linz 
& Meyer, 2000), that have a longer and pronounced plateau phases of action potential. 
The rat ventricular action potential is characterised by a pronounced phase I repolarisation 
that precedes a very transient late plateau phase at E. more negative than —20mV (Linz & 
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Meyer, 2000). The changes in action potential profiles are reflected in changes in 
variations in the types, kinetics and amplitudes of inward and outward currents although it 
appears that there are little differences in the 'Na  and 'CaL  (Sah ci at 2003). in contrast 
however, repolarisation is primarily controlled by a number of K-channel properties, and 
differences in these channels appears to the primary reason for the variation in Ap between 
species (Varro et at 1993; Nerbonne ci at 2001; Oudit ci at 2001; Rosati ci at 2001). in 
particular the transient outward current (/), encoded by Kv4.2/4.3 genes, which is present 
in the rat has been reported to effect the duration and shape of the Ap (Josephson ci at 
1984). It has been reported that the large I current densities in rat myocytes in comparison 
with other mammals is the major determinant to reduce the depolarising effects of the 
'CaL, and in doing so reduce the plateau of the Ap in these species (Greenstein ci at 2000). 
However, in human and rabbit myocytes, where 'to  is less prominent, homeostatic balance 
favours 'CaL,  which results in a clear plateau phase (Greenstein ci at 2000). Studies in 
rodents were the 4,, is removed have resulted in a long plateau phase of the Ap that is 
similar to that of the guinea-pig, which lacks I entirely (Wickenden ci at 1997; Gaughan 
ci at 1998). Differences in the Ap at the apex/base of the heart in the rat were first shown 
by Watanabe ci at (1983). More recent reports, have utilised isolate myocytes from sub-
endocardium and sub-endocardial portions of the heart, and have reported that the Ap 
duration to be prolonged in the in sub-endocardial myocytes compared to that of sub-
epicardial myocytes in normal rats (Clark ci at 1993; Shipsey ci at 1997; Natali ci at 
2002). Moreover, it has also been shown that isolated myocytes from the mid-myocardium 
have Ap durations that lie between those of the sub-epi and sub-endocardium (Shipsey cI 
at 1997). A increase in expression of I (Antzelevitch ci al., 1991) and density of 4, 
(Clark ci at 1993; Shimoni ci at 1995) in sub-epicardial myocytes compared to sub-
endocardial myocytes may well reflect the increase of Ap duration that has been reported 
in sub-endocardial myocytes compared to that of sub-epicardial myocytes (Clark ci at 
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1993; Shipsey ci al. 1997; Natali ci at 2002). Changes in the duration and amplitude of the 
Ap, are mirrored by changes in the open probability of the L-type Ca 2 and 'CO.L  (Sah ci 
at 2003). Because of this Ca 2 influx can be increased within the heart leading to 
increased trigger Ca 2t and SR load (Bouchard ci at 1995). Moreover, it has been reported 
that cell shortening is significantly greater in rat myocytes obtained from the sub-
endocrinal compared to sub-epicardial portion of the heart (Clark ci at 1993; Natali ci 
at 2002). It is likely that a change in the expression of I is responsible for these changes 
in contractility. 
1.4.6 Electrical conductance within the heart 
The electrical stimulus needed for a heartbeat is initiated by the pacemaker conduction 
system. The dominant pacemaker region within the heart is the SA node. Spontaneous 
electrical activity generated in these cells causes the spread of electrical impulses through 
the gap junctions of the myocytes. The speed of the electrical input is fast enough to 
simultaneously initiate the contraction of the right and left atria. This wave of electrical 
conductance is responsible for the depolarisation of the AV node, which is positioned at 
the base of the right atrium. Depolarisation in this node is slower than other nodal cells, 
which results in a slight delay in electrical propagation and conductance through these cells 
in the heart. The mechanical consequences of this action are important, because this delay 
coincides with late atrial contraction and in doing so adds extra blood to the ventricle 
before they contract. The impulse then passes into the bundles of His, which divide into 
left and right branches that run down the entire ventricular septum into the network of 
Purkinje fibres. The conductance is finally passed on to the myocytes within the ventricle 
to initiate ventricular contraction. One of the important features of the heart is that the AV 
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node and the bundles of His are the only means by which electrical conductance can be 
carried from the atria through to the ventricles (Litwin c/ a/i 1998; Vander a at 1994; 
Katz, 1977). 
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Figure 1.4. Representative recordings of differential sites of action potentials taken from 
specific regions within the heart (Taken from Bers, 2002a). 
Figure 1.5.a Schematic model of E-C coupling in a normal ventricular 
cell, showing mechanisms that underpin Ca2 transport following 
membrane depolarisation and contraction. 
'CaL (L-type calcium 
current), NCX (NaVCa 2 -exchanger), SR (sarcoplasmic reticulum), 
RyR (ryanodine receptor). 
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Figure 1.5.b Schematic model of E-C coupling in a normal 
ventricular cell, showing mechanisms that underpin Ca 2 transport 
following membrane repolarisation and relaxation. NCX (Na/Ca 2 -
exchanger), SR (sarcoplasmic reticulum). PMCA (plasma membrane 
Ca2 -ATPase pump) 
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1.4.7 Excitation-contraction coupling in the normal heart 
Cardiac E-C coupling is the process of electrical excitation ofa cardiac myocyte that elicits 
contraction and enables the propulsion of blood out of the heart (Bers, 2002a). The initial 
rapid depolarisation of the cell membrane by an action potential triggers the signalling 
events of E-C coupling. This leads to a small entry of Ca 2 via the voltage-gated L-type 
channels (Barry & Bridge, 1993). There may also be a small entry of Ca 2 via the 
Na7Ca2
-exchanger operating in reverse mode (Nuss & Houser, 1992; Barry & Bridge, 
1993; Kohmoto ci at 1994; Vornanen ci at 1994) although the magnitude and potency of 
this mechanism are still controversial (Levi ci at I 993a; Lipp & Niggli, 1994; Litwin ci at 
1996; Wright c/aL 1997). This small influx of Ca2 triggers a much larger release of Ca 2 ' 
from the SR. When the SR is activated to release Ca 2t there is a transient rise in [Ca 2 i 
typically from a basal level of 100 nM to a peak between I and 2 ptvl within a period of 20 
to 40 msec after depolarisation (Beuckelmann & Wier, 1988; Cannell ci at 1987a). This 
rise in [Ca2 ]1 is commonly referred to as the Ca 2 transient. This process is referred to as 
"Ca2 '-induced C a2t re l ease" (OCR) and is generally accepted as the main mechanism of 
Ca2 release from the SR (Fabiato, 1983; Litwin ci at 1998; Muller, 1965). The process of 
contraction is initiated when Ca 2 binds to troponin-C. The decay of the Ca 2 transient is 
initiated by the re-uptake of Ca 2 into the SR by a SR Ca 2
-ATPase- dependent pump 
(SERCA)(Bers, 1991; Balke ci at 1994) and the extrusion of Ca 2 from the cell by the 
NaVCa2texchanger (Barry & Bridge, 1993; Barcenas-Ruiz ci at 1987; Jorgensen ci al. 
1982). Recent studies have proposed that, as well as CICR, a voltage-activated Ca 2 release 
(VACR) mechanism (similar to that seen in skeletal muscle) may exist in cardiac muscle 
(Levi ci at 1997; Ferrier & Howlett, 1995). 
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1.4.8 Calcium sparks underlying local control in heart cells 
The global Ca2t 
 transient within a cardiac myocyte is believed to be made up of the spatial 
and temporal summation ofa number of individual Ca 2 sparks (Cannell cial. (1994). Ca 2 
sparks were first described in single isolated cardiac myocytes by Cheng ci at (1993) as 
the spontaneous release of Ca 2 
 from a number(s) of RyR's on the SR. Subsequent work 
showed how Ca2t 
 sparks could be initiated through the activation of electrical stimulation, 
and synchronically regulated with the aid of Ap's and the 
'CaL  (Cannell ci al. 1994; Lopez-
Lopez ci at 1994). Therefore, Ca 2 
 sparks can be described as an event(s) in the process of 
E-C coupling, which, when activated by Ca2t 
 efflux through 
'Cal, and the Na 1iCa2t-
exchanger underlies the process of contraction. The relationship between 
'CaL and Ca2t 
sparks has been described, to support the hypothesis that a single L-type C a2tchanne l 
opening can lead to the initiation of a single Ca2* spark (Lopez-Lopez ci at 1995; Cannell 
& Soeller, 1997; Collier ci at 1999). This phenomenon is however, favourable at more 
negative potentials (- 40mV), whereas a larger number of L-type C a2tchanne l s 
 may be 
required to be open at more positive potentials (+ 60mV) (Guatimosim ci at 2002). The 
number of Ca ions that are required to bind to a RyR to initiate a Ca2t 
 spark remains 
controversial. It has been reported that the localised Ca 2 signal, produced by the opening 
of one L-type C a2tchanne l (known as "Ca 2 sparklef') is enough to trigger a Ca2t 
 spark 
(Wang ci at 2001; Wang ci at 2002). Moreover, Fan & Palade, (1999) reported that a 
single Ca2t 
 was sufficient to activate RyR's and incur Ca2t a transient release. The number 
of RyR's that is needed to be activated to initiate a Ca spark is unresolved. Original 
theory suggested that a single RyR would be sufficient to initiate a release ofa Ca2t 
 spark,, 
but more recent data have shown, that flux through a single RyR's is approx 4 pA whereas 
a single 
'Ca,L Ca 2  is approx 0.6 pA (Mejia-Alvarez ci at 1999).This suggests that the Ca 2t 
spark is due to a number or cluster of release channels on the SR. The termination of the 
Ca2t spark is abrupt and is necessary for the relaxation of the cardiac muscle. The exact 
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process that underpins the termination of a Ca 2 are poorly understood, but it has been 
shown that the process cannot be explained by the depletion of the SR or the stochastic 
closure of the RyR's (Sham ci al. 1998; Lukyaneko ci al. 1999). One recent report using 
sarponin-permeabilisd myocytes has shown that intra-SR Ca 2 buffering increased the 
amplitude and time course of Ca 2 sparks, which suggested that the termination of the Ca 2 
spark is brought about by the control of local intra-SR Ca 2 regulated RyR openings 
(Terentyev ci al. 2002). 
1.5 	 Diabetic cardiomyopathy and cardiovascular disease 
There is clear evidence of the negative influence of type I diabetes on the prevalence, 
severity and prognosis of cardiovascular disease (coronary head disease (CHD), stroke, 
peripheral vascular disease) (Julien, 1997). Cardiovascular disease represents the 
commonest cause of morbidity and mortality within diabetic patients (Schaffer, 1991; 
Schernthaner, 1996; Mahgoub & Abd-Elfattah. 1998; Rarnan & Nesto, 1996; Laakso, 
1999). Human and animal studies have shown that the excess risk of cardiovascular 
complications cannot be explained by conventional cardiovascular risk factors alone and 
therefore the diabetic state itself is likely to account for this alteration in cardiac function 
(Laakso, 1999; Albanna ci at 1998). This developing disease in the absence of any 
cardiovascular complications is termed diabetic cardiomyopathy (Kiss ci at 1988) and is 
defined as a decrease in cardiac contractile performance, which results in an abnormality 
in systolic function leading to a defect in expulsion of the blood ( systolic heart failure ), or 
by an abnormality in diastolic function leading to a defect in ventricular filling ( diastolic 
heart failure ) and resulting in congestive heart failure (Cl-IF) (Schaffer. 1991). Many 
invasive and non-invasive clinical studies on human diabetic patients have reported 
alterations in cardiac performance. Studies in type I diabetes patients have reported an 
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increase in atrial contraction, impaired diastolic function of left ventricle and reduced rapid 
filling rate (Albanna ci at 1998; Kiss ci at 1988; Astorri cial. 1997; Nicolino cial. 1995). 
It is thought to be the diastolic dysfunction in the diabetic heart that is responsible for 
increased morbidity and mortality (Fein c/at 1980; Tahiliani ci at 1983). 
1.5.1 Contractile dysfunction in the diabetic heart 
Several mechanisms of contractile dysfunctions have been reported in experimentally-
induced diabetic heart muscle. Depressed SV, aortic output (AO), positive (+dPldt) and 
negative (-dP/dt) left ventricular developed pressure have all been reported in various type 
I diabetic heart preparations (Regan ci at 1974; Fein ci at 1985; Litwin ci at 1990; Miller 
1979; Vadlamudi ci at 1982). 
1.6 	 Cardiac myocyte in the resting state 
In resting cells, [Ca 2+ ]i is determined by a Ca 2 leak that is compensated for by the 
sarcolemmal plasma membrane C a2tATPase 
 (PMCA) pump and the sarcolemmal 
Na/Ca2texchanger (Barry ci at 1986). In cultured cardiac myocytes the rate of Ca 2 
extrusion by the myocardial membrane bound ATPase is around 1/10 that of the Na/Ca 2 -
exchanger (Barry ci at 1986). Cannel (1991) reported that the Na/Ca 2texchanger 
accounts for as much as 75 % of the resting Ca 2 efflux within the cardiac cell. Therefore, 
the primary role of maintaining the basal [Ca 2+ 
 ]i level is the responsibility of the NaVCa 2 '-
exchanger (Cannell, 1991). 
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1.7 Mediators of calcium influx 
Stimulated Ca 2 influx results in the release of Ca 2 from the SR, which in turn leads to 
contraction of the cardiac myocyte that contributes to E-C coupling in the heart. The 
underlying mechanisms associated with the transport of Ca2t 
 within the cell including the 
'CaL, Na/Ca 2texchanger and adrenergic receptor mediated events will be discussed: 
1.7.1 Sarcolemmal calcium channels 
There are two types of Ca 2 ' channels in cardiac tissue. The L (large conductance) and T 
(tiny conductance) type Ca 2+ 
 channels. T-type Ca 2+ channels are present in various cardiac 
regions but are small or absent in ventricular myocytes, whereas L-type Ca 2 channels are 
very prominent in all regions of the heart (Bers, 2002a). L-type Ca2t 
 channels are highly 
sensitive to the dihydropyridines (DHP's) and most act as antagonists (e.g. nifedipine) to 
reduce L-type Ca2t 
 channel opening. Initial depolarisation of the cell membrane leads to 
the rapid activation of 'CaL around —40 mV Em and activates the opening of voltage-
sensitive L-type channels (Bers, 1991). Ca 2 influx through L-type channels has been 
shown to be 13.8imol/l cytosol in rat ventricular myocytes (Yuan c/at 1996). However, 
during normal physiological conditions SR Ca2t 
 release inactivates Ca2t influx by around 
50% in rabbit (Bers, 2002a) and rat (Shame! at 1995). 
In type I diabetic myocytes a few reports have suggested that L-type Ca 2t channel opening 
is impaired. Bergh c/at (1988) have reported that Ca 2t influx was significantly reduced in 
both acute and chronic diabetes compared to age-matched controls, while, Yu c/at (1995) 
proposed that the L-type Ca 2 channel in type I diabetes showed enhanced activity and 
was qualitatively and quantitatively altered. With regards to 
'CaL,  it has been suggested 
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that 'Ca,L  density-voltage relationships and steady-state inactivation curves Of 'CaL are not 
significantly altered in type I STZ-diabetic ventricular cells (Schneider & Sperelakis, 
1975; Tamada et at 1998; Jourdon & Feuvray, 1993). Moreover, Choi ci at (2002) 
reported that 'Ca,L was not significantly different in 8 week treated STZ-induced 
ventricular myocytes at voltages from —40 to +60 my. However, it has been reported that 
the 'Ca,!.  was significantly decreased in 24-30 wk STZ-induced diabetic myocytes (Wang 
et al. 1995). The differences in reports may be attributable to the changes in treatment 
time, methods of acquiring 
'CaL recordings and changes in solutions used to perfuse and 
equilibrate cells. Any change in 'CaL would alter the trigger Ca2t  on the SR and may also 
affect the reversal potential of the Na'JCa 2texchanger. Changes in these mechanisms may 
alter the amount of Ca2t 
 released from the SR and would therefore modify contraction. 
The response of Ca 2 channel activation and opening, is dependent on its phosphorylated 
state (Sperelakis 1988), which in turn regulates the length of time it is opened for and 
consequently the regulation of 
'Ca.L . Phosphoprotein phosphatases I, 2A, 2B and 2C, 
within the sarcolemmal regulate the life span of the opening time of the L-type C a2t 
channel, which, in the normal heart is likely to be around a few milli seconds (Allo & 
Schaffer, 1990). If the phosphorylation rate is altered, then the time span of opening may 
be affected in the diabetic heart and therefore contribute to changes in Ca 2 influx. 
1.7.2 Sarcolemmal sodium/calcium exchanger 
The Na+ 2+ /Ca -exchanger on the sarcolemmal membrane is a reversible pump that generates 
the transportation of three Na to one Ca 2 ' (3:1) (Philipson & Nicoll, 2000). However, 
recent data suggest a higher ratio rate (>3:1)(Fujioka etaL 2000). The isoforni of the gene, 
which generates the Na7Ca 2texchanger in the heart is the NCXI and consists of 970 
amino acids with a molecular mass of 110 kDa (Nicoll ci aL 1990). Ca2 extrusion is 
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recognised as inward Na/Ca 2texchanger current ('Na/ca)  as one Ca2E  extruded being 
replaced by three Nat so therefore Na extrusion is named outward 'Na/C.  (Bers. 2002b). 
The Na'7Ca 2texchanger is sensitive to current changes and therefore, has been implicated 
in the contribution ofCa2 influx and SR Ca 2 release during cell membrane depolarisation 
(Litwin et al. 1998). High [Ca 2+ ] 2+ favours Ca efflux while a positive E 11, and high [Na+  ] 
favour Ca 2 influx (Bers, 2002b). Therefore, in normal physiological conditions the 
Nat'Ca2texchanger works to decrease [Ca 2 ] by an inward 'Na/Ca.  However, if the Ap 
duration is increased through changes in either 
'CaL , SR Ca2 release or if [Na +]i is 
elevated, Ca 2 influx will occur (Bers, 2002b). 
1.7.3 Adrenergic response and calcium mobilisation in the heart 
Agonist occupation of 13-adrenoceptors leads to the activation of GTP binding protein (Ga) 
and the dissociation of the a subunit (Gsa) to activate adenylate cyclase, increasing the 
production of adenosine 3',5'-cyclic-monophosphate (cAMP). Elevated levels of cAMP 
leads to the dissociation of the regulatory and catalytic sub units of cAMP-dependent 
protein kinase A (PKA), which, phosphorylates a number, and variety of regulatory 
proteins. These include the phosphorylation of the L-type Ca 2 channel, ryanodine receptor 
(RyR), phospholamban (PLB) and troponin-1 (Trautwein & Hescheler, 1990). The 
phosphorylation of the L-type Ca 2 channel results in the increased probability of its 
opening within normal activation volatges. This in turn increases the Ca 2 availability for 
CICR. Similarly, phosphorylation of PLB (Kranias & Solaro, 1982), results in an increase 
in Ca 2 uptake by SERCA (Tada & Katz, 1982). Elevated SR Ca 2 increases the 
availability of Ca 2 for release by phosphorylated, RyR (Philbin ci all 2000) therefore 
increasing the speed of SR Ca 2 release. Phosphorylation of troponin-1 (Okazaki ci all 
1990) results in decreased sensitivity of the myofilarnents to Ca 2 . The net result of 
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myocardial f3-adrenoceptor stimulation is a systolic increase in cytoplasmic [Ca 2 ]1 and an 
increase in contractility (Tamada etal. 1998). 
The mechanism associated with increased sympathetic drive represents an important factor 
in maintaining cardiac output (CO) in the malfunctioning heart (Ha a at 1999). A number 
of reports have documented impaired cardiac responsiveness to 13-adrenoceptor stimulation 
in experimental-induced diabetic hearts. Reports using STZ-induced type I diabetic hearts 
suggested that stimulation with isoprenaline resulted in a decrease in the force of 
contraction in whole heart preparations (Atkins ci at 1985), in 4-6 week (Gando ci at 
1997) and 8 week (Heyliger ci a/i 1982) STZ-treated papillary muscles and in isolated 
cardiomyocytes following 8-10 weeks of STZ treatment compared to control preparations 
(Horackova & Murphy, 1988). The rate at which, isoprenaline induced SR Ca 2 uptake was 
depressed in 180-day STZ-induced whole hearts when compared to age-matched controls 
(Vadlamudi & Mcneill, 1984). Therefore. -adrenergic sensitivity seems to be defective in 
the STZ-induced type I diabetic heart. The inotropic responses to dibutyryl-adenosine 
3',5'-cyclic-monophosphate (DBcAMP) and forskolin (an activator of the adenylate 
cyclase supply) were also prominently reduced in the type I diabetic heart compared to 
control (Gando 1994; Tamada ci at 1998). Competitive binding studies have shown that 
0-adrenergic receptor number are significantly decreased in the myocardial membrane 
(Gando. 1994; Caterson ci at 1982; Savarese & Berkowitz, 1979; Nishio c/ at 1988) 
taken from type I diabetic hearts, although it appears that f3-adrenergic receptor affinity for 
agonists is not compromised (Nishio c/at 1988). Competitive binding studies have shown 
(Gando, 1994) that the interaction between -adrenoceptor and Gs-protein is not altered in 
type I diabetic hearts. This observation implies that the dysfunctional responsiveness 
associated with type I diabetic hearts may not necessarily be caused by an alteration in 
28 
cAMP or changes in G- proteins but is more likely to be caused by a defect, distal to the 
adenylate cyclase system. This would seem to implicate an alteration in Ca 2t homeostasis 
in the cardiac cell during diabetes. Gando ci al. (1994) have also postulated that this 
dysfunctional response may be associated with impaired phosphorylation of 
phosphoproteins including PLB. 
1.8 	 Mediators of systolic calcium 
The trigger and release of Ca 2 from the SR into the cytosol contributes to myofilament 
activation, which leads to contraction in the heart. The mechanisms associated with this 
process will be discussed: 
1.8.1 Ryanodine receptor activation and sarcoplasniic reticulum release 
Ryanodine is a neutral plant alkaloid, which is a specific and selective ligand for the Ca 2 
release-channel, RyR within the SR (Yu c/ at I 994a). Ryanodine produces a progressive 
decline in cardiac muscle contraction (Yu cicit 1994a). At low concentrations (1-30 nM), 
ryanodine is thought to bind to high affinity sites resulting in the release of Ca 2 from the 
SR. [i-l] ryanodine has been employed previously to show that the number of high 
affinity binding sites in type I diabetic heart is reduced compared to control (Yu c/ al. 
1994a). This observation suggests that the density of RyR's is lowered in type I diabetic 
hearts. Ca2t 
 influx accumulates around the RyR at the SR. where it binds to RyR's to 
trigger the SR Ca 2 ' release. Reduced density of RyR's may lead to an impairment of Ca2t 
release from the SR, although it has yet to be reported if the decrease in numbers of RyR's 
(reported in type I diabetic hearts) is indicative of the sensitivity of Ca 24 release from the 
SR. 
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Fabiato (1983), carried out preliminary studies using caffeine to assess SR Ca2t 
 content in 
skinned cardiac muscle fibres and more recently caffeine-induced Ca2t response has been 
used to assess SR Ca2t 
 content in single cardiomyocytes. Caffeine increases SR Ca2t 
channel opening, thus promoting Ca 2 leakage into the cytoplasm. The permanent opening 
of Ca2t  channels prevents accumulation of Ca2t 
 into the SR (Rousseau & Meissner, 1987). 
The peak [Ca2t] induced by caffeine can be used as a measurement of an index of 
releasable Ca2t 
 from the SR, although it should be noted that caffeine also effects 
myofilaments sensitisation as well as inhibiting phosphodiesterase (which can increase 
cAMP and in turn activate of cAMP dependent PKA) (Yu ci at 1995). Several studies 
have demonstrated that the amplitude of the caffeine-induced Ca2t transient is depressed in 
type I diabetic cardiomyocytes (Tamada ci at 1998; Lagadic-Gossmann ci at 1996; 
Woodbury & Hecht, 1952). Yu etal. (1994) reported that caffeine-induced contracture and 
subsequent Ca2t 
 transient in diabetic myocytes to be 75% that of control cells. Rapid 
cooling contracture (RCC) are another established method of assessing SR Ca2t 
 release in 
the contracted cell. Rapid cooling (from 30 °C - 1 °C) of the SR (in situ) results in the rapid 
release of Ca 2 
 from the SR, this is followed by a contracture. Bouchard & Bose (1991) 
showed a 50 % reduction of RCC in diabetic cells, while Yu ci at (1994a) observed a 
reduction in the amplitude of RCC in the diabetic heart that was 68% that of control cells. 
This evidence suggests that a reduction in caffeine and RCC seen in type I diabetic cardiac 
cells may be indicative ofa diminished Ca2t 
 storage mechanism in the SR. 
1. & 2 My oft/amen! interaction 
A rise in Ca 2+ 
 transient raises the probability of free Ca 2+ 
 interacting with the troponin-C 
complex and initiating the sliding action of the actin and myosin, culminating in 
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contraction. This process may be greatly altered by a change in the pharmacological 
environment and an alteration in the pathological state (Morgan et of, 2000). Therefore, 
changes in myofilament sensitivity may contribute to cardiac contractile abnormalities in 
the diabetic heart. Myosin, the thick filament associated with contraction is comprised of 
two heavy chains molecules, MI-IC and four light chain molecules (MLC). In cardiac 
myocytes there are two isoforms of MI-IC (ct-MI-IC and I3-MHC) that are distinguished by 
their heavy chain composition and Ca 2tdependent ATPase activity (Schaffer, 1991). a-
MI-IC or VI has around four times the activity of the r3-MI -IC or V3 isoform. In the adult 
rat heart over 90% of the adult isoform is made up of a-MI-IC and it is this isoform that 
predominantly contributes to contraction in normal conditions (Depre ci al. 2000a). It has 
been reported that in the type I diabetic state, expression of the MHC is switched from the 
active a-MI-IC to the less active -M1-1C isoform. (Golfman etaf 1999; Depre ci at 2000a; 
Pierce & Dhalla, 1981) which has been reported as a factor in cardiac dysfunction (Brouty-
Boye et of 1995). It has been suggested that a change in isoform expression may 
contribute to disturbances in ventricular dysfunction and ultimately lead to a specific 
diabetic cardiomyopathy (Schaffer, 1991). A change in [Ca 2 ] i may be indicative of this 
change (from (x-MHC to 13-MHC), which is seen in diabetic cells (Malhotra & Sanghi, 
1997). 
1.9 	 Mediators of relaxation 
During the relaxation phase of contraction, there is intracellular competition to decrease the 
2+- 	 + 	 2+ [Ca ] between the SERCA pump, the Na /Ca -exchanger, PMCA and mitochondrial 
uptake. The role each has to play in lowering [Ca 2 ]1 is discussed below. 
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1.9.1 Sarcoplasmic reticulum uptake 
The SR possesses a pump (SERCA), which is distinct from the sarcolemmal PMCA 
pump. The SERCA pump is a member of the P-type ion transporting ATPase family that 
includes the Na/KtATPase, PMCA and the H/K-ATPase (Bers. 2002a). The only isoform 
of SERCA in the cardiac muscle is SERCA2a. The decay of the Ca 2t transient is initiated 
by the re-uptake of Ca 2t into the SR by SERCA (Bers. 1991; Balke c/at 1994) and the 
extrusion of Ca2t 
 from the cell by the Na 4iCa2texchanger (Barcenas-Ruiz et at 1987; 
Jorgensen c/aL 1982; Barry & Bridge, 1993). In rat ventricular myocytes re-uptake of Ca2t 
into the SR accounts for between 87 and 92 % of the total removal of Ca 2 from the 
cytosol, while the Na 4iCa2texchanger accounts for approximately 9-7 % (Negretti ci at 
1993; Bassani dat 1994). 
Defects in the activity of SERCA are likely to impair accumulation of Ca 2 into the SR 
leading to a steady-state decline in SR Ca 24 load. Several studies have observed decreased 
activity of the SERCA pump of the SR in STZ-induced type I diabetic cells (Ganguly et 
at 1983; Lopaschuk c/aL 1983b; Takeda c/at 1996; Misra ci at 1999). Zarain-Herzberg 
ci at (1994) reported that 3 and 5 week STZ- induced diabetic rat heads exhibited a 
decrease of SERCA activity although Northern blot analyses failed to significantly show a 
reduction in the relative level of SERCA mRNA expression in either diabetic or insulin-
treated rat hearts. Moreover, quantification of SERCA protein by Western blot did not 
reveal any change between diabetic and insulin treated animals. These results would 
therefore suggest that any defect within the SERCA pump may not be attributed to 
alterations at transcriptional or translational levels within the diabetic heart (Zarain-
I-lerzberg ci at 1994). Although the SERCA pump is important in decreasing the beat-to-
beat [Ca2t]1 
 levels, it is incapable of extruding Ca 2t from the cell. Therefore, steady-state 
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increases of [Ca 2+ ] in diabetic myocytes cannot be explained by a defective SR Ca 2+ 
 
transport system alone (Schaffer, 1991). 
1.9.1.1 P/s ospiwlaniban 
Ca2 
 uptake into the SR is regulated by PLB. PLB is an endogenous protein that inhibits 
SERCA pump activity and therefore decreases Ca 2 transport in the cardiac myocyte. 
When phosphorylated, PLB reverses its inhibitory effects on the SERCA pump and 
therefore, potentiates the uptake of Ca 2 from the cytoplasm into the SR (Tada & Katz, 
1982). PLB can be phosphorylated by cAMP dependent PKA at the serine-16 residue 
(Tada ci at 1974). 
It has been reported that isoprenaline enhanced the rise of [Ca 2 ]1 in response to a rapid 
caffeine induction in control myocytes more markedly than in type I diabetic cells 
(Tamada ci at 1998). In agreement with this. Gando cial. (1997) showed that stimulation 
with isoprenaline resulted in a 3-fold increase in PLB phosphorylation in control myocytes. 
Moreover, the same workers also demonstrated that type I diabetic hearts were less 
responsive to forskolin (Gando ci at 1997). This would suggest that the SR Ca 2 uptake 
through the SERCA pump might be impaired in the type I diabetic heart. 
1.9.2 Sodium calcium exchanger 
Although the Na/Ca 2
-exchanger has been suggested to be a mechanism of Ca 2 influx 
and a trigger for SR Ca 2 
 release, its main role is to reduce Ca 2 during diastole and 
therefore increasing [Na]1 (Bridge ci a/i 1990). A few workers have demonstrated 
depressions in the activity of the NaVCa 2texchanger pump in type I diabetic ventricular 
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cells (Takeda ci al. 1996; Pierce ci at 1990). Chattou ci al. (1999) have reported that the 
'Na-Ca is significantly decreased in the 3-4 week treated STZ-induced diabetic myocytes 
similarly Elattori ci at (2000) have also observed that the 'NaCa  was reduced in ventricular 
myocytes taken from the diabetic head when compared to control. Activity of the 
Nat'Ca 2
-exchanger is partly regulated by the intracellular sodium concentration ([Na4]) 
showed that the level of [Na]1 was significantly lower in diabetic myocytes (9.2 mM) than 
that in normal myocytes (12.0 mM) and it has been suggested (Katoh cial. 1995) that the 
decrease in [Na*]j 
 in diabetic myocytes may be due to an attenuation of the activity in the 
Na/Ef exchanger system. Pierce ci at (1990) have demonstrated a depression in Na/H 
exchanger isolated from chronically diabetic rats, suggesting an imbalance of pH and Na 
concentration within the cell. A reduction in [Na4]1 would favour operation of the 
exchanger in forward mode (influx ofNa* etilux ofCa 2 ) and may explain the decreases in 
cytoplasmic Ca2 concentration (Pierce c/ at 1990), which have been demonstrated in 
diabetic cells (Lagadic-Gossmann ctat 1996). Other reports however, suggest an increase 
in [Ca2 ]1(Allo c/at 1991). Increased [Na]1 would result in the increase of [Ca 2 ]1 through 
the Na/Ca 2
-exchanger. ADo c/at (1991) have suggested that a significant decrease in the 
ability of the Na/KtATPase activity would lead to increased levels [Na +] i. 
 
1.9.3 PMCI4 pump 
The PMCA is a P-type ATPase that uses energy ATP to drive Ca 2 out of the cell during 
relaxation. The pump is coupled to a proton counter flux that transports I proton in and I 
Ca2 
 out of the cell (Kuwayama, 1988). In the rat heart, the PMCA is likely to account for 
approximately 10% of the total Ca 2 
 efflux and contribute around 1% to overall Ca 2 
decrease in diastole (Bassani ci at 1994). In the STZ-induced type I diabetic heart, the 
PMCA pump has been reported to be significantly depressed following 18 and 24 days of 
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treatment (Takeda ci al. 1996) and in 8 week (Heyliger ci al. 1987; Makino ci at 1987) 
diabetic preparations. This alteration in the sarcolemmal (1-leyliger ci al. 1987) PMCA 
pump would contribute to a small defect in the Ca 2 efflux across the myocardial 
membrane in the diabetic heart. 
In conclusion, there is clear evidence of the negative influence of type I diabetes on the 
severity of cardiovascular disease. Several mechanisms of contractile dysfunctions have 
been reported in experimentally-induced diabetic heart muscle and current evidence 
reviewed in the introduction suggests that an altered process that underpins the 
mechanism(s) of E-C coupling are responsible for the contractile dysfunction seen in 
diabetic heart cells. In particular, it has been suggested that abnormal Ca 2 movement is 
responsible for the impairment seen in diabetic hearts. 
1.10 The story so far 
To date, several studies have utilised the STZ-induced model of diabetes to look at the 
effects of diabetes in the heart. Unfortunately many studies appear to contradict each other 
in their reports and it appear that the degree and variety of experimental procedures may 
underpin, to some extent the apparent changes that have been observed. It is therefore 
worth while tabulated a number of reports to educate the reader in recent publications that 
have arisen from this model ofdiabetes. 
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Table I.I. A comparison of studies looking at the effect of STZ-induced diabetes 
on the isolated cardiac myocytes from the rat heart 
Study Findings Treatment A uihor(1s) 
time 
Contraction Reduced 8 weeks Choi ci aL (2002) 
8 weeks Ren & Davidoff, (1997) 
5 months Okayama ci at (1994) 
6 weeks Yu ci at (1994a) 
No change 4-6 weeks Tamada ci at (1998) 
4-6 weeks Ishitani cial. (2001) 
Increased 8-12 weeks Howarth c/a! 2001 
Calcium Reduced 8 weeks Chol ci at (2002) 
transient 8 weeks Noda ci at (1992) 
6 weeks Lagadic-gossman ci at (1996) 
No change 4-6 weeks Tamada ci at (1998) 
4-6 weeks 1-lattori ci at (2000) 
Ap duration Prolonged 4-6 days Shimoni ci at (1994) 
8 weeks Magyar ci at (1992) 
3-4 weeks Jourdan & Feuvray, (1993) 
ICa,L Reduced 24-30 weeks Wang ciat (1995) 
3-4 weeks Chattou c/at (1999) 
No change 8 weeks Choi ci at (2002) 
4-6 weeks Tamada ci at (1998) 
3-4 weeks Jourdan & Feuvray, (1993) 
Ito 	 Reduced 	 4-6 days Shimoni ci at (1994) 
24-30 weeks Wang ciat (1995) 
3-4 weeks Jourdan & Feuvray, (1993) 
8 weeks Magyar c/at (1992) 
JNaJCa 	 Reduced 	 4-6 weeks Hattori ci at (2000) 
3-4 weeks Chattou c/at (1999) 
1.11 Changes in Cation distribution wit/tin the diabetic heart 
It has been reported that a change in specific cations within the body can result in a 
disruption of the contractile machinery of the heart (Elamin & Tuvemo, 1990). If this is 
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the case then it is reasonable to presume that changes in specific cations brought on by a 
diabetic state may synergistically lead to alteration in contraction that has been reported in 
the diabetic heart. One of the most abundant cations within the body is magnesium (Mg 2 ) 
(Sasaki ci at 1999). In the heart. Mg2t plays a pivitol role in myocardial functioning 
(Topalov ci al. 2000). It has been reported changes in Mg 2 can, induce changes in 
membrane integrity and in doing so alter Ca 2 homeostasis (Altura & Altura, 1996), change 
the resting membrane and alter Ap duration (Altura & Altura, 1985). Moreover. [Mg 2t I 
has been reported to be important in the regulation of the Na/Ca 2texchanger. Therefore, 
any changes in Mg 2+ 
 levels may contribute to changes in the Na+ 2+ /Ca -exchanger and 
cause a reduced or increased concentration of Ca 2 ' within the cell (Howarth & Levi, 1998). 
Therefore, any perturbation of Mg2t 
 within the heart may lead increased cardiac failure 
(Altura & Altura. 1985; Chakraborti ci at 2002). 
It has been reported that Fe2t 
 when increased within the heart can result in heart failure. It 
has been reported that Fe2t 
 overload can result in heart failure and diabetes mellitus 
(Phatak & Cappuccio, 1994; Vonherbay ci at 1996). 
Copper (Cu 2 ) can act as a specific co-fator for over 20 enzymes that contribute to the 
normal function of the heart (Prohaska ci at 1990). Deficiency of this important cation has 
been implicated in a variety of cardiovascular complications including, IHD (Klevay, 
2000), cardiac hypertrophy, cardiac fibrosis and changes in cardiac myofibrils (Saari ci at 
1999). Copper deficiency has also been implicated in reducing cardiac action by altering 
Nat and K transport through changes in NatKtATPase isoform expression (Huang ci at 
1995). In the whole heart, it has been reported that reducing [Cu 2 ] resulted in reduced 
contractile function (Allen ci at 1993; Prohaska ci at 1982). However, it has also been 
reported that isolated cardiac myocytes from Cu 2 deficient rats exhibit enhanced 
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contraction and speed of contraction (Wold c/al. 2001). This implies that a change in Cu 2 
content within the diabetic heart may contribute to changes in contractile function. 
Zinc (Zn 2 ) also acts as an important co-factor that is involved in numerous important 
physiological processes (Pras ci at 1983). It has been reported that changes in Zn 2 
metabolism may be important in the induction of athroscelrosis (Paolisso ci at 1999). 
Whether or not changes in Zn 2 metabolism occur in diabetes, it is clear that changes in 
dietary Zn 2 can bring about changes in cardiac behaviour. One study reported that 
isoprenaline induced stimulation of the adenylate-cyclase activity, was significantly lower 
in diabetic rats that were given a low Zn 2 
 diet comparable to age-matched controls 
(Mooradian ci at 1988). This report would indicate that alterations in Zn 2 may directly 
effect the working of the cell through the 3- adrenergic responsiveness of the diabetic heart 
(Mooradian ci cii. 1988) and therefore, any changes in Zn 2 metabolism in diabetes may 
contribute to changes at the cellular level. 
Therefore, it can be seen that a changes in the total amount and variety of cations can have 
a profound effect on the normal functioning of the heart. Changes in the contractile 
dysfunction that has been reported in the diabetic heart may in pan be brought about by 
altered cation metabolism 
1.12 The effect of IaIot/iane on the heart 
In patients that are attending elective surgical procedures under general anaesthesia, the 
commonest cause of significant morbidity and mortality corresponds to cardiovascular 
complications (Mangano & Goldman, 1995). Many volatile anaesthetics have been used in 
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the clinical environment to promote unconsciousness in patients undergoing surgical 
operations on the heart (Davies a at 2000). It is well established that volatile anaesthetics 
have a potent negative inotropic effect on the heart, not only in clinical situations (Eger ci 
at 1970) and in animal, in situ hearts (Mahaffrey ci at 1961), but also in isolated heart 
muscle preparations (Housmans & Murat, 1988; Bosnjak ci at 1992), isolated cardiac 
myocytes (Harrrison ci at 1999; Davies ci at 1999) and regionally isolated cardiac 
myocytes (Ritahlia et at 2001). Halothane is one such volatile anaesthetic that is widely 
used in a clinical and research environment and is reported to have a potent negative 
inotropic effect on the heart (Harrrison ci at 1999; Davies ci at 1999). The negative 
inotropic effects of halothane on the heart are brought about by either a reduction in the 
Ca2 transient, through altered Ca 2 homeostasis or by a change in myofilament sensitivity 
for Ca2 (Davies ci at 2000). Moreover, it has been reported that myofilament sensitivity 
for Ca2 is reduced in isolated rat cardiac myocytes in the presence of halothane (Harrison 
ci at 1999; Davies). It is well established that volatile anaesthetics such as halothane have 
a depressive effect on the 'Ca,L (Ikemoto et at 1985; Terrar ci at 1988; Bosnjak ci at 1991; 
Kanaya ci at 1998). Reductions in 'Ca,L  in the presence of halothane may contribute to a 
decrease in Ca2 influx, SR Ca2 content (Connelly ci at 1994), fractional Ca 2 release 
(Han ci at 1994), and Ca 2 transients (Wheeler ci at 1988), that have been reported in the 
heart preparations in the presence ofhalothane. As well as 'CaL,  it has also been shown that 
halothane also affects other current, such as 'CaL (Eskinder ci at 1991 ), 'Na (Weigt ci at 
1997) and the 4, (Davies ci at 2000). Changes in current status in the presence of 
halothane are likely to account for changes in Ap characteristics that have been reported in 
the heart (Harrison ci at 1999). Moreover, it has recently been shown that halothane 
shortens the Ap duration to a greater extent in the sub-endocardial myocytes compared to 
sub-epicardial myocytes of the ventricle (Rithali ci at 2001). Any halothane-induced 
changes in Ap may contribute to the negative inotropic response that has been described 
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in the heart. Overall it has been shown that halothane-induced changes in current activity, 
Ca2* mobilisation and Ca2 myofilament sensitivity synergistically contribute to the 
negative inotropic effect in the heart. 
It has been shown that changes in pathological disease states such as myocardial ischemia 
(Kissin et at 1983;) and congestive heart failure have altered the negative inotropic effects 
of volatile anaesthetics. It is noteworthy that little is known about the effect of volatile 
anaesthetic on the diabetic heart. It has however been reported that halothane, isoflurane 
and enflurane did not significantly effect the papillary muscles 0fSTZ-induced diabetic rat 
heart but increased the time course of contraction (1-lattori etal. 1989). 
1.13 Aims of the study 
It has been reported in human patients and animal models with diabetes that contractility 
and Ca2 homeostasis are compromised in the heart. A chemically induced model of type I 
diabetes will be employed by using the antibiotic STZ in the rat. To test the hypothesis that 
the underlying mechanisms of E-C are corrupt in the diabetic heart we will utilise cardiac 
myocytes that will be enzymically isolated from the ventricle of the heart. To date, there 
appears to be a great deal of contradiction surrounding changes in contractile dysfunction 
within the STZ-induced type I diabetic rat. We will therefore set up a time-course study to 
compare the effects of STZ-induced type I diabetes following, acute (4 week and 8-12 
week) mid (4 and 5 month) and chronic (10 months) treatment on the mechanism of 
contraction in isolated ventricular myocytes. A cation imbalance is associated with cardiac 
dysfunction. This study will therefore test the hypothesis that the STZ-induced model of 
diabetes in the rat causes a specific cation imbalance. To test the hypothesis that there is a 
derangement in contractile function and Ca 2-3- 
 mobilisation within the heart of the STZ- 
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induced diabetic rat, a video-edge detection system and a fluorescence system will be set 
up to measure contraction and Ca 2 simultaneously. The simultaneous recording of 
contraction and Ca 2 ' will allow the myofilament sensitivity Ca 2 to measured and test the 
hypothesis that these may be affected in the STZ-induced diabetic heart. Pharmacological 
tools such as caffeine. NiCl2 will then be employed to pin point changes in Ca 2+ 
 
homeostasis, in particular to changes in Ca 2 efflux out of the cell within the STZ-induced 
diabetic heart. In some experiments isolated ventricular myocytes will be patched in whole 
cell mode and the voltage dependence of contraction will be measured to test the 
hypothesis that changes in membrane voltage are associated with differences in contractile 
function in the STZ-induced diabetic heart compared to age matched control. Throughout 
the series of experiments, the volatile anaesthetic halothane will be employed to test the 
hypothesis that the STZ-induced diabetic heart is more vulnerable to the inotropic effect of 
halothane compared to that seen in the normal heart. 
II 
Chapter 2 
Materials and Methods 
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2.! 	 Materials 
Streptozotocin; Sigma, S-0130, Collagenase; Worthington, LS004 196, Protease, Sigma, P-
5147, Insulin; Actrapid, 2-Bromo-2-chloro-1. 1,1 -trifluoroethane (halothane); Sigma, 
134388: stock 99%), Fura-2 AM; (Molecular probes. Leider, The Netherlands), Nickel 
chloride; Sigma, N-5756. 
2.2 	 Induction of diabetes 
Diabetes was induced in male Wistar rats (200-250 g) by a single i.p. injection of STZ (60 
mg kg - '; Sigma, 5-0130). STZ was dissolved in a citrate acid buffer solution (0.1 M citric 
acid; Sigma. C-0759 and 0.1 M sodium citrate; Sigma, S-4641 pH 4.5) (Ren & Davidoff, 
1997; Tamada et cii. 1998; Yu c/ al. 1994a; Noda ci al. 1993). Age-matched control rats 
received an equivalent volume of citrate acid buffer solution alone. Control and diabetic 
animals were caged separately but housed under similar conditions. Both groups were fed 
the same diet and water ad/iN/un, until they were used I. 1 4, 5 and 10 months later. All 
experiments had relevant ethical clearance from the Ethics Committees at the University of 
Central Lancashire and United Arab Emirates University. 
2.2.1 Measurement of blood glucose, plasma osnwlarity and plasma insulin 
Glucose was measured in whole blood with a glucose meter (One Touch II glucose meter, 
Lifescan Inc) prior to administration of STZ, 3-5 days following administration of STZ to 
confirm diabetic state and immediately after humanely killing of the animal, prior to 
experiments. Blood plasma osmolarity was measured with a vapour pressure osmometer 
(Westcor Inc, Model 5500XR). Plasma insulin analysis was measured with a standard 1251 
radioimmunoassy kit (Coat-A-Count Insulin, Diagnostic Products Corp, CA). 
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2.3 	 Preparation of heart ti&cue for cation analysis 
At 2 and 4 month intervals diabetic and control animals were anaesthetised by an i.p. 
administration of pentobarbitone (60 mg kg' body weight) and also received 200 j.xl 
heparin (Leo Pharmaceutical Products, 5000 i.u. mY'). Hearts were rapidly excised, before 
being blot dried and weighed. These hearts were then used for the analysis of cardiac 
cation contents. 
24 	 Cardiac myocyte isolation for contractility study and calcium measurement 
Rats were humanely killed by a blow to the head followed by cervical dislocation and the 
hearts rapidly removed. Samples of blood were taken at this stage for subsequent 
measurement of whole blood glucose, osmolarity and plasma insulin. Cardiac myocytes 
were isolated according to previously described techniques (Frampton et aL 199 Ia). In 
brief, hearts were perfused retrogradially at a constant flow rate by Langendorffs method 
(Langendorff, 1895) with a physiological solution (Appendix) containing Ca 2t (0.75 mM) 
at 37 °C. Perfusion flow rates were adjusted to 8 ml g heart 1 mm 'to allow for differences 
in heart weight between the diabetic and control animals. When the preparation appeared 
stable (regular contractions 300 beats mm 
_5, perfusion was switched to a nominally Ca 2 - 
free physiological salt solution (Appendix) containing ethylene glycol-bis(2-
aminoethylether)-N,N,N',N'-tetraacetic acid (ECTA, 0.1 mM; Sigma, E-0396) for 4 mm. 
The heart was then perfused with a physiological salt solution (Appendix) containing Ca 2 
(0.05 mM), collagenase (0.75 mg ml '; Worthington. LS004 196) and protease (0.075 mg 
ml '; Sigma, P-S 147). This solution was then re-circulated to give a total enzyme exposure 
of6 mm (see Figure 2.1.) 
24.1 Isolation of ventricular myocytes 
Following enzyme perfusion, the heart was cut down free from the perfusion apparatus and 
ventricles excised and cut into small pieces (I-S mm). The ventricular tissues were then 
shaken (300 osc/min) in S ml enzyme solution (Appendix) containing 1% bovine serum 
albumin (BSA; Sigma, A-4503) for 4 min at 37°C. The mixture was then filtered through 
gauze (300 jim aperture, Cadish precision meshes, Finchley, London) and suspended in a 
physiological salt solution (Appendix) containing 0.75 mM Ca 2 . The filtrate was then 
centrifuged (400 rpm, I mm), the supernatant was removed and the cell pellet was re-
suspended in physiological salt solution (Appendix) containing 0.75 mM Ca 2 . The process 
was repeated a total of four times. Myocytes from shakes 2 and 3 were accumulated and 
stored at 4°C prior to use. Cells were used during a period of 1-8 hr after the isolation. Rod 
cell viability was measured (viability of the ratio of living cells (rods) to dead cells 
(rounds)) with an improved Neubauer haemocytometer within 1 hr after completion of the 
cell isolation (see Figure 2.2), 
2.4.2 Isolation of sub-endocardial and sub-epicardial myocpte.s 
In a number of experiments sub-endocardial (endo) and sub-epicardial (epi) myocytes 
were isolated in preference to ventricular myocytes. Following enzyme perfusion, the heart 
was removed from the perfusion apparatus and the ventricle excised. The outer and inner 
layers of the left ventricle were dissected free and cut into small pieces. Endo and epi 
portions were then isolated (as total ventricular myocytes) separately to give two cohorts of 
cells (Rithalia ci al. 2001). 
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Figure 2.2. Close up of isolated heart (top), isolated ventricular myocyte (middle) and 
isolated ventricular myocyte attached to a patch pipette in whole cell mode (bottom). 
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25 Measurement of total cardiac calcium, copper, iron, magnesium and zinc 
Heart tissue was placed in 10 ml of Analar grade nitric acid (10 g tissue 100 mr' nitric 
acid; VWR, 45004) and left to digest overnight at room temperature. Appropriate dilutions 
were made with Milli-Q grade water prior to measurement of cations. Total cardiac Ca 2t 
Mg2t Fe2 ; Cu2 and Zn2 concentrations were measured by atomic absorption 
spectrophotometery (PYE Unlearn, Model SP9) using air/acetylene and nitrous 
oxide/acetylene flames, respectively. Calibration standards (Ca 2 , Mg2 , Fe2 , Cu2 and 
Zn 2) were obtained from VWR Laboratory Suppliers. Values for cation contents were 
expressed as mg (100mg of heart tissue'. 
2.6 Measurement of contraction in cardiac myocytes 
Cardiac (either epi, endo or total ventricular) myocytes were allowed to settle on the glass 
bottom of a chamber mounted on the stage of an inverted microscope (Nikon Diaphot-
TMD, Japan) with X40 (Nikon, Japan) objective lens. Myocytes were superfused (3-5 ml 
mm 1 ) with a normal Tyrode (NT) solution (Appendix) containing 1 mM Ca 2t using a 
power driven magnetic micro pump (Cole-Parmer instrument Co.Ltd, London) system, 
maintained at 35-37°C with a heating system coupled to a temperature controller (Medical 
systems corp., USA) and field stimulated (S88 stimulator, G rass-Te le factor, USA) via two 
platinum electrodes located on either side of the chamber. Contraction was measured with 
a video edge detection system (Crystal Biotech. VED-1 14) (Howarth & Levi, 1996). 
SIGNAL software (Cambridge Electronic Design, England) was used to acquire and 
analyse data (see Figure 2.3.). 
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26.1 Effects of insulin and STZ on contraction 
Ventricular myocytes isolated from diabetic and age-matched control hearts were 
incubated with either STZ (10 pM) or with insulin (I MM; Actrapid) for 2-3 hr at room 
temperature prior to experiments. Contraction was measured with a video edge detection 
system (Crystal Biotech. VED-! 14) (Howarth & Levi, 1996). SIGNAL software 
(Cambridge Electronic Design, England) was used to acquire and analyse data. 
2.6.2 Effect of halothane, glucose and perturbation of external calcium on contraction 
In separate experiments a rapid solution changer (Levi cial. 1996) was used to apply either 
2-Bromo-2-chloro-1,I,I-triuluoroethane (0.6 mM, halothane; Sigma, B4388. stock 99%) 
(Appendix) or different concentrations of either glucose (25 mM; VWR, 1011747) or Ca 2 
(0.25, I and 5 mM; VWR, 100703-H) to perfused ventricular myocytes. Contraction was 
measured with a video edge detection system (Crystal Biotech, VED-1 14) (Howarth & 
Levi, 1996). SIGNAL software (Cambridge Electronic Design, England) was used to 
acquire and analyse data. Osmolarity of the NT solution and NT (25mM) glucose was 
measured using a calibrated Burnett osmometer. 
2.7 Measurement of intracellular calcium transients in cardiac myocytes 
In order to measure the [Ca 2 ]1 transients, cardiac myocytes were firstly loaded with the 
fluorescent indicator fura-2-AM (Molecular probes, Leider, The Netherlands) using an 
established method (I-4owarth ci all 1999). Briefly, a volume of 6.25 itI of a 1.0mM stock 
solution of fura-2-AM (dissolved in dimethylsulphoxide, (DMSO; Sigma, D-5879)) was 
added to 2.5 ml of cells to give a final fura-2-AM concentration of 2.5 pM. Myocytes were 
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shaken gently for 10 min at room temperature. Following loading, the cells were 
centrifuged at 400 rpm for I mm, the supernatant was removed and cells were resuspended 
in NT (1 mM Ca 2 ) (Appendix). Cells were then incubated for at least 30 min at room 
temperature to ensure complete hydrolysis of the intracellular ester. 
[Ca24]1 transients were measured by alternately illuminating the loaded myocytes with 
light at 340 and 380 nm using a dichromatic mirror (Cairn Research Ltd., Faversham, 
Kent, UK) and an inverted microscope with X40 (fluo) oil objective lens. The resultant 
fluorescence emission at 510 nm was recorded by a photomultiplier tube (PMT; Cairn 
research Ltd., Faversham, Kent, UK). The ratio of emitted fluorescence at the two-
excitation wavelengths (340/380 ratio) was calculated to provide an index of [Ca 2 ']1 (see 
Figure 2.3.). A time course of Ca 2 
 analysis was measured by taking the time taken from 
stimulation to the peak of the Ca 24 . The decay of the Ca 2 transient was measured as either 
the time taken from the peak amplitude of Ca2* 
 transient to half its decay or the rate of 
decay measured by plotting a gradient of at least 8 points on the decay of the Ca 2 
transient. 
2. 7.1 Effect of halothane and calcium on cardiac calcium transients 
In separate experiments a rapid solution changer (Levi ci al. 1996) was used to apply either 
halothane (0.6 mM) or different concentrations of extracellular Ca 2 (0.25, I and 5 mM) 
throughout the experiments. 
2.8 	 Sin,ulta,,eoug measurement of contraction and calcium in cardiac myocytes 
In some experiments it was possible to measure contraction and Ca 2 transient 
simultaneously using a long pass illumination filter (1`8 10 .Cairn Research Ltd., 
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Faversham. Kent, UK) fitted in the path of the microscope light source, therefore 
transmitting infra-red light whilst block light of shorter wavelength. This enabled viewing 
of myocytes via a CCD camera, which is sensitive to infrared light. 
2.9 Effect of caffeine on fractional calcium release in cardiac myocytes 
Following a train of steady-state Ca 24 transients, stimulation was abbreviated for 10 sec 
and a rapid application of caffeine (10 mM; Sigma C-l778) was applied to myocytes (10 
sec) to assess fractional Ca2t release from the SR. Following the application of caffeine, 
cells were switched to a NT (I mM Ca 2 ') solution (Appendix) re-stimulated (I Hz) and 
allowed to recover prior limits. The decay of the caffeine induced Ca 24 transient was 
measured as either the time taken from the peak amplitude of caffeine-induced Ca 2 
transient to half its decay or the rate of decay measured by plotting a gradient of at least S 
points on the decay of the Ca 2 transient. 
2.10 Effects of nickel chloride on caffeine-induced calcium release 
In some experiments, following the recovery of myocytes from a caffeine-induced Ca 24 
release, stimulation was abbreviated for 10-20 sec while. Nickel chloride (NiCl 2 , 10 mM; 
Sigma, N-5756 ) was rapidly applied to cells before a 10 sec re-application of caffeine (10 
mM). Myocytes were then re-perfused with a NT (I mM Ca 2) solution (Appendix) and re-
stimulated (I Hz) to allow recovery to prior steady state. 
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2.11 Voltage dependence of contraction and calciu,n current in cardiac niyocytes 
Voltage dependence of contraction was measured in patch-clamped ventricular myocytes 
in whole cell mode. Patch pipettes (Harvard patch glass capillaries PGI-50T-10) were 
pulled (Narishege, Japan PP-83) and fire polished (Narishege. Japan MF-79 microfuge) to 
between 2 and 5 U. Patch pipettes were filled with a cesium based pipette solution 
(Appendix). Patch-clamp recordings were made in whole cell, voltage clamp mode using 
an EPC-7 patch amplifier and headstage (HEKA, Germany). The "pipette to bath"junction 
potential was corrected before negative pressure was applied to cells which were then 
subjected to a holding potential of-40 mV to inactivate the sodium current ('Na)  and 1-
type Ca2 current ('Car)  (Brown ciaL 1981). Test pulses (200 msec duration) were applied 
at potentials between —30 and + 60 mV in 10 mV increments. Membrane capacitance 
(compensated for differences in cell size using c-slow/c-fast with a slow range of 100 pF), 
series resistance (g-series compensation) (c15M0) and capacitance compensation (30-
40%) were corrected before recordings were taken. A train of four conditioning pulses 
were applied before each test pulse to standardise SR Ca 2 load (Howarth & Levi, 1998). 
'CaL was measured using WINWCP (version 3.2) electrophysiological software (John 
Dempster, Strathclyde University, Glasgow, UK) at the same time as measuring the 
voltage dependence of contraction using a video edge detection system. The time to peak 
of the 'Ca.L was measured from the start of the test pulse to the time at the peak of 
'CaL 
The amplitude of the 
'Ca.. was measured as the difference between 
'Cal. at peak and 'Ca,I, 
at the end of the depolarising pulse. 
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2.11.1 Effects of halothane on calcium current (lild i'oltage dependence of contraction 
In another series of experiments 'CaL and contraction was measured in ventricular 
myocytes prior and during incubation with 0.6 mM halothane. 
2.12 Data analysis and stat istics 
All data are expressed as mean ± S.E.M. of(n) preparations/cells. Statistical comparisons 
were made (SPSS software) using independent samples Student's t-test, paired t-test or 
ANOVA followed by Bonferroni post hoc analysis. P-values of less than 0.05 were 
considered significant, while P-values of less than 0.01 were considered very significant. 
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Chapter 3 
General characteristics of the 
streptozotocin-in duced diabetic rat 
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3.1 	 General characteristics of the streptozotocin-induced diabetic rat heart and 
ventricular myocytes at djffering treatment times 
3.1.1 Introduction 
A single dose of STZ (between 40 and 60 mg Kg) administered to young adult rats is 
sufficient to initiate a stable model of type I diabetes (Szkudelski 2001). STZ acts to 
disrupt and destroy pancreatic 3-cells, which leads to alterations in glucose and insulin 
(Szkudelski 2001). It has been reported that two hours, post injection of STZ, there is a fall 
in plasma insulin level leading to a rise in blood glucose, which is should be followed, 
around 6 hours later by a transient decrease in blood glucose and concurrent elevation in 
levels of circulating insulin. Finally, blood chemistry stabilises to a state of 
hyperglycaemia and hypoinsulinaemia (West el ciL 1996). Therefore, induction of diabetes 
results in a state of 3-cell necrosis that is manifested by a temporary return of 
responsiveness, which appears to be followed by a permanent disruption and/or destruction 
of the -celIs (West ci cii 1996). Following a short incubation of up to 3 days, STZ-
induced rats present symptoms, which include severe hyperglycaemia and polydipsia. 
Within the next two wceks, rats start to show symptoms of muscle wastage increased food 
consumption, decrease in muscle mass and after a number of weeks some rats appear to 
acquire a cataract like condition (some features associated with type-I diabetes) (Bracken 
et al. 2003). Data, which follow show the general characteristics associated with the 
induction of STZ-induced diabetes. These include glucose, insulin and plasma osmolarity 
and there differences according to the different treatment times (4 and 8-12 weeks, 4 and 
10 months) comparing age-matched with STZ-induced diabetic rat. 
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3.1.2 Methods 
See chapter 2 for details. 
3.1.3 Results 
The general characteristics of age-matched controls and diabetic rats and ventricular 
myocytes following 4 and 8-12 weeks, 4 and 10 months of treatment are shown in table 
3.l.a, b, c and d. All rats within each group were supplied or bred together and weighed the 
same weight (±15g) at the start of treatment. Figure 3.1. shows the typical weight gained 
over a period of 8 weeks of treatment. It can be seen that STZ-induced rats gained 
significantly (P<0.01) less body weight at each week (week 3-8) of treatment compared to 
age-matched control rats. Moreover, table 3.1. a, b. c and d shows that diabetic animals 
had reduced body weights and had smaller hearts in all treatment time periods (not 
significantly (P>0.05) different in 4 weeks of treatment), compared to age-matched 
controls. Whole blood glucose was significantly (Pc0.05) elevated in all treatment times 
compared to controls. Plasma osmolarity measured in 8-12 weeks and 10 month STZ-
treated rats was significantly (P<0.05) higher than in age-matched controls. Cell viability 
measured by the percentage (%) of viable myocytes was significantly decreased (P<0.01) 
in 4 week (43.3% Vs. 66.0 %) and 8-12 week (25.3% Vs. 49.4 %) STZ-treated hearts 
compared to controls. This trend was decreased in the 10 month treatment to 32.2% in 
control and 23.8% viability in diabetic cells, although no significant (P>0.05) difference 
was reported. Plasma insulin was significantly (P<0.05) decreased following 8-12 weeks 
and 4 months of treatment, but was unchanged after 10-month STZ treatment compared to 
age-matched controls. 
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Figure 3.1. Typical, time dependent effects of STZ-induced (n16) diabetes on mean body 
weight of Wistar rats compared to age-matched controls (n=16). Data shown are mean ± 
SEM. Statistical significance showing control Vs. STZ using independent samples t-test is 
represented by ttP<0.01. 
58 
Table 3.1.a General characteristics of control and STZ-treated rat heart and 
ventricular myocytes following 4 weeks of treatment. 
Control STZ-treated 
Body Wt. (g) 371.0 +/-5.72 (4) 267.5 +1-6.55 (4)* 
Heart Wt. (g) 1.2 +/- 0.01 	 (4) 1.2+1-0.04(4) 
Blood glucose (mgldl) 87.7 +1- 5.4 (4) 441.4 +1-51.3 (4)** 
Cell viability (% rod cells) 66.0 +1-5.7 (5) 43.3 +1-6.5 (4)* 
Table 3.I.b General characteristics of control and STZ-treated rat heart and 
ventricular myocytes following 8-12 weeks of treatment. 
Control STZ-treated 
Body Wt. (g) 381.4 +1-12.5 (5) 232.8 +1-7.2 (6)** 
Heart Wi. (g) 1.1 +1- 0.04 	 (5) 1.0 +1- 0.03 (6)** 
Blood glucose (mg/dl) 92.4 +1- 2.42 (5) 407.5 +/39.9(6)** 
Cell viability (% rod cells) 49.4+1-3.5 (5) 25.3+1-1.2 (6)** 
Plasma Osmolarity (osmol kg 	 ) 3083 +1- 3.6 (4) 330.0 +1- 3.5 (4)** 
Plasma Insulin (ng mr') 20.63 +1- 7.52 (7) 4.80 +1- 1.28 (4)* 
In table 3.l.a and 3.l.b, data are means ± S.E.M. Number in parenthesis indicates 
number of rats or ventricular myocytes. All data were obtained at the end of the 
treatment period. Control Vs. STZ compared using Student's independent samples I 
test. * P<0.05. **p<ØØJ 
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Table 3.1.c General characteristics of control and STZ-treated rat heart and ventricular 
myocytes following 4 months of treatment. 
Control 	 STZ-treated 
Body Wt. (g) 
	
420.3 +1-8.6 (6) 	 285. 5+7- 9.4 (6)** 
Heart Wt. (g) 	 1.0 +7- 0.03 (6) 	 0.9 +7- 0.03 (6)** 
Blood glucose (mg/dl) 	 120.0+1-3.8(6) 	 381.0 +1-1 8 . 7(6)** 
Plasma Insulin (ng mr') 	 11.86+1- 1.09(6) 	 7.25 +7- 0.87 (6)** 
Table 3.1.d General characteristics of control and STZ-treated rat heart and ventricular 
myocytes following 10 months of treatment. 
Control 
Body Wt. (g) 414.6 +7-21.2 (5) 
Heart Wt. (g) 13 +1- 0.02 (5) 
Blood glucose (mgldl) 81.2 +7- 3.1 (5) 
Cell viability (% rod cells) 32.2+/-4.8 (5) 
Plasma Osmolarity (osmol kg 	 ) 311.6±1.3 (5) 
Plasma Insulin (na mr') 10.67 +7- 336 (7) 
In table 3.1.c and 3.1.d, data are means ± S.E.M 
STZ-treated 
270.0 +/-12.6 (5)** 
1.0 +7- 0.02 (5)** 
415.0 +1-52.8 (5)** 
23.8+/-6.2 (5) 
332.0 ± 7.3(5)* 
8.300 +7- 2.92 (8) 
Number in parenthesis indicates 
number of rats or ventricular myocytes. All data were obtained at the end of the 
treatment period. Control Vs. STZ compared using Student's independent samples (test. 
* p<0.05, p<0.01. 
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3.1.4 Discussion 
STZ-induced diabetic rats displayed typical characteristic features, which have been 
previously reported in STZ-treated animals (Yu c/at I 994b; Howarth ciat 2001; Howarth 
c/at 2002). The results of this study have shown that there is a reduction in body and heart 
weights in the STZ-induced diabetic rats after 8-12 weeks and 4 and 10 months following 
treatment compared to healthy age-matched controls. Other workers have also reported 
decreases in heart and body weights at I and 2 weeks. (Gordon & Guppy, 1999) 4-6 weeks, 
(Tamada c/at 1998) 8-12 weeks (Howarth c/at 2001) and 7 months (Satoh c/al. 2001) 
following STZ-treatment. An increase in blood glucose and a reduction in serum insulin 
levels are indicative of a diabetic state (Choi ci at 2002). It has been reported that blood 
glucose levels are 3-times as high in STZ-induced diabetic rats compared to control (Choi 
ciat 2002), which, is in agreement with this study, that has shown elevated blood glucose 
in all treatment times. Insulin levels were significantly depressed at 8-12 weeks and 4 
months in agreement with other reports who have also shown hypoinsulinaemia in this 
model of diabetes (Shimoni c/at 1998; F-Iowarth c/at 2001; Choi c/at 2002). Although 
there was a reduction of insulin at 10 months of treatment, it was not significant. This 
could be a result of some adaptive mechanism associated with the regenerative action of 
the pancreas, similar to that which has been reported in the STZ-induced type 2 model of 
diabetes (Schaffer, 1991). The viability of cardiac myocytes, when comparing good (rod) 
cells with dead (round) cells has shown to be significantly decreased at 4 and 8-12 weeks, 
in agreement with Yu c/at (1994) who also reported a reduction in rod cell viability. Any 
changes in cell viability may be a consequence of the fragility of the diabetic state. Hence, 
the cell becomes more disrupted and sensitive to any enzymic and mechanical disruption 
within the isolation process itself. Some reports (Okayama c/ at 1994; Tamada c/ at 1998) 
have suggested that though viability was altered from experiment to experiment, no 
significant changes were seen between control and diabetic cells, which mirrors what we 
have seen in 10 months of STZ-treatment. The normalised insulin levels that were noted in 
10 month treated rats may act to protect the heart in some way, and in doing so decrease its 
vulnerability in the isolation process and hence increase cell viability to levels similar to 
that of control myocytes. 
3.1.5 Conclusion 
The STZ-induced diabetic rat undergoes severe changes in body mass, muscle tone and 
eating/drinking habits that are underpinned by the destruction of the insulin producing 
pancreatic n-cells. Decreased circulating insulin gives rise to massively high amounts of 
unutilised blood glucose, which is transported around the body and some of which is 
excreted in the urine. The combination of changes in blood chemistry synergistically leads 
to altered physiological properties in the body's infrastructure and most importantly, 
notable changes in the heart functioning. 
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3.2 	 Distribution of specific diva/ent cation wit/tin the streptozotocin-induced diabetic 
- rat heart 
3.2.1 In! roduction 
It is known that an imbalance in specific cations can cause disruption to the contractile 
mechanisms of the heart (Elamin & Tuvemo, 1990). It is therefore reasonable to presume 
that any alteration in specific cations within diabetes may contribute to the alteration in 
contraction that has been reported in the diabetic heart. 
3.2.1.1 Magnesium 
Mg 21  is the fourth most abundant total cation in the human body and the second most 
abundant intracellular cation (Sasaki ci at 1999). Mg 2 regulates over 300 enzyme systems 
directly or indirectly (via Mg-ATP transport) (Neinesanszky & Gerencser, 1992; Altura & 
Altura, 1996). Mg2 is predominantly found in three forms; bound to protein complexes, 
complexed to anion ligands and in its free ionised form. The concentration of intracellular 
magnesium ([Mg 2 1 ) in whole blood is on average around 0.5-0.7 mmol f' and 
approximately 65-72% of total Mg 2 being free or biologically-active Mg 2+ (Altura & 
Altura, 1996). In the heart, Mg 24 plays a key role in myocardial functioning (Topalov ci al. 
2000). Perturbation of Mg 2 can effect contractility in cardiac cells by; inducing 
alterations in membrane and intracellular organelle binding, changes in Ca 24 transport, 
including actions of Ca 2 release from the SR (Altura & Altura, 1996), changes in resting 
membrane and Ap's and disrupting E-C coupling cascades (Altura & Altura, 1985). 
Therefore, any changes in Mg 2 can act to, or contribute to the aetiology of cardiac and 
vascular disorders (Altura & Altura, 1985; Chakraborti ci al. 2002). Moreover, a dietary 
deficiency of Mg 24 can result in a loss of intracellular K ([K 4J) and concurrent gain in 
cellular Na 4 and Ca 2 (Chakraborti et at 2002), which can induce electrolyte imbalance 
leading to changes in membrane integrity (Chakraborti et at 2002). Mg24 deficiency has 
been implicated in many cardiovascular-related disorders including; IFID, CITIF, sudden 
cardiac death, hypertension, eclampsia, athroscelrosis, cardiac arrhythmias and ventricular 
complications in diabetes mellitus (Altura et at 1981; Chakraborti ci at 2002). 
Measurement of total cardiac Mg 2 
 will indicate whether this cation contributes to the 
changes in contractility that has been reported in the diabetic heart. 
3.2.1.2 Calcium 
Ca 2+ 	 i 2+ 
 i represents perhaps the most important on within the heart. Ca 	 s crucial to the 
normal process of heart chamber, contraction and relaxation (Bers, 2002b). Consequently, 
perturbation of Ca2 
 within the heart can contribute to alterations in contractile kinetics. In 
the normal heart Ca 2 
 levels are controlled bya number of transport systems including L-
type Ca2 channel (through 'CaL activity), PMCA channels, NaVCa 24-exchanger and 
SERCA pump on the SR. Therefore, in a normal heart beat, Ca 24 homeostasis is controlled 
by any or all of these system. Any alteration or modulation to any of these Ca 24 transport 
systems may contribute to both contractile dysfunction and arrhythmic pathological 
conditions (Pogwizd ci at 2001). This study will evaluate the total cardiac Ca 24 in STZ-
treated rats after 2 and 4 months treatment. A change in total Ca 24 may be indicative of an 
underlying diseased state. 
3.2.1.3 Copper 
A deficiency in dietary Cu 24 
 can lead to cardiac disorder such as hypertrophy, fibrosis, 
derangement of myofibrils, and impaired contractile and electrophysiological function 
(Wold ci ci. 2001). It has been suggested that such disorders are directly related to the 
decrease in a specific a Cu2tdependent enzyme reaction (Saari, 2000). 
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3.21.4 Iron 
Fe2 is an important trace element in the body. However, changes in Fe 2 metabolism can 
lead to clinical problems. Haemochromatosis is an autosomal-recessive hereditary disorder, 
which is characterised by excessive increases in amounts of absorbed dietary Fe 2 . This 
induces a state of Fe 2 overload, which, over a period of time manifests increased deposits 
of Fe 2 in tissue. This can result in skin discoloration, arthropathy, hepatic cirrhosis, heart 
failure, diabetes mellitus and impotence (Phatak & Cappuccio, 1994; Vonherbay c/ at 
1996). It is not clear in the literature if diabetes mellitus is a true cause or consequence of 
increases in heart Fe 2 content. We have therefore determined total cardiac Fe 2 content in 
STZ-induced diabetic rats at 2 and 4 month treatment. 
3.2.1.5 Zinc 
Zn2 acts as an important co-factor that is involved in numerous important physiological 
processes (Pras et al. 1983). Although little data are available to suggest any direct 
evidence of diabetes-induced cardiomyopathy with cardiac Zn 2 content, it has been 
observed that Zn 2 
 metabolism may be important in the induction of athroscelrosis 
(Paolisso et at 1999). 
3.2.2 Method 
See chapter 2 for details. 
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3.2.3 Results 
Figure 3.2.a shows the time dependent changes in total concentration of total Cu 24 at 2 and 
4 months following diabetes induction with STZ. The results show that diabetic heart 
tissue has a significantly (Pc 0.01) elevated level of Cu 2 in 2 (0.0056 ± 0.0002 mg (100 
mg tissue') and 4 months (0.0049 ± 0.0008 mg (100 mg tissue)') compared to control 
heart tissue at 2 (0.0021 ± 0.0001 mg 100 mg (100 mg tissue') and 4 months (0.0030 ± 
0.00009 mg (100 mg tissue)- , respectively. Figure 3.2.b shows a significantly (P< 0.01) 
elevated level, of Fe 2 at 2 months (0.011 mg ± 0.0005(100mg tissue') and 4 months 
(0.013 ± 0.0004 mg (100 mg tissue') in STZ-treated heart tissue compared to age-
matched controls at the same treatment time. Figure 3.2.c shows a significant (Pc 0.01) 
increase in total Ca 2 in 2 month STZ treated hearts (0.0 15 ± 0.001 mg (100 mg tissue') 
compared to age-matched controls ( 0.0076 ± 0.0007 mg (100 mg tissue'). Similarly, 
significant increases were obtained in 4 month STZ treated hearts (0.016 ± 0.001 mg (100 
mg tissue') compared to age-matched controls (0.0089 ± 0.0008 mg (100 mg tissue'). 
Figure 3.3.a shows that Mg24 
 levels remain similar at both 2 months and 4 months. At 2 
months treatment, the total Mg 2 content in control and STZ-treated heart tissues was 
0.010 ± 0.0003 mg (100 mg tissue' and 0.010 ± 0.0005 mg (100 mg tissue)', respectively 
but in 4 month control heart tissues it was 0.012 ± 0.0002 mg (100 mg tissue 1 compared 
to 0.011 ± 0.0002 mg (100mg tissue' in the diabetic tissue. Figure 3.3.b shows total Zn 2 
content and reports a significant (Pc 0.05) rise in Zn 2 content from 0.0 15 ± 0.0007 mg 
(100 mg tissue' in control to 0.019 ± 0.001 mg (100 rng tissue' in the 2-month treated 
diabetic heart. At 4 months no significance was seen between Zn 2 content in control 
(0.019 ± 0.0007 mg (100 mg tissue') and diabetic (0.020 ± 0.001 mg (100 mg tissue') 
tissue. 
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Figure 3.2. Time dependent effects of STZ-induced diabetes on (a) Cu 2 content, (b) 
Fe2 content and (c) Ca 2 
 content in rat heart. Data shown are mean ± SEM. Numbers 
within bars represent number of experiments. Statistical significance showing control 
vs. STZ using independent samples t-test is represented by tPc0.05 and **<ØJj 
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3.24 Discussion 
3.24.1 Magnesium content 
Total cardiac Mg2 
 levels within this study were not significantly different between control 
and STZ-treated rats after 2 and 4 months of treatment. The data in this study would 
suggest that cardiac Mg 2 
 is not affected in STZ-induced diabetes. l-lypomagnesaemia, 
characterised by reduced serum Mg 2 
 has been reported in a number of human patients 
with diabetes (Saito, 1996; Sasaki et at 2000; Nagase. 1996) as well as experimental-
induced models of diabetes (Altura & Altura. 1995). Reports in experimental-induced 
diabetes have shown a significant decrease in cardiac Mg2t 
 levels from STZ (Bhimji ci at 
1986) and alloxan (Bhimji ci at 1985) treated animals compared to controls. However, in 
another study it has been shown (Ewis & AbdelRahman. 1995) that there were no 
significant changes in heart Mg2t 
 in STZ-induced and controls. These later findings are in 
agreement with the results obtained in the present study. 
[Mg2t]1 and extracellular Mg 2 
 ([Mg2t]0) concentrations play an important role on a variety 
of cellular events and are also an important co-factor for ATP in many cellular enzyme 
systems (Howarth & Levi, 1998). [Mg 2+ 
 ]i has been reported to be important in the 
regulation of the Na/Ca 2texchanger. Therefore, any changes in Mg 2 levels may 
contribute to changes in the Na t/Ca2t
-exchanger and consequently cause a reduced or 
increased concentration of Ca 2 
 within the cell (Howarth & Levi, 1998). It has also been 
reported that Mg2* 
 deficiency can induce thç rise of [Ca2t]. changes in cell membrane 
permeability and transport processes in cardiac cells. It has been suggested that the reason 
for the opposing effect of Ca2t 
 and Mg2t 
 is that there is competitive for the same site of 
action proteins such as troponin-C (Chakraborti c/ at 2002). 
Me 
3.24.2 Calcium content 
The total Ca2* 
 concentration following 2 and 4 months of diabetes was significantly 
elevated after STZ treatment. Total tissue Ca 2 transient has also been reported in type 2 
diabetic hearts were a 35 % increase in Ca 2 was reported (Schaffer et at 1989). Moreover, 
ventricular muscle stiffness (Schaffer ci al. 1989), as measured by changes in left 
ventricular pressure, is more rigid in diabetic hearts. Brady & Farnsworth (1986) have 
suggested that the increase in muscle stiffness may be caused by an elevation in basal 
[Ca 2 '] i and partial activation of myosin. Because this experiment has reported an elevated 
Ca2 content in both treatment times, it is tempting to suggest that Ca 2 influx through leak 
channels and reductions in the Na 47Ca2 -exchanger working to shunt Ca 2 out of the cell is 
compromised in the diabetic heart and may contribute to the results reported in our 
experiments. 
3.2.4.3 Copper content 
Total cardiac Cu 2 
 concentrations in this study were significantly elevated versus age-
matched control after 2 and 4 months STZ-treatment. It has been shown that a decrease in 
Cu2 within the diet and subsequent Cu 2 ' deficiency leads to Il-ID (Klevay, 2000). As a 
result of decreased Cu 2 
 intake, hearts would also appear to have lesser amounts of Cu 2 . 
We, however, have shown an increase in Cu2F 
 in the diabetic heart. Moreover, It has been 
shown (Ford, 2000) that elevated levels serum Cu 2 concentrations may be associated with 
higher incidence of cardiovascular disease. There is little data available to directly link 
'-3- 
experimental diabetes with elevated levels of cardiac Cif however, it has been shown 
that Cu 2 
 is elevated in the liver of diabetic animals (Halimans & Lithner. 1980). From the 
literature and results presented in this study it seems unclear if there is a direct link with 
alterations in Cu 23- 
 and an increase in diabetic-induced cardiomyopathy. 
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3.2.4.4 Iron content 
This experiment would suggest that Fe 2 metabolism is changed in the diabetic state but if 
or how these changes affect the diabetic state or contractility within the cardiac cell need 
further investigation. Previous reports suggest that an alteration in Fe 24 levels is not 
implicated in the pathophysiology of diabetes (Tuvemo & Gebre-Medhin, 1983). 
3.24.5 Zinc content 
The direct implication of changes in Zn2* 
 metabolism and diabetes is unclear. The present 
study has demonstrated that total Zn 2 content in the heart is shown to be significantly 
elevated in 2 months, while, Zn 24 content was similar in 4 months following STZ-induced 
diabetes compared to control. 
Though little data are available to compare cardiac Zn 24 content, it has reported that serum 
Zn 21  levels are unchanged in diabetic patients (Golik cIa.t. 1993; Pras ci at 1983), wheras 
plasma Zn 24 concentrations have been reported to be significantly reduced in diabetic 
patients (Williams ci at 1995; Chen ci at 1995). l-Iowever, other reports that showed no 
significant differences in plasma Zn 24 from with patients who had type 2 diabetes. It is 
widely accepted that during diabetes significantly high amounts of Zn 24 are lost through 
the urine (Tuvemo & Gebre-Medhin. 1983; Chen ciat 1995; Golik ci at 1993). 
3.2.5 Conclusion 
In conclusion, this study has demonstrated that STZ-induced diabetes elicits a state of 
hyperglycaemia and hypoinsulinaemia in the rat and also alters specific metabolic cations 
within the heart compared to healthy age-matched controls. It is proposed that these 
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metabolic disturbances may alter the mechanical functioning, that has been reported in the 
diabetic hearts. This study has reported differences in cation content in the diabetic heart. It 
is also clear that any perturbation of cardiac cation content can influence the cells ability to 
function "normally". It is suggested that specific alterations in cation imbalance may lead 
to changes in cardiac heart function that has been reported in the STZ-induced diabetic rat 
heart. 
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Chapter 4 
Effects of streptozotocin-induced 
diabetes on contraction in rat 
cardiomyocytes 
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4.1 	 Time dependent effects of streptozotocin-induced diabetes on the kinetics of 
contraction in ventricular myocytes icolated front rat heart 
4.1.1 Introduction 
Derangement of cardiac functionality is a common feature associated with experimentally-
induced diabetes. Contractile responses have been measured in many different animal 
models of diabetes with varying methods, different treatment times and consequently 
different results. In the STZ-induced diabetic rat model of diabetes alone there are many 
contradictory results, but most are consistent to agree that there is underlying contractile 
dysfunction or alteration in the diabetic model, to serve as a valid tool to investigate 
diabetic-induced cardiomyopathy. Contractile defects have been reported in a wide range 
of STZ-induced diabetic tissues. These include the intact animal (Al Shafei ci at 2002), 
isolated perfused heart (Choi et at 2002), papillary muscle preparations (Hattori et at 
2000; Marshall, 2000) and single isolated cardiac myocytes (Tamada ci at 1998; Yu ci at 
I 994a; Hattori c/at 2000; Choi c/at 2002). By using single isolated cardiac myocytes it is 
possible to investigate and study contraction consistently without possible problems e.g. 
extrinsic factors such as, changes in circulating hormones and metabolites in the in vivo 
preparation and changes in perfusion rates associated with intact hearts (Choi ci at 2002). 
Isolated cardiac myocytes from STZ-induced diabetic hearts have been reported as having 
depressed shortening (44% decrease compared with controls), reduced maximum rates of 
shortening and re-lengthening (58 and 56% decrease, respectively) and prolonged 
'pk 
shortening (47% increase)(Yu el at 1994a). Decreased shortening and a reduction in rates 
of contraction and relaxation have also been demonstrated by (Okayama ci at 1994) while, 
Ren & Davidoff(1997) showed that diabetes markedly prolonged both the contraction and 
relaxation phases of isolated ventricular myocytes. However, other groups (Tamada et at 
1998; Ishitani ci at 2001) have reported that STZ-induced diabetic hearts have no 
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significant differences in cell shortening. A significant increase in the amplitude of 
contraction has also been reported in conjunction with an increase in the fpk of contraction 
(Howarth et at 2000; Howarth et at 2001). Importantly, it has been reported that STZ-
induced diabetic rats treated with daily doses of insulin (to normalise blood glucose) have 
attained normal contractile function, thus indicating that defects associated with STZ-
induced diabetes are specific to the disease state itself(Yu eat 1994a). 
This study investigated contractile characteristics associated with short (4 and 8-12 weeks), 
mid (5 months) and long-term (10 months) STZ-induced diabetes. 
4.1.2 Met/tad 
See Chapter 2 for details. 
4.1.3 Results 
The amplitude of contraction (compared as a % of resting cell length-RCL) was increased 
in all STZ-treated myocytes following each period of treatment (see Figure 4.1.a). 
Following 4 weeks treatment, the amplitude of contraction was significantly (P<0.01) 
increased (9.72 ± 1.04% Vs. 5.01 ± 0.53 %) compared to control, respectively. After 8-12 
weeks of treatment the amplitude of contraction was markedly, reduced in diabetic 
myocytes compared to 4 weeks of treatment, but was still significantly (P<0.01) increased 
in diabetic myocytes (6.8 ± 0.5 %) compared to that of age-matched controls (4.1 ± 1.04 
%) over the 8-12 weeks of diabetes. Following 5 months of treatment, the amplitude of 
contraction was similar to that after 8-12 weeks, with a significant (P<0.01) increase in the 
diabetic cells versus control (6.4 ± 0.6 % Vs. 3.2 ± 0.4 %), and although reduced slightly 
after 10 months treatment. This was also significantly (P<0.01) increased in diabetic 
75 
myocytes compared to age-matched controls, respectively (4.7 ± 0.3 % Vs. 3.3 ± 0.3 %). 
The 1p4 of contraction was significantly (Pc0.01) increased in diabetic myocytes (207.2 ± 
8.0 ms) following 4 weeks of treatment compared to control (167.2 ± 8.1 ms) (see Figure 
4.1.b). This trend, although blunted was seen after 8-12 weeks of treatment as well, in 
diabetic and control myocytes (164.1 ± 7.4 ms Vs. 132.3 ± 5.9 ms), respectively. Following 
5 months of treatment, 'p4 of contraction was significantly (P<0.05) longer in diabetic 
myocytes (134.7 ± 6.6 ms) compared to control myocytes (110.3 ± 6.2 ins). Following 10 
months of treatment no significance (P>0.05) difference was observed between diabetic 
and control myocytes. 
The t relax was not significantly (P>0.05) altered after 4 weeks (95.8 ± 7.1 nis Vs. 
106.4±8.7 ms) , 8-12 weeks (60.6 ± 4.1 ms Vs. 70.6 ± 5.6 ms) and 5 months (53.8 ± 1.6 
ms Vs. 55.4 ± 4.3 ms) following induction of diabetes in myocytes from diabetic and 
control hearts, respectively (see Figure 4.1.c). However, following 10 months of treatment 
the t relax was significantly (P<0.01) shorter in diabetic (55.32 ± 2.7 ins) myocytes 
compared to control (85.1 ± 7.1 ms). 
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Figure 4.1. Time-dependent effects of STZ-induced diabetes after 4, 8-12 weeks and 5 and 
10 months of treatment on amplitude of contraction (a) and 'pk  of contraction (b) in 
electrically stimulated myocytes (I Hz) perfused at 35-37 °C with a NT solution containing 
1 mM Ca2 . Age-matched control myocytes are also shown in the figure for comparison. 
Data are mean ± SEM. Numbers of cells are shown in bars. * Pc 0.05, Pc 0.01 
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(c) 
4.1.4 Discussion 
Contraction was measured as a % of RCL in isolated ventricular myocytes and was 
increased in each treatment time of STZ-induced diabetes. This is in agreement with 
previous studies (Howarth ci at 2001), which demonstrated an increase in contraction 
following 2 and 10 months of treatment. The increase in contraction in diabetic myocytes 
was more marked at shorter time periods compared to control. Increase in contraction is an 
indication of either altered or an increased amount of [Ca 2+ 
 ]i or changes in myofilament 
sensitivity to Ca 2 during systole in the contractile phase. Other reports suggest that 
contractility is decreased in the STZ-induced diabetic cardiac myocyte following 5 months 
(Okayama ci at 1994), 6 weeks (Yu c/at 1994a) and 8-weeks (Noda ciat 1993; Choi ci 
at 2002) of STZ-treatment, while other reports suggest that there is no change in 
contraction following 4-6 weeks and 8 weeks of STZ-treatment (Tamada ci at 1998), 
respectively (Ishitani ci at 2001). Inconsistencies in data may well reflect differences in 
dose, time treatment, experimental protocol, and strains of animals used. What does seem 
evident is that in most reports there is either an alteration or/and disturbance in contraction 
in the diabetic heart. The ipk of contraction was significantly increased in STZ-induced 
diabetes following 4, 8-12 weeks and 5 months but not following 10-months of STZ-
treatment. An increase in the tpk has also been reported in STZ-induced diabetic myocytes 
following 4-6 days (Ren & Davidoff, 1997), 6 weeks (Choi ci at 2002) and 8 weeks of 
treatment (Yu ci at 1994a; Ren & Davidoff, 1997; Howarth c/at 2000). However, in this 
study, it has also been observed that following 10-months of STZ-treatment there was no 
significant different in the 
'pk contraction between diabetic and age-matched control 
myocytes. The t retax was not significantly altered by STZ-induced diabetes following 4, 8-
12 weeks and 5 months of treatment, but was significantly (P<0.01) decreased after 10 
months of treatment. This is in agreement with a previous study (Howarth ci at 2000), 
which, reported an increase in the relaxation phase following 10 months of STZ- 
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treatment. Either way little/or no other data are currently available to compare the effect of 
such chronic treatment times on the type I model of diabetes. However, longer relaxation 
phases have been reported in shorter periods (8 weeks) of treatment (Choi et al. 2002). 
The changes in the amplitude and the time-course of contraction would suggest that over 
time the STZ-induced diabetic rat heart undergoes a compensatory adaptive process to try 
and secure the integrity of the heart. It could be that a change in blood glucose and insulin 
instigates a slow change in gene regulation that is characterized by changes in contractile 
performance. This is an interesting hypothesis needing future investigation. Furthermore, 
because contraction is ultimately dependent on Ca 24 homeostasis, it is likely that a change 
in [Ca2 ]1 regulation and or a change in myofilament sensitivity may explain differences 
seen in the STZ-induced diabetic model of diabetes versus age-matched control. 
80 
4.2 	 Post rest potenhiation in STZ-induced diabetic heart 
4.2.1 Introduction 
E-C coupling is the process underlying contraction in the heart (Bers, 2002a). In the 
steady-state, contraction is followed by a short period of rest, which is characterised, by a 
refractory period (restitution). The predominant factor responsible for this is the recovery 
of the RyR from an inactivated or adapted state (Hers. 2002a). In the non-steady-state, 
cardiac cells are left in a quiescent phase for artificially long periods. Thus, the subsequent 
amplitude of contraction is greatly increased versus prior steady state in the rat (Yu & 
Mcneil!, 1991; Bassani & Hers, 1994; Bers ci al. 1993; Maier ci al. 2000) and human 
(Pieske ci' aL 1999) but is diminished in the rabbit heart (Bassani & Hers, 1994; Bers et al. 
1993; Maier c/al. 2000). It is thought that an increase in amount of fractional Ca 2 release 
coupled together with the total available SR Ca 2 is likely to contribute to the increase in 
the amplitude of contraction. Increased availability ofCa 2 
 in the SR leads to an increase in 
contracture and therefore, longer periods of resting phases produce larger contractions. 
This phenomenon is referred to as the post rest potentiation (PRP), and is an indication of 
the degree of stored Ca 2 
 available for contraction (Yu & Mcneil!, 1991). This study 
investigated the contractile characteristics of PRP in the STZ-induced diabetic rat heart 
compared to age-matched control. Changes in the STZ-induced diabetic heart may have 
implications regarding SR loading and Ca 2 release from SR stores. 
4.2.2 Method 
See Chapter 2 section for details. 
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4.23 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Myocytes were stimulated at 1 Hz until 
steady state contraction was attained. Stimulation was then abbreviated for periods 
between 2 and 60 s (Figure 4.2.). PRP was assessed by comparing the amplitude of the first 
PRP contraction with pre steady-state. 
'pk of contraction and / reiax were also measured 
after each of the rest periods in control and diabetic myocytes. Figure 4.3. shows (a) PRP 
shortening. (b) tpk and (c) ty. relax of myocytes. The amplitude of PRP shortening increased 
progressively in diabetic and control myocytes as rest periods increased between 2 and 60 
s. PRP increases of shortening were not as marked in myocytes from diabetic cells 
compared to control although at no stage were changes significant (Figure 4.3.a). The tpk 
of PRP contraction was consistently longer in myocytes from the diabetic heart compared 
to control. Following 20 sec rest interval, tpk contraction was 173 ± 4 ms and 143 ± 8 ms 
in diabetic and control myocytes, respectively (Figure 4.3.b). relax of PRP contraction 
after 2 months was not significantly different (P> 0.05) in myocytes from diabetic 
compared to control following all rest periods (Figure 4.3.c). 
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Figure 4.2. Determination of mechanical restitution in isolated rat ventricular 
myocytes. The trace shows the cell contraction (jim) from an isolated myocyte. 
After steady-state contractions (1Hz) extra systoles were interpolated after the test 
intervals above. Traces are typical of 15-25 such myocytes taken from 6-8 diabetic 
and 6-8 control hearts. 
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4.2.4 Discuss ion 
PRP of shortening was observed in control and diabetic myocytes, however, shortening 
was less marked in diabetic cells versus contrOl. Yu & Mcneill (1991) have also reported a 
change in PRP contractions in diabetic papillary muscles from Wistar and spontaneously 
hypertensive rats. In contrast, the same workers have reported no change in PRP 
contraction in the left atria suggesting that there may be species as well as regional 
differences in PRP contraction in the heart. The fpk  of contraction has been shown to be 
significantly longer in diabetic myocytes following PRP at all periods. The 'pk in diabetic 
myocytes markedly increased over the increase in time period, however, in the control 
myocytes there was no increase in the 
'pk . A change in the /;,k may indicate a slower 
sustained release of Ca 2 from the SR. 
The two factors contributing to changes in the amplitude of PRP contraction in the rat heart 
are the amount of SR Ca 2 and the degree of fractional release (Bers, 2002a). During rest 
periods Ca 2 leaks out of the SR into the cytosolic compartment where it competes with 
other Ca2 to be either transported back into the SR or out of the cell via the Na/Ca 2 -
exchanger and the PMCA (Bassani & Bers, 1995). Because the SR pump predominates 
over the other mechanisms in the rat heart (Bassani cial. 1994), the great majority of Ca 
leek is pumped back into the SR which ultimately contributes to unaltered Ca 2 flux that 
has been reported in the rat heart (Bassani & Bers, 1994). Another reason for the 
predominance of the SERCA pump over the Na/Ca 2 -exchanger is the high resting [Na]1 
that has been reported in the heart (Shattock & Bers. 1989). This would contribute to an 
influx of Ca2 during quiescent phases. The marked decrease in the PRP amplitude of 
shortening (although not significant) and the significant changes in the 'pk  of PRP 
contraction in myocytes from the STZ-induced diabetic heart may be associated with one 
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or more changes in [Na] , SERCA pump activity and fractional Ca 2 release as well as a 
alteration in myofilament sensitivity. 
E;r 
4.3 	 Effects of chronic streptozotocin-induced diabetes on contraction-frequency 
relationships in ventricular myocytes isolated from rat heart 
4.3.1 Introduction 
Force-frequency relationships have been studied for many years in many different animals 
models. In rabbit (Maier etal. 2000), guinea-pig (Kurihara & Sakai, 1985) and non-failing 
human hearts (Pieske et aL 1999), it has been shown that following an increase in the 
frequency of stimulation, contractile response, as well as SR Ca 2 ' content increase up to a 
point where a maximum frequency response is reached (Bers, 2002a), known as the 
positive staircase response (Bers, 2002a). However, in some rat cardiac myocytes, 
following an increase in frequency stimulus, it has been reported that there is a decrease in 
contractile force (Frampton ci at 1991), although SR Ca 2 does not appear to alter 
significantly (Maier et at 2000). This response has therefore been named a negative 
staircase effect. One of the main reasons why some rat cardiac tissue should behave in this 
way is due to the loading of the SR with Ca 2t In the rat heart, SR Ca 2 is relatively high 
(Maier ciat 2000) which, is due to a predominately strong SERCA pump that mops up the 
greatest percentage of Ca 2 leek from the SR. This is mirrored by a high level of [NC]1 
(Shattock & Bers, 1989) that drives Na+ 2+ 2+ ICa -exchanger to reduce Ca efflux from the 
cell. The aim of this part of the study was to investigate the effect of STZ-induced diabetes 
on the force frequency relationship in isolated ventricular myocytes. A significant change 
in force frequency within the diabetic heart may be associated with a derangement of SR 
Ca2 release sequestration or alterations in myofilament sensitivity. 
4.3.2 Method 
See Chap/cr 2 section for details. 
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4.3.3 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 4.4. shows the (a) amplitude of 
contraction (b) tpk of contraction and (c) 1 Y. re/ax in myocytes of STZ-treated and age-
matched control rat hearts. The amplitude of contraction was significantly (P<0.0I) larger 
in myocytes from diabetic heart during electrical stimulation at I liz and 2 Hz frequency, 
compared to age-matched control, but was not significantly altered following 0.2 Hz 
stimulation (Figure 4.4.a). The t;,k of contraction was significantly (Pc0.01) longer in 
diabetic myocytes at all (0.2, I and 2 Hz) frequency ranges compared to age-matched 
control (figure 4.4b). Although 're/ay was markedly decreased in diabetic myocytes at all 
frequencies (0.2, I and 2 Hz) it was found not to be to a significant level (Figure 4.4.c). 
There was a significant difference in the amplitude on contraction in control myocytes 
when frequency stimulation was switched from 0.2 to I Hz, but was not significantly 
altered between I and 2 Hz. In STZ-induced diabetic myocytes there was no significant 
differences between all (0.2 Hz to I Hz and 1Hz to 2 Hz) frequencies of stimulation. 
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4.3.4 Discussion 
The results from this study have shown that the amplitude of contraction is significantly 
greater in STZ-induced diabetic myocytes compared to age-matched control at frequencies 
of I and 2 Hz. However the amplitude of contraction was not significantly different 
between control and STZ-induced myocytes following 0.2 Hz stimulation. This would 
indicate that at lower frequencies (0.2 Hz) differences in contractile function are 
normalized between the control and diabetic heart. In contrast, it has been reported that the 
amplitude of contraction is significantly reduced in the STZ-induced diabetic myocytes 
compared to control. Differences in reports may reflect changes in experimental 
procedures. Within this study, myocytes obtained from 8-12 weeks STZ-induced diabetic 
hearts did not exhibit either a significantly positive or negative contraction-frequency 
response. However, in age-matched control myocytes there was significantly negative 
contraction-frequency response in control myocytes, when stimulation was changed 
between 0.2 and I Hz. Frampton et al. (1991), showed that around 40% of isolated 
ventricular myocytes responded in a negative manner when stimulation was switched from 
0.2 Hz - 1Hz. It has been shown that the reduction in contraction that is seen in a negative 
force-frequency response is coupled with a modest change in the size of the Ca 2+ transient 
(Frampton ci at 2+ i 1991). In the rat heart, SRCa s relatively high (Maier ci aL 2000) 
which, is due to a predominately strong SERCA pump that mops up the greatest percentage 
of Ca2 leek from the SR. This is mirrored by a high level of [Na] (Shattock & Bers, 
1989) that drives Na/Ca 2texchanger to reduce Ca 2 efflux from the cell. Therefore, when 
stimulation is increased in cells that respond in a negative manner the SR load is similar, 
which usually results in a similar release ofSR Ca 2t In the diabetic heart, a small change 
in [Na']1 or/and SR loading may underpin differences between control and diabetic 
myocytes. The tpA of contraction was significantly longer in the diabetic cells. This 
observation agrees with other workers who have reported significant increase in 'pk at 
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frequencies ranging from 0.1-5 Hz (Ren & Davidoff, 1997) in myocytes following 8 weeks 
STZ-treatment. This may reflect binding properties associated with myofilament binding. 
In this study t1, relax reduced (not to a significant level) in both control and diabetic cells as 
the stimulation frequencies increased from 0.2 Hz to 1 Hz and from 1Hz to 2 Hz. This is in 
agreement with Frampton et al. (1991), who also reported quicker rates of relaxation as 
stimulation of frequency was increased. There were however, no significant differences 
between control and diabetic myocytes, suggesting that the processes that underpin 
relaxation are not affected by the increase in stimulation frequency between control and 
diabetic cardiomyocytes. 
4.4 	 Effect of insulin, streptozotocin and perturbation of external calcium 
concentration on the contractility of streptozotocin-induced diabetic ventricular 
myocytes. 
4.4.1 Introduction 
Insulin is a key regulator of the metabolic pathways associated with glucose transport 
homeostasis, and the synthesis and storage of many carbohydrates, lipids and proteins 
(Aulbach et at 1999; Ren ci at 1999). Insulin also participates in gene expression, ionic 
flux as well as cell proliferation and apoptosis (Myers, Jr. & White, 1996). In mammalian 
heart preparations insulin has been reported to exert positive inotropic effect including, 
increases in left ventricular function, SV, CO, isometric tension, contractility as well as 
faster relaxation times (Lucchesi ci at 1972; Reikeras & Gunnes, 1986; Lee & Downing, 
1976; Riekereta/. 1975). 
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This study investigated the effects of exogenous applications of insulin on the contractility 
of isolated ventricular myocytes from STZ-induced diabetic and age-matched control rat 
hearts. 
4.4.2 Method 
See Chap/er 2 for details. 
4.4.3 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 4.5. shows a typical fast time base 
recording of a twitch contraction in (a) control, (b) STZ and (c) STZ + insulin treated 
ventricular myocytes stimulated at I Hz. Table 4.1. shows amplitude of the contraction, 
the 1pk of contraction and the t. relax The t1,A myocyte shortening was significantly 
(P<O.Ol) longer in STZ myocytes and was further prolonged in STZ myocytes that had 
been incubated with insulin compared with controls (Figure 4.6. b). Insulin had no 
significant effect on t relax (Figure 4.6. c). The amplitude of cell shortening was 
significantly larger in STZ myocytes and was not significantly affected by exogenous 
insulin treatment (Figure 4.6. a). 
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400 msec 
Figure 4.5. Typical fast time base records of shortening in (a) control (NT), 
(b) STZ (NT) and (c) STZ myocytes incubated and superfused in insulin (I 
pM) Cells were stimulated at I Hz and perfused at 35-37 °C. Traces are typical 
of 9-I5 myocytes from 4-6 hearts 
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Figure 4.6. The effects of exogenous insulin application (10 jiM) on (a) the amplitude of 
contraction, (b) Ipk of contraction and (c) tre/ax  in ventricular myocytes isolated from age-
matched control and STZ-induced diabetic hearts. Data shown are mean ± SEM. Numbers 
within bars represent number of cells. Statistical significance showing control Vs. STZ 
using independent samples t-test is represented by tP <0.05 and * *P <0.01 
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In separate experiments we established that 2-3 h incubation of STZ-induced and control 
myocytes with exogenous STZ (I x M) had no significant effects on tpk, IreIaT or the 
amplitude of myocyte shortening. 
5pm 
400 msec 
Figure 4.7. Typical fast time base records of shortening in (a) STZ (NT) and (b) STZ 
incubated in exogenous STZ (10 pM) Cells were stimulated at I Hz and perfused at 35-37 
T. Traces are typical of 9-15 myocytes taken from 4-6 hearts 
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In a further separate study the effect of perturbation of [Ca2t]0  on the contractility was 
assessed in control and STZ-induced ventricular myocytes following 8-12 weeks of 
treatment. Table 4.1 shows the effect of perturbation of [Cal0  on the amplitude of 
shortening, /pk of contraction and 're/ax 
CNT STZ CNT STZ CNT CNT 
0.25 mM 0.25 mM 1 mM 1 mM 2.5 mM 2.5 mM 
ICa2i0 ICa 2 ] 0 ICa2i0 ICa2 I 0 ICa 2 '10 jCa 2 J 0 
Shortening 2.32+1-0.3 3.1+1-0.2 5.2+1-0.3 6.9+/-0.4 10.2+1-0.7 11.9+/-0.6 
(%RCL) (IS) (lS)* (15) (15)* (15) (15)* 
tpk 100.2+/- 109.6+!- 108.2+/- 117.1+/- 115.5+1- 125.5+/- 
contraction 2.3(15) 2.4(15)* 3.1 (IS) 2.5(15)* 3.8(15) 2.1 (15)* 
t½re/ax 47.5+1-3.0 48.0+/2.8 47.1+13.6 43.9+1-1.4 51.9+1-3.4 48.9+7-2.3 
(IS) (IS) (IS) (IS) (IS) (15) 
Table 4.1. The effects of changes in [Ca 2 ] 0 (0.25, I, and 2.5 mM) on the amplitude on 
contraction, 'jik  of contraction and t1z re/ax in ventricular myocytes obtained from age-
matched control and STZ-induced diabetic rat hearts. Data are means ± S.E.M. Number in 
parenthesis indicates number of cells. Control Vs. STZ was compared using Student's 
independent samples I test and, ANOVA and Bonferroni analysis. * P<0.05. 
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4.4.4 Discussion 
Many studies have reported that daily administration of insulin to diabetic rats reverses the 
symptoms of the disease and normalises the contractile dysfunction that has been reported 
in the diabetic hearts (Lee ci at 1992;   Litwin ci al. 1990; Tamada ci at 1998; Yu ci at 
1994b; Yu ci at 1994a). Therefore, this series of experiments was undertaken to see if the 
effect of exogenous application of insulin could reverse the contractile dysfunction seen in 
the STZ-induced hearts at the level of the myocyte. It has been reported that insulin has 
positive inotropic effect on various cardiac preparations. It has also been shown that 
myocardial contractility and the amplitude of cardiomyocyte shortening is enhanced in 
diabetes (Ren ci at 1999). This study, has found that insulin, does not significantly affect 
contractility in diabetic and control myocytes. One possibility for this may lie in the 
treatment time of the diabetic rats. In this study, diabetes treatment with STZ-treatment 
was performed for 5 months, while, other reports have utilised myocytes from 5-7 day 
treated animals (Ren ci at 1999). The myocytes used in this particular experiment were 
isolated and used fresh within 5 hours of isolation, where other reports have used cells that 
have been in a primary culture for up to 24 hrs (Ren c/at 1999). It has been shown that in 
some cases the contractility of the cardiac myocytes have been irreversibly altered when 
stored in primary culture (Ellingsen c/at 1993). Any such change could affect the results 
acquired from these cells. 
When administered to young adult rats. STZ (60 mg/kg) destroys the insulin producing 0-
cells of the pancreas and produces symptoms, which include severe insulinopaenia, 
hyperglycaeniia, glycosuria, polydipsia and muscle wasting (features associated with type 
I diabetes) (Bracken c/at 2003). In this series of experiments, incubating control and STZ 
myocytes had no significant effect on the contractility of the cell. 
it has been shown in table 4.1 that a increasing the [Ca 2 ] 0 from 0.25 mM to I mM to 2.5 
mM significantly increases the amplitude of contraction and 1pk of contraction in control 
and STZ-induced ventricular myocytes. However it can be seen that the amplitude of 
shortening and the !pk of contraction in STZ-induced myocytes is significantly greater 
compared to that of control myocytes in all the [Ca , ranges. Table 4.1 also shows that 
increasing the [Ca 2 ] 0 
 ranges has no significant effect on the tl. re/as in ventricular 
myocytes obtained from age-matched control and STZ-induced diabetic rat hearts 
following 8-12 weeks treatment. This study would therefore suggest that changes in the 
amplitude of contraction and the /pk of contraction that have been reported in this study 
may not be directly associated with the concentration of [Ca2t]0 and is more likely to be 
associated with changes in mechanism associated with Ca 2 mobilisation. 
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4.5 	 Effects of varying glucose concentrations on the kinetics of contraction in 
ventricular myocytes Lcolated from streptozotocin-induced diabetic rat bean 
4.5.1 Introduction 
Following the administration of STZ to young adult rats, after a number of days, whole 
blood glucose levels rise to a hyperglycemic status, between 20-30 mmol 1* Chronic 
hyperglycemia is a potent initiator of diabetic micro vascular complications including 
retinopathy, neuropath and nephropathy (Sheetz & King, 2002). Hyperglycemia has been 
linked to the aetiology of a variety of cardiovascular complications, which are associated 
with the diabetic state (Gerstein 1997; Pacher ci' at. 2002). This is hardly surprising as 
glucose metabolism and its metabolites contribute to a vast number of cellular pathways. It 
is however, unclear whether the effects of hyperglycemia are in response to direct toxic 
effects of glucose including change in oxidants, hyperosmolarity or glycosylation products 
or if hyperglycemia is directly related to alteration in sustained signaling pathway changes 
(Sheetz & King, 2002). Increases in glucose concentration in the STZ-induced diabetic 
heart have been shown to potentiate certain cellular pathways including diacylglycerol 
(DAG) (Inoguchi ci al. 1992) and PKC (Kang ci al. 1999) production. Changes in 
contractility have also been reported in the isolated STZ-induced diabetic heart, where the 
perfusion of high glucose concentration caused a significant prolongation of the Q-T 
(measure of cardiac repolarisation) interval (DtAmico clot. 2001). 
This series of experiments investigated the effect of high glucose concentration on the 
contractility in the control and STZ-induced diabetic isolated ventricular myocytes. Altered 
glucose metabolism may underlie contractile dysfunction that has been reported in the 
diabetic heart. 
ME 
4.5.2 Method 
See Chapter 2 for details. 
4.5.3 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 4.8. shows real time traces of 
contraction in (a) control and (b) STZ-induced diabetic ventricular myocytes following 8-
12 weeks treatment before and after the incubation with glucose (25 mM). The RCL of 
control and STZ-induced diabetic myocytes was not significantly (P>0.05) changed. The 
amplitude of cell shortening (% of RCL) was significantly (P<0.05) increased in the 
diabetic heart compared to the control (7.30 ± 0.59 % Vs. 4.83 ± 1.12 %), respectively 
with NT solution (Appendix). Following the addition of 25 mM glucose the amplitude of 
cell shortening in the control myocyte significantly (P<0.01) increased (8.88 ± 1.38 %). In 
contrast, elevated extracellular glucose (25 mM) had no effect on the amplitude of 
shortening in STZ-induced myocytes (Figure 4.9.c). The rate and 11g of contraction 
measured was significantly (N0.05) increased in control myocytes following the addition 
of the high (25 mM) glucose concentration (Figure 4.9.a). The rate of relaxation was 
significantly (P<0.05) increased in control myocytes following the addition of high glucose 
concentration (25 mM). Changes in glucose concentration did not significantly (P>0.05) 
affect the time course of contraction or relaxation in STZ-induced diabetic myocytes. 
Osmolarity of the NT solution was 303 +1- 5 mosmol kg' with the addition of 25 mM 
glucose was 323 +1- 5 mosmol kg'. 
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Figure 4.8. Representative real time traces of contraction in (a) control and 
(b) STZ-induced diabetic ventricular myocytes (Bottom) pre and post 
incubation with glucose (25 mM) at 35-37°C. Traces are typical of 8 
(control) and 22 (STZ) some myocytes from at least 4 different rat heads. 
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Figure 4.9. Effects of normal and high glucose concentration on (a) the rate 
of contraction and (b) the rate of relaxation in isolated ventricular myocytes 
from STZ-induced and age-matched controls at 35-37 °C. Data are mean ± 
SEM. Numbers of cells are shown in bars. ** PC0.01 * P<0.05. 
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Figure 4.9. Effects of normal and high glucose concentration on (c) amplitude of 
shortening (% RCL) in isolated ventricular myocytes from STZ-induced and age-matched 
control hearts at 35-37°C. Data are mean ± SEM. Numbers of cells are shown in bars. '' 
P<0.0l* P<0.05. 
Control STZ Control STZ 
10mM Glucose 10mM Glucose 25 mM Glucose 25 mM Glucose 
tpk 
167.6 +/-4.0 (8) 199.6+1-7.6 (22)* 212.1 +1-17.3 (8)a 208.8 +/-9.4 (22)a 
contraction 
ti'1 
103.8 +1-8.5 (8) 88.8 +1-6.3 (22) 95.9 +/-10.3 (8) 87.6 +1-5.3 (22) 
relaxation 
Table 4.2. The effects of normal (10 mM) and high (25 mM) glucose on the amplitude on 
contraction, /pk of contraction and i,-e/ax in ventricular myocytes obtained 8-12 weeks 
STZ-induced and age-matched control rat hearts. Data are means ± S.E.M. Number in 
parenthesis indicates number of cells. Control Vs. STZ was compared using Student's 
independent samples nest. * P<0.05. 
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4.5.4 Disc ussion 
Within this study, it has been previously shown that in control conditions, the amplitude of 
contraction is significantly increased in the STZ-induced diabetic heart compared to age-
matched control. However, following the incubation of control and STZ-induced myocytes 
in a NT solution containing high glucose (25 mM) (similar to that found in the whole blood 
chemistry of diabetic rats), the amplitude of shortening and the rate and 
'pk of contraction 
was significantly increased in control myocytes, but appeared to be unchanged in STZ-
induced diabetic myocytes. In fact following the application of high glucose, control cells 
exhibited similar amplitude of contraction and 'pk of contraction to that observed in the 
STZ-induced diabetic. The rate of relaxation following the addition of high glucose 
concentration was significantly increased in control myocytes but had no significant effect 
in STZ-induced myocytes. This is in agreement with Davidoff and Ren (1997) who 
reported markedly longer relaxation in control myocytes culture incubated for 4 days in 
high glucose and low insulin medium. A decrease in Ca 2 transient decay was also reported 
in control myocytes subjected to high glucose and low insulin for 4 days in culture 
(Davidoff& Ren, 1997). An increase in glucose concentration is mirrored by an increase in 
Osmolarity. An increase in the osmolarity is associated with cell shrinkage and has 
reported to lead to a decrease in contraction and an increase in the time of contraction in 
control and STZ-induced diabetic myocytes (Howarth et of 2001). It is therefore unlikely 
that the effects of high glucose concentration can be attributable, purely to a change in 
osmotic effects. One possible explanation for the results seen in this study is that the STZ-
induced diabetic myocytes may be more acclimatized or adapted to high levels of glucose, 
due to the high level of circulating glucose in the blood and therefore they become more 
sensitized. An increase in the amplitude of contraction is likely to be due to an increase in 
SR load and subsequent releasable Ca 2 from the SR. In a agreement with this, it has been 
shown that the cytosolic [Ca 2 ]1 in control cardiac myocytes significant increased following 
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the incubation of cardiac myocytes in high glucose (30 mM) (Smogorzewski ci at (1998). 
Moreover, the increased response of high gludose was abolished when myocytes were 
superfused with either low extracellular Ca 2+ 
 or Ca 24- channel blockers, suggesting that 
increases in [Ca 24-]1 are likely to be associated with a changes in Ca 24- influx through 
Na/Ca 24--exchanger or L-type Ca 2 channels. It has also been reported that control cells 
incubated with a high glucose concentration had significantly longer Ap duration's 
compared to control (Ren el at (1997). Prolonged Ap's have been reported in STZ-induced 
diabetic myocytes following 8 weeks treatment (Magyar ci at 1992), probably through a 
decrease in I (Jourdan & Feuvray, 1993). In the STZ-induced diabetics head it has been 
shown that the expression and activity of PKC is significantly increased compared to 
control (Liu ci at 1999; Kang ci at 1999; Guo ci at 2003). Moreover it is known that 
PKC inhibits the JK (Ren ci at 1997). This suggests that in the STZ-induced diabetic 
heart, hyperglycaemia may increase PKC activity, which may lead to increased Ap 
duration. However, it is suggested that in control myocytes a transient application high 
glucose is unlikely to alter expressional changes of PKC and it is therefore more likely that 
increases in [Ca 24-]1 may increase SR load and subsequent SR Ca 2t release, which may 
lead to an increase in contraction. 
4.6 	 Regional djfferences in the streptozotocin —induced diabetic heart 
4.6.1 Introduction 
The heart is made up of a variety of specific myocardial cells according to their position 
and electrical properties. The largest portion of the heart, the left ventricle largely governs 
the contractile propulsion of blood around the body in a heartbeat (Katz, 1977). The 
plateau phase of an Ap in ventricular cells of the heart is far longer than in other areas 
including the atria. The reason for this is two fold, firstly it prevents the re-excitation of 
another Ap, by prolonging the depolarised membrane and therefore inactivating the Na 
and Ca2t 
 channels on the cell membrane, thus not allowing any tetanic twitch effects that 
can be seen in skeletal muscle. Secondly, it allows the heart to relax, so that the ventricles 
can be filled with blood for the next heart beat (Bers. 2002a). The three main regions 
within the ventricle are the epi, endo and myocardium. The regions differ according to 
their differential ion channel expression, which in turn leads to a differential in electrical 
properties that is seen in a typical action potential. The plateau phase of the ventricular Ap 
is shortest in the epi cells, increased in the endo cells and longest still in the myocardial 
cells. 
The aim of this study was to ascertain if STZ-induced diabetes effects regional specificity 
within the ventricle from the endo and epi portions of the ventricle. Any changes in 
contractile characteristics seen in specific regions of the heart may underpin alterations of 
contractile characteristics that have been reported in the diabetic heart. 
4.6.2 Method 
See Chap/er 2 for details. 
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4.6.3 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 4.10 shows (a) cell shortening, (b) 
tpk of contraction and (c) t re/ax  relaxation in endo and epi cell taken from STZ-induced 
diabetic and age-matched control hearts following 8-12 weeks treatment. Cell shortening 
as a % of RCL was not significant (P>0.05) altered between in endo and epi cardial cells in 
control (5.94 ± 0.42 % Vs. 6.46 ± 0.59 %), respectively and STZ-induced (6.59 ± 0.5 % 
Vs. 6.22 ± 0.35 %) diabetic hearts and comparing endo and epi cells with diabetic 
counterparts (Figure 4.6.a). 
The tpk of contraction was significantly (Pc0.05) longer in endo compared to epi cells in 
age-matched control heart, respectively (103.5 ± 3.1 ms Vs. 94.1 ± 2.76 ms). Moreover, 
endo (137 ± 432 ms Vs. 103.5 ± 3.1 ms) and epi (139.6 ± 5.2 ms Vs. 94.1 ± 2.76 ms) 
myocytes from STZ-induced hearts were significantly (F> 0.01) longer than age-matched 
control, respectively, however, there was no significant (P>0.05) difference between i rk of 
endo and epi cells in STZ-induced hearts (Figure 4.6.b). 
The frreiax was significantly (F> 0.05) increased in endo compared with epi cells in control 
(48.1 ± 2.54 ms Vs. 40.7 ± 1.51 ms) and STZ-induced cells (52.3 ± 2.66 ms Vs. 45.1 ± 
1.80 ms) respectively, however, there was no significant (P>0.05) difference in the t re/ca 
between control and STZ-induced epi and endo cells (Figure 4.6.c). 
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Figure 4.10. Regional specific changes in contractile characteristics of control 
and STZ-induced diabetic following 8-12 weeks treatment on shortening (a) and 
time to peak of contraction (b) in isolated endo and epi myocytes at 35-37 °C 
perfused with a NT solution containing I mM Ca 2 . Cells from age-matched 
control myocytes are also shown for comparison. Data are mean ± SEM. 
Numbers of cells are shown in bars. Cells were obtained from 10-12 hearts. * 
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4.10.c. Regional specific changes in contractile characteristics of control 
and STZ-induced diabetic from peak to half relaxation in isolated endo and 
epi myocytes at 35-37 °C perfused with a NT solution containing I mM 
Ca2 . Control myocytes are shown are also shown in figure 4.6.c for 
comparison. Data are mean ± SENt Numbers of cells are shown in bars. 
Cells were obtained from 10-12 hearts. * P<0.05. 
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4.6.4 Discussion 
Cell shortening as a % of RCL was not significantly altered between epi and endo 
myocytes in control and diabetic hearts. This is agreement with other workers who found 
no difference in the shortening of control and diabetic hearts (Tamada etal. 1998; Ishitani 
el at 2001). Moreover, it has also been reported that there were no significant changes in 
peak amplitude between endo and epi myocytes (Bryant etal. 1997). Results presented in 
this chapter have shown that there is an increase in shortening in STZ-induced myocytes. 
Hence, it is apparent that both epi and endo cells are not affected by diabetes. The tpk of 
contraction was significantly longer in endo cells from control heart, but not in the diabetic 
heart. However, STZ-induced diabetes significantly increased the tpk  in both endo and epi 
cells compared to control. This observation suggests that the rate at which Ca 2 is released 
from the RyR is longer than in normal endo cells. Moreover, the Ap plateau is longer in the 
endo cells, so therefore it may be suggested that increased Ap plateau contributes to a 
slower sustained release trigger for Ca 2 from the SR. The increase in 'pk  in the diabetic 
heart is in agreement with other workers (Choi ci at 2002; Yu c/at 1994a) who have also 
reported similar findings. This suggests that the transport mechanisms that contribute to the 
speed of contraction are affected in diabetes. Alteration in /pk of contraction may be 
associated with either a change in SR Ca 2 release or a change in triggered Ca 2 induced 
SR Ca 2 release. The re/ar was increased in endo compared to epi cells in control and 
diabetic heart but this was not altered between groups. This may well be associated with a 
longer Ap that has been reported in the endo heart cells. Moreover, it can be seen from the 
present results that diabetes has no significant effect on the 'r9/ar  which, is in agreement 
with other workers (Howarth c/ at 2000). 
Overall regional differences in the age-matched control and diabetic hearts may contribute 
to changes in the speed of contraction and relaxation. Moreover, this study has shown that 
STZ-induced diabetes abolishes the speed of contraction in the head, and this in turn may 
be associated with contractile abnormalities that have been reported in the diabetic head 
(Choi el al. 2002) 
4.7 Conclusion 
Contraction as a percentage of RCL length was significantly increased in diabetic 
myocytes. This may be due to altered sensitivity of Ca 2 to myosin activation or an 
increase in the available Ca 2+ 
 during the Ca transient within systole. Although a slower 
Ca 2 transient in acute type I STZ-induced cardiomyocytes has been reported (Ren & 
Davidoff, 1997), other workers have observed little or no significant differences in the 
characteristics of the Ca 2 transient (Tamada c/aL 1998). The amount of Ca 2 released by 
the SR is thought to be graded and dependent upon the amount of trigger Ca 2 entering the 
cardiac cell via the single L-type channel and possibly through the NaH7Ca2exchanger 
operating in reverse mode (Levi ci aL 1993b). Defects in the mechanisms which are 
involved in Ca2 transport including sarcolemmal PMCA, L-type Ca 2 channels, NaH7Ca2+ 
exchanger or SR Ca2 uptake or release mechanisms, may have significant effects on 
contractile function of heart muscle. The tpk  of contraction was longer in diabetic cells 
with STZ treatment. A reduction in jCa,I,  and/or SR Ca 2 release may underlie the increase 
Of tpk of contraction. However, it has been reported that the 'Ca,L  is not effected after STZ-
treatment (Schneider & Sperelakis, 1975; Tamada ci aL 1998). The yre/ax  was not altered 
significantly within the STZ-induced myocytes. Any alterations in the removal of Ca 2 by 
the Na/Ca2texchanger or by increased uptake of Ca 2 through the Ca 2tATPase pump 
back into the SR would alter [Ca2 ] within diastole. 
112 
Chapter 5 
Effrcts of streptozotocin-in duced 
diabetes on calcium homeostasis in 
rat cardiomyo cytes 
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5.1 	 Genera/introduction 
The homeostatic control of [Ca 2+ 11 is crucial in the management of contraction and 
relaxation in the heart. Ca 2 homeostasis is regulated by mechanisms associated with Ca 2 
transport into and out of the cell and its intracellular compartments (Bers, 2002). If this 
equilibrium is unaltered the heart is capable of normal contraction and relaxation. 
However, if any of the mechanisms are impinged, a state of imbalance can arise, which can 
ultimately lead to an alteration in the contractile kinetics of the cell. In order to measure 
the specific mechanisms involved in Ca 2 homeostasis it is necessary to measure the 
amounts of [Ca 2 ]1 at any given point in the contracti on/rel axat ion process. In recent years 
many indicators (including fura and indo) have been manufactured that enable the worker 
to ascertain the relative amounts on [Ca2t]1 
Following depolarisation of the cardiac cell, the L4ype Ca 2 channels open, leading to a 
small influx of Ca2 into the cell. Ca 2 influx contributes to the increased probability of 
RyR opening, which leads to SR Ca 2 release and a Ca2E  transient (Fabiato, 1983). The 
release of SR Ca2t 
 is graded and dependent upon triggered stimulation from the Ca2t 
 influx 
(Fabiato 1983). When the SR releases Ca2t 
 there is a transient rise of[Ca 2 ]1 from resting 
levels of around 60-100 nmol E' to 600-1000 nmol (Cannell c/aL 1987b). An elevation 
in [Ca 2+  ]i following SR Ca 2 release increases the probability of myofilament sensitive 
sites to alter functional properties, which results in the induction of contraction (Bers, 
2002a). A decrease in Ca2* 
 in the repolarisation phase induces the decrease in [Ca 24 ]1 and 
+ the dissociation of Ca 2 away from the myofilaments. The same amount of Ca entering 
the cell during L- type channel opening and SR Ca 2 release must either be taken out of the 
cell or pumped back into the SR leading to relaxation. Any changes in these mechanisms 
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may contribute to derangement in the E-C coupling process and this in turn can lead to a 
diseased state 
The effects of type I diabetes on the levels of diastolic [Ca2t]1  are still unclear. It has been 
reported that diastolic [Ca 2 ]1 is either reduced or unchanged. Significant reductions 
(approx. 52%) in diastolic levels of [Ca 2t]1 in type I diabetic heart cells have been reported 
(Lagadic-Gossmann el at 1996; Hayashi & Noda. 1997; Noda ciot 1992). However, in 
another report Yu ci at (1995), reported no significant changes in diastolic [Ca 2t] 
between, type I diabetic and control cardiomyocytes. The effects of diabetes on systolic 
[Ca2 ii in ventricular myocytes obtained from type I diabetic hearts are not well 
understood. It has been reported that the peak systolic Ca2t 
 transient was reduced in type I 
STZ-induced rat cardiomyocytes by 43 % compared to control (Lagadic-Gossmann ci at 
1996), while other reports have observed little or no significant differences in the 
characteristics of the Ca 2 transient obtained diabetic hearts (Tamada dat 1998). Many of 
these discrepancies may be due to several factors including; varied nature of the 
experimental protocols and in particular, treatment time of the STZ-induction, the type of 
fluorescence indicator employed in the study and the temperature at which experiments 
were carried out. 
This study was designed mainly to investigate Ca 2 ' homeostasis in the STZ-induced 
diabetic and age-matched control ventricular cardiomyocytes. 
115 
5.2 	 Effect of perturbation of extraceilular calcium on calcium transients in the 
streptozotocin induced ventricular myocytes in the diabetic heart 
£2.1 Introduction 
The amount of Ca 2 entering the cell, during cell depolarisation acts as a trigger for SR 
Ca2 release (Fabiato, 1983). A model for CICR was initially described by Fabiato et al., 
(1983), showing how free Ca2*  can trigger SR Ca 2 release from skinned cardiac myocytes 
(Fabiato, 1983). In the presence of high free extracellular Ca 2 ([Ca 2 ] 0) the trigger for SR 
Ca2t is diminished or inhibited due to the specific binding attributes of Ca 2 on RyR 
(Fabiato 1985). The RyR has two binding sites, a fast low affinity site and a slow high 
affinity site, If Ca 2 binds to the fast sites the channel is activated and allows SR Ca 2 
release, however, if the high affinity site is occupied then the channel becomes deactivated 
and reduces Ca 2 release (Fabiato 1985). Therefore, altering extracellular Ca 2 below or 
above the physiological standard may change the binding and release parameters of Ca 2 
from the SR. It may then be possible to study the affects this has on the control and 
diabetic heart. 
The aim of this section of the study was to investigate the effects of [Ca 2 ] 0 on Ca 2 
handling in the diabetic heart. To pin point any dysfunction, the amplitude (peak ratio 
minus resting ratio), tpk  and t decay of Ca 2 transient were recorded and analysed. 
5.2.2 Method 
See chapter 2 for details. 
In 
5.23 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 5.1. shows typical Ca 2 transients 
recorded in control and STZ-induced ventricular myocytes, perfused with (a), 0.25 mM 
[Ca24] 0, (b), I mM [Ca24] 0 and (c) 5 mM [Ca2 '] 0 . Ventricular myocytes isolated from 8-12 
week STZ-induced diabetic hearts and age-matched controls were superfused with a NT 
solution containing 1 mM [Ca 2 '] 0 . Subsequent Ca 24 transients were recorded during the 
application of electrical stimulation at I }-lz. In some cells a rapid solution switcher was 
used to change [Ca 2 '] 0 (0.25, I, and 5 mM) throughout the experiment. Figure 5.2. shows 
(a) the amplitude of the Ca 2 ' transient (ratio units), (b) the ',,k  of the Ca 2 transient, and (c) 
the decay of Ca 2 transient in age-matched control and STZ-induced myocytes with 
differing [Ca 2 '] 0 . Basal resting Ca 2 (measure by fluorescence ratio units) was significantly 
(N0.01) increased in STZ-induced diabetic myocytes following 8 weeks of treatment 
compared to control (0.599 ± 0.009 ratio units, n=23 Vs. 0.521 ± 0.012 ratio units) 
respectively. The amplitude of Ca 2 release from the SR, induced by electrical stimulation 
was not significantly (P>0.05) different between control and STZ-induced myocytes in the 
presence of different concentrations of [Ca 24] 0 . There was however, a significant (N0.05, 
ANOVA and Bonferroni) difference between the amplitude of Ca 2 release seen in the 
STZ-tnduced myocytes superfused with 0.25 2+ 2+ mM Ca and I mM Ca . The 'pk of Ca 
2+ 
transient was not significantly (P>0.05) altered between control and diabetic myocytes in 
each group, nor was it significantly (P>0.05) different between groups of cells (ANOVA). 
The decay of the Ca2 transient was significantly longer in STZ myocytes perfused with 
0.25 mM [Ca2 '] 0 (P<0.01), I [Ca2 ']0 (P<0.05) and 5 mM [Ca 2 ']0(P < 005). However, 
there were no significant (P>0.05) differences in control and STZ-induced diabetic groups 
(ANOVA-Bonferroni). 
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(a) (b) (c) 
0.25mM 1.0mM 5MmM 
Ca2 Ca2 Ca2 
0.05 
ratio units 
300 msec 	 300 msec 	 300 msec 
Figure 5.1. The effects of perturbation of extracellular calcium concentration 
(a) 0.25 mM, (b) 1 mM, and (c) 5 mM on electrically stimulated (1 Hz) Ca 2+ 
 
transients in ventricular myocytes isolated from age-matched control and STZ-
induced diabetic rat hearts at 35-37 T. Traces are typical of 10-20 such 
myocytes obtained from 6-8 hearts. 
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Figure 5.2. The effects of changes in [Ca 2 ] 0 (0.25, I. and 5 mM) on, (a) amplitude of the 
Ca2 transient (ratio units) and (b) 'pk  of Ca2 transient in ventricular myocytes isolated 
from age-matched control and STZ-induced diabetic rat hearts. Data are means ± S.E.M. 
Number in bars indicates number of cells. Control Vs. STZ was compared using Student's 
independent samples / test and, ANOVA and Bonferroni analysis. * P<0.05. 
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Figure 5.2. The effects of changes in [Ca 2 ] 0 
 (0.25, 1. and 5 mM) on, (C) i decay of Ca 2 
transient in ventricular myocytes isolated from age-matched control and STZ-induced 
diabetic rat hearts. Data are means ± S.E.M. Number in bars indicates number of cells. 
Control 1Cs STZ was compared using Student's independent samples (test and, ANOVA 
and Bonferroni analysis. * P<0.05, ttP<0.01. 
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5.24 Discussion 
It has been shown within this report, that contractility is deranged in the experimentally 
induced diabetic heart. It is envisaged that an alteration in Ca 2 handling within the 
cardiomyocyte is responsible for this change in contractility. The effects of diabetes on 
systolic [Ca 2+  ] i in ventricular myocytes obtained from type I diabetic hearts are still 
somewhat unclear and contradictory. The amplitude of Ca 2 release and the 'pk  of the Ca2* 
transient in electrically stimulated (I Hz) ventricular myocytes were not significantly 
altered at varying concentrations of [Ca 2 ] 0 in 8-12 week STZ-induced diabetic ventricular 
myocytes. This is in agreement with Tamada ci at (1998), who observed little or no 
significant differences in the characteristics of the Ca 2 transient from diabetic hearts 
compared to control. However, this study has shown that an increase in [Ca 2 ]. from a low 
(0.25 mM) up to normal (I mM), significantly increased the amplitude of Ca 2 transient in 
STZ-induced diabetic myocytes. This observation suggests that an elevation in external 
Ca 2 from 0.25 mM to I mM in the diabetic myocyte may contribute to a greater amount of 
trigger Ca 2 , which, may ultimately lead to a greater fractional release ofCa 2 from the SR 
compared to control. The diabetic heart, therefore, may be more sensitive to changes in 
extracellular Ca2F 
 compared to the control heart. It is worth noting that the amplitude of the 
Ca2 ' transient in the presence of 5mM [Ca 2 ] 0 was similar to that observed when perfusing 
with I mM [Ca 2 ] o . It is likely, in this case, that the high (5 mM) [Ca 2 ] 0 may have 
saturated the internal system, as it would be expected that a 5 fold increase (compared to I 
mM [Ca2 ] 0) in [Ca 24] 0 would have significantly increased increase the amplitude of the 
Ca2 transient. Moreover, the amplitude of contraction was significantly increased in both 
diabetic and control myocytes when perfusing with 2.5 mM [Ca 2 ] 0 when compared to the 
amplitude of contraction in myocytes perfused with I mM [Ca24]0 (Table 4.1.). This study 
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it has also demonstrated that the basal level of Ca 2 is increased in the diabetic heart. 
Increased levels of basal Ca 2 would increase available Ca 2 for contraction. Resting Ca 2 
is governed mainly by the Na 47Ca2 -exchanger. If this transport mechanism were corrupt, 
or if [Na11 was high, it would benefit Ca 2 influx and may lead to an increase in basal 
Ca2 . The decay of the Ca 2 transient measured from the idecay is longer in diabetic cells 
superfused with Ca 2 (0.25, I and 5 mM) compared to control cells. This is in agreement 
with other workers who have also shown a slower decay of Ca .f- transient in type I STZ-
induced ventricular myocytes (Lagadic-Gossmann ci at 1996; Kotsanas dat 2000; Choi 
ci at 2002; Ren & Davidoff. 1997; Ha etal. 1999). A slower decay in Ca 2 transient is 
likely to be caused by a discrepancy in the homeostatic control mechanisms within the cell. 
It appears likely that either, the SERCA pump situated on the SR membrane (or one of it 
components) and/or the Na/Ca 2 -exchanger on the sarcolemmal membrane is disrupted in 
the diseased state. This would result in a reduced amount of Ca 2 being taken up by the SR 
and out of the cell through the Na/Ca 2texchanger . The consequence of this would be a 
greater amount ofCa 2 within the cytosol in diastole, which has been reported in this study. 
5.3 	 Time dependent effects of STZ-induced diabetes 
The aim of this part of the study was to investigate whether, the contractile changes that 
have been reported (chapter 4) in 4 weeks STZ-induced diabetic is a consequence of 
altered Ca 2 homeostasis as early as 4 week post injection. 
£3.1 Results 
Figure 5.3. shows a typical Ca2 transient following 4 weeks STZ-treatment and age- 
matched controls in electrically stimulated (I Hz) ventricular myocytes (bottom). Basal, 
resting Ca 2 (measured by fluorescence ratio units) was significantly (P<0.01) increased in 
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STZ-induced diabetic myocytes following 4 weeks of treatment compared to control 
(0.738 ± 0.017 ratio units, n=l0 Vs. 0.472 ± 0.07 ratio units, n10). respectively. The 
amplitude and 1 k of Ca2 transient were not significantly (P>0.05) altered in 4-week STZ-
induced diabetic myocytes compared to control. However, the decay of the Ca 2 transient 
measured as the rate of ratio units/sec was significantly (P<0.05) longer in the diabetic 
myocytes versus control (Figure 5.4). Moreover, there was no significant difference 
between STZ-induced myocytes following 4 and 8-12 weeks treatment of STZ (Figure 
5.5). 
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Figure 5.3 Fast time base recordings of a train (a) and a single extrapolated Ca 2 transient 
(b) in electrically stimulated (I Hz) ventricular myocytes isolated from age-matched 
control and STZ-induced diabetic rat hearts. Cells were superfused with a NT solution (I 
mM Ca2 ) at 35-37 T. Traces are typical of 7-10 such myocytes obtained from 3-5 hearts 
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Table 5.1. The effects of 4 and 8-12 weeks STZ-induced diabetes on Ca2 
homeostasis in ventricular myocytes stimulated at I Hz perfused with a NT solution 
(I mM Ca2 ) at 35-37°C 
Control 	 STZ 4 weeks 
Ca2 reIease 	 19.9±2.9 (10) 
	 14.8±1.4 (7) 
(% rise Vc. basal) 
tj'k of Ca 2 transient 	 109.6±7.5 (10) 	 98.6±8.4 (7) 
(msec) 
Rate of Ca 2 decay 0.56±0.07 (10) 	 0.32±0.07 (7)* 
(ratio units/see) 
IV Ca2 decay (msec) 	 91.8±4.8(10) 	 166.5±12.9 (7)* 
STZ Sweeks 
18.5±1.1 (23) 
102.6±6.3 (23) 
0.37±0.02 (23) 
156.1±8.4 (23) 
Data are means ± S.E.M. Number in parenthesis indicates number of cells. Controls 
Vs. STZ and STZ (8 weeks) Vs. STZ (4 weeks) were compared using Student's 
independent samplesi test. *P<0.05. 
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Discussion This study has shown that the amplitude and 'pk  of Ca 2 transient was not 
significantly altered in 4 week STZ-induced diabetic myocytes compared to control, 
similar to results observed for the 8-12 weeks treated rats. However, basal Ca 2 is 
significantly increased in the diabetic heart following 4 weeks STZ treatment compared to 
age-matched controls. It is proposed that increases in basal Ca 2t may contribute to the 
increase in contraction that has been reported in the diabetic heart. Moreover, this study 
has shown that resting [Ca 2 ]1 is higher following 4 weeks STZ compared to 8 weeks. 
Furthermore, the amplitude of contraction is bigger after 4 weeks compared to 8 weeks 
STZ treatment. The rate of Ca 2 transient decay is also significantly slower in the diabetic 
heart following 4 weeks of treatment. This study has shown that the defects associated with 
changes in Ca 2 ' homeostasis and contractions are in place after 4 weeks post injection of 
STZ. Therefore, the slower decay of the Ca 2 and the increase in resting Ca 2 may lead to 
an increase in contraction that has been reported within this study. 
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5.4 	 The effects of caffeine-induced calcium transients in isolated ventricular 
myocytes from streptozotocin-induced diahetk rat heart 
5.4.1 Introduction 
The velocity and measure of Ca2* 
 released from the SR following an action potential, is 
indicative of the speed of Ca 2 release from the SR but not an overall measure of the total 
amount of Ca2 in the SR. The rapid application of caffeine however, activates the SR 
RyR channels to open and initiate a total release of Ca 2 from the SR (O'Neill & Eisner, 
1990). If the caffeine application is sustained, Ca 2 re-sequestrated back into the SR (via 
the SERCA pump) will be spontaneously released back into cytosol (Rousseau & 
Meissner, 1987). Therefore, a caffeine-induced Ca 2 release will enable the worker to 
assess: (a) total capacity of Ca 2 within the SR and (b) an indication of the speed or rate of 
Ca2 efflux from the cell and back into the mitochondria (although the relative amount of 
Ca 2 pumped into the mitochondria is so little, that it does not contribute to changes in Ca2* 
homeostasis and will therefore will not be discussed). Caffeine also effects myofilaments 
sensitisation as well as inhibiting phosphodiestarse (which can increase cAMP and in turn 
activate of cAMP dependent PKA) (Yu et at 1995). 
The aim of this part of the study was to investigate the effects of caffeine-induced Ca 2 
release in isolated ventricular myocytes from age-matched control and STZ-induced 
diabetic myocytes following 8-12 weeks of STZ-treatment. 
5.4.2 Method 
See C/zap/er 2 for details. 
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5.4.3 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 5.6. shows an original chart 
recording of the time course of the experimental protocol used to investigate the effects of 
caffeine (10 mM) on age-matched control and STZ-induced ventricular myocytes. 
Myocytes were electrically stimulated at I Hz before stimulation was abbreviated and the 
myocytes were rapidly superfused with 10mM caffeine. Following a 10 sec application of 
caffeine, myocytes were re-stimulated and superfused with NT solution (1 mM Ca 2 ) until 
Ca2 transients reached pre-caffeine levels. 
Caffeine (10 mM) 
4 	 to 
Stimulation 	 Recovery period 
p 
0.05 
ratio 
units 
30 See 
Figure 5.6. Original trace showing the time course protocol for caffeine-induced Ca 2 
release and recovery in rat ventricular myocyte. Myocytes were stimulated and superfused 
with NT solution (I mM Ca2 ) at 35 0C-37 0C. The trace is typical of 18 such myocytes from 
6 rats. 
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Table 5.2. shows that the amplitude of caffeine-induced Ca 2 release was not significantly 
(P>0.05) altered between control and STZ-induced myocytes. Moreover, fractional release 
of Ca2 was not altered significantly in control and STZ myocytes The 'pk of the Ca2 
transient was not significantly (P>0.05) altered between control and STZ-induced. 
However, the Iv.. decay of Ca2 transient following the application of caffeine was 
significantly longer (43%) in myocytes obtained from STZ-induced compared to age-
matched controls (Figure 5.7). Moreover, the rate of relaxation was significantly (P<0.05) 
smaller in diabetic myocytes compared to control (Table 5.2). 
Table 5.2. The effects of 8-12 weeks STZ-induced diabetes on caffeine-induced 
Ca 2 release in isolated ventricular myocytes obtained from rat heart at 35-37°C 
Age-matched control STZ-induced (8 weeks) 
Amplitude of Ca 2 release 	 25.7±1.9 (18) 
(% rise Vs. Basal) 
Fractional Ca 2 release 	 89.7±14.8 (18) 
t,,4 of Ca2 transient (msec) 	 250.3±50.1(18) 
Rate of Ca 2 decay 	 0.73±0.07(18) 
(ratio units/see) 
'½ Ca 2 decay (msec) 	 91.8±4.8(18) 
25.9±2.2 (17) 
83.5±8.8 (17) 
330.1±48.2 (17) 
0.56±0.04 (17)* 
156.1±8.4 (17) 
Data are means ± S.E.M. Number in parenthesis indicates number of cells. Controls 
Vs. STZ were compared using Student's independent samples / test. *Pc005 
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Figure 5.7.a Original chart recording of Ca 2 transient in age-matched controls (black) and 
STZ-induced (green) myocytes. Traces are typical of 18 such myocytes obtained from 6-8 
rat hearts. 
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Figure 5.7.b shows the tz. deem' of a caffeine-induced Ca 2 release in STZ-induced and 
age-matched control myocytes. Data are means ± S.E.M. Number in bars indicates cells. 
Control Vs. STZ was compared using Student's independent samples t test. 
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5.4.4 Discussion 
The amount of Ca 2 released by the SR is dependent on the SR Ca 2 content and the 
magnitude and duration of the trigger stimulus (Baartscheer ci al. 2000). A rapid 
application of caffeine activates the SR RyR channels to open and initiate a total release of 
Ca2 
 from the SR (O'Neill & Eisner, 1990). In this study, the amplitude of the caffeine-
induced Ca2 release was not significantly altered in control and diabetic myocytes. In 
contrast, it has been reported that, following a caffeine-evoked Ca 24 transient the amount of 
Ca2 released from the SR is reduced in the diabetic heart (Lagadic-Gossmann el al. 1996; 
Tamada ci at 1998; Yu ci at 1995; Choi ci at 2002). The reported changes in caffeine-
induced SR Ca2 
 release may be attributable to the rest period preceding an application of 
caffeine. In this study, stimulation was abbreviated for 10 sec, prior to a rapid caffeine 
pulse, but in other reports there was a 30 sec (Choi ci al. 2002) and 40 sec (Lagadic-
Gossmann et at 1996) quiescent phase. Longer rest periods may be associated with 
alterations in SR loading abilities and may contribute to a change in releasable SR Ca 2 . 
Interestingly, Choi eta! (2002) reported that the decrease in caffeine-induced Ca 2 release 
was mirrored by a decrease in the amplitude of contraction. In contrast, this present study 
has shown that that the amplitude of contraction is significantly larger in the diabetic heart 
compared to age-matched controls. It seems likely that alterations in Ca 2 release and 
myofilament sensitivity may contribute to changes in contractile dysfunction. Fractional 
Ca 2 
 release was not significantly different in STZ-induced diabetic myocytes compared 
to control. This suggests that the triggered response and release of Ca 2 from the SR is 
similar in the diabetic heart. It has been shown that the gain of CICR is dependent on the 
'Ca,L and subsequent influx of Ca 2 to trigger Ca 24 release from the SR (Wier ci at 1994). 
This study has shown that stimulated Ca 24 release and caffeine-induced Ca 2 ' release are 
similar, therefore any changes in 
'Ca,L may be indicative of changes in the gain in the 
diabetic heart. The tpk of a Ca2  transient following a rapid application of caffeine is an 
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indication of RyR release sensitivity/activity. In this study, it has been reported that the 'pk 
of a caffeine-evoked Ca 24 transient was increased in the STZ-induced diabetic myocytes 
but not to a significant level. It has however, been reported that the time course of the 
caffeine-induced Ca 24 transient decay was significantly prolonged in the diabetic myocytes 
(Choi et at 2002). Similarly, in this study it has also been shown that the i decay of the 
caffeine-induced Ca 24 was significantly longer in the diabetic myocytes compared to 
control (Figure 5.7.b). This is in agreement with, other workers who have also reported 
longer rates of Ca 2 transient decay in 8 weeks (Choi ci at 2002) STZ-induced diabetic 
myocytes. 
Caffeine application causes the release of Ca 24 from the SR and causes the SR to become 
"leaky". However, the SR is still functional and can sequester Ca 24 back into the SR, where 
it is then expelled out into the cytosol through RyR channels affected by caffeine. It is 
worthwhile to note that a series of experiments were undertaken to look at the effects of 
thapsigargin on the decay of Ca 2+ 
 release during the application of caffeine. However 
following a 10 min incubation of thapsigargin, caffeine induced Ca 24 release was reduced 
and the measure of the decay of the Ca 2 transient was impossible to measure accurately 
due to an increase in noise. Moreover, it has been reported that the rate of decay of a 
caffeine induced Ca 2 transient is largely dependent on the Na/Ca 2texchanger (Bassani ci 
at 1992; Bassani ci at 1994; Negretti c/aL 1993; Choi & Eisner, 1999) and therefore, the 
decay of the Ca 2+  transient during a caffeine-evoked response in the absence of 
thapsigargin provides a direct measure of the rate of Ca efflux out of the cell, although a 
tiny proportion of Ca 24 is sequestered back into the mitochondria. It can therefore, be said 
that in this study the prolonged time course of [Ca 2+ 
 ji decay is associated with a 
derangement in efflux pathways. The prolonged decay of [Ca 2+ 
 ji may also contribute to the 
change in contractile function that is a feature of human and experimentally induced 
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diabetes (Albanna el at 1998; Kiss ci at 1988; Astorri ci al. 1997; Nicolino ci at 1995; 
Regan ci at 1974; Fein ci at 1985; Litwin ci at 1990; Miller 1979; Vadlamudi ci at 
1982). 
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5.5 	 Effects of nickel on caffeine-induced calcium transients in the isolated 
ventricular myocytes front streptozotocin-induced diabetic rat heart 
5.11 Introduction 
In order to isolate the mechanism responsible for the delay in [Ca 2 ] efflux, following an 
application of caffeine, it is useful to use a pharmacological too] to block Ca 2 pathways. 
The main transport mechanisms involved in Ca 2 efflux are the Na/Ca 2texchanger and 
the PMCA pump. The Na 17Ca2 -exchanger is the main mechanism by which, Ca 2 is taken 
out of the cell. It has been reported that the Na/Ca 2 -exchanger accounts for between 68 
and 87 % of Ca2 effiux, while the PMCA pump and mitochondria, collectively, accounts 
for between 13 and 32 % (Bassani ci at 1992; Bassani ciat 1994; Negretti ci at 1993; 
Choi & Eisner, 1999). NiC1 2 (10 mM) blocks the Na/Ca 2 -exchanger (as well as the L-
type Ca 2 channel) but has no effect on the PMCA (Egger ci at 1999; Leoty c/at 2001). 
Therefore, following caffeine-induced Ca 2 transient, the rate of efflux in the presence of 
NiCl2 is indicative of the rate at which, Ca 2 is taken up by the mitochondria and passed 
out of the cell via the PMCA. 
Therefore, the main aim of this part of the study was to initiate caffeine-induced Ca 2 
release in the presence ofNiCl 2 , in control and STZ-induced diabetic ventricular myocytes. 
An alteration between control and diabetic myocytes may implicate the PMCA and 
mitochondria to be deranged, while, a similar rate of Ca 2 efflux would imply that the 
NaVCa 2 -exchanger may contribute to changes in Ca 2 efflux that has been reported in the 
diabetic heart. 
5.12 Method 
See Chapter 2 for details. 
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3.5.3 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. Figure 5.8. shows a time course trace of 
the protocol used for this series of experiments. Following a caffeine protocol (see Figure 
5.6) electrical stimulation is stopped and NiCl 2 
 (10 mM) is applied to cells for 10 sec, 
caffeine (10 mM) is then rapidly applied to cells for 10 sec, before NT solution is re 
applied to the cells and cell re-stimulated (1 Hz) until pre caffeine controls are reached. 
(i) Caffeine protocol 
	 (ii) Caffeine plus NiCl 2 protocol 
0.08 
ratio 
units 
20 sec 
Figure 5.8. Original trace showing the time course protocol for (i) caffeine-induced Ca 2 
release and for (ii) caffeine-induced Ca 2 release in the presence of NiCl2 (10 mM) and 
recovery in rat ventricular myocyte. Myocytes were stimulated and superfused with NT 
solution (I mM Ca 2 ) at 35 0C-370C. The trace is typical of 18 such myocytes from 6 rats. 
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Figure 5.9. The effects of NiCI on the caffeine induced Ca 2 release. 
Superimposed traces of caffeine induced SR Ca 2 release in the absence (blue) and 
presence of nickel (black) from isolated ventricular myocytes. Traces are typical of 
IS cells taken from at least 5 rat hearts. 
In the presence ofNiCl 2, the amplitude ofCa2 
 release measured by the percentage change 
versus pre caffeine pulse was not significantly (P>0.05) altered in control and diabetic 
myocytes, respectively (Table 5.1). Moreover, there was no significant (P>0.05, Paired t-
test) difference in the amplitude of caffeine-induced Ca 2 release between the pre and post 
application ofNiCl2 in control and STZ-induced myocytes. The /pk of the caffeine-induced 
Ca2 
 release (peak taken from first point of peak transient) in the presence of NiCl2 was 
significantly (P<0.05) longer in diabetic myocytes compared to control (Table 5.1.). 
Moreover, the 'pk was significantly (P<0.0 I, Paired t-test) increased in both control and 
diabetic myocytes between pre and post application of NiCl2. The !and rate of decay of 
the Ca2 
 transient was not significantly (P>0.05) altered in STZ-induced myocytes in the 
presence of NiCl2 (Table 5.1.). However, both control and STZ-induced myocytes had 
significantly (P<0.01, Paired t-test) longer decays in the rate of Ca 2 transient decline 
following an application of NiCl 2 . 
Table 5.2. The effects of STZ-diabetes on the caffeine-induced Ca 2 transient in the 
presence of N1Cl2 of isolated ventricular myocytes obtained from rat heart at 35-
3 7°C. 
Age-matched control 	 STZ-induced 
Amplitude of Ca 2 transient 
% rise Vs. stimulated) 
Fractional CaZ*  release 
Time to peak (tpk), (sec) 
Time to half decay (t),(sec) 
Rate of Ca 2 decay (ratio units /sec) 
	
25.6±1.9(18) 	 25.8±2.0(17) 
	
90.7 ±15.4 (18) 
	 82.3 ± 8.7 (17) 
	
0.49 ±0.06 (18) 
	 0.71 ±0.08 (17) * 
	
2.5±0.23 (18) 	 2.9±0.26(17) 
0L03 ± 0.003 (18) 	 0.03 ± 0.002 (17) 
Data are means ± S.E.M. Number in parenthesis indicates number of cells. Control 
Vs. STZ was compared using Student's independent samples flest. *P<005. 
5.5.3.1 Gomparison of rate of decay 
The rate of cytosolic Ca 2 decay in electrically stimulated (I Hz) ventricular myocytes 
taken from control hearts was significantly (P<0.0 I) quicker (39.8 %) than that of STZ-
induced diabetic hearts (Figure 5.10.a) Moreover, the rate of decay following an 
application of caffeine was significantly (Pc005) faster (23.6 %) in control compared to 
diabetic myocytes. However, the rate at which. Ca 2 efflux and uptake in caffeine in the 
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presence of NiCl 2 was not significantly (P>0.05) altered in diabetic and control. versus 
control (Figure 5.10.). 
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Figure 5.10. The rate of Ca 2 decay in electrically stimulated, caffeine-induced 
and caffeine-induced Ca 2 transient in the presence of NiCI in ventricular 
myocytes isolated from controland STZ-induced rat heart perfused with a NT (I 
mM Ca2 ) at 35-37°C. Data are means ± S.E.M. Numbers in bars indicates 
number of cells. Control vs. STZ was compared using Student's independent 
samples nest. P<0.05,**P<0.01.  
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5.5.4 Discussion 
From the results, it can be seen that, in the presence of N1Cl2 the amplitude of Ca 2 
released from the SR, in control myocytes following an application of caffeine was not 
significantly different than in STZ-induced myocytes. Therefore, it would seem that the 
total available amount of Ca2* 
 is similar in the normal and diabetic heart and that the 
Na/Ca2 -exchanger does not contribute to changes in caffeine-induced Ca2* 
 release in 
ventricular myocytes. However, it has been reported that in the diabetic heart caffeine-
induced Ca2 release is significantly diminished (Choi el at 2002). In the presence of 
NiCl2, the tpk of the caffeine-induced Ca 2 transient is longer in both control and diabetic 
myocytes (compared to caffeine-induced Ca 2 release without NiCl2) but is significantly 
increased in the STZ-induced myocyte compared to control. This would suggest that either 
NiCl2 itself or the action of NiCl 2 on the Na/Ca 2texchanger changes the tpk of the a 
caffeine-induce Ca 2 release in STZ-myocytes significantly more than control myocytes. 
Because, the speed of Ca 2 release of the SR is indicative of RyR, sensitivity, it is 
suggested that in the diabetic heart the sensitivity of RyR release channels is altered though 
the action of NiC12 itself or through changes in [Ca 2 ] through the Na7Ca 2texchanger 
blockade. The rate of decay of the caffeine-induced Ca 2 transient is longer in diabetic 
niyocytes versus control, but in the presence of NiCl 2 the rate of decay is not significantly 
altered. Because NiCl 2 blocks the Na/Ca 2 -exchanger. the rate of decay during caffeine-
induced Ca2 release in the presence ofNiCl 2 is a rate ofefflux from the PMCA and uptake 
into the mitochondria. Therefore, it is tempting to suggest that in this series of experiments 
the sustained elevation in [Ca2*]j 
 following caffeine treatment is directly associated with 
the Na7Ca2 -exchanger, but not the changes in PMCA Ca 2 efflux or mitochondrial Ca 2 
uptake. 
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Chapter 6 
Effects of halothane on 'Ca,L, 
[Ca2 jj and contraction in the 
streptozotocin-in duced diabetic 
and age-matched control 
cardiomyocyte 
Eno 
6.1 	 Introduction 
Volatile anaesthetics have been used in the clinical environment to produce unconscious 
effects in patients undergoing clinical procedures including surgery on the heart (Davies et 
at 2000). However, cardiovascular complications are a major source of morbidity and 
mortality in patients in surgery under anaesthesia (Campling ci at, 1993). Halothane is a 
well known modern volatile anaesthetic, but has been reported to produce several adverse 
side effects within the heart (Davies c/at 2000). Several reports suggest that halothane can 
induce a negative inotropic (contraction) effect in the heart (Housmans & Murat, 1988). 
The negative inotropic and lusitropic (relaxation) effects of halothane (Harrison et at 
1999; Davies ci al. 1999) have been reported to be attributable to alterations in Ca2t 
sarcolemmal influx (Ikemoto ciat 1985), SR Ca2t uptake (Connelly & Coronado, 1994) 
and release, and changes in sensitivity of contractile myofilament sensitivity (Davies c/at 
2000). 
The rate of inward 'CaL determines the rate of Ca 2 influx leading to the triggered response 
of Ca2t  from the SR, following depolarisation of the sarcolemmal. Initial depolarisation of 
the cell membrane leads to the rapid activation of 'CaL  around —40 mV Em (Bers, 1991). 
Ca2 influx through L-type channels has been shown to be around 13.8 imol/l cytosol in 
rat ventricular myocytes (Yuan c/at 1996). Given that the rate of inward 'Ca,L  is the trigger 
for SR Ca2t  release (in normal conditions), any alteration in the 'CaL  may effect its opening 
and subsequent ability to trigger Ca 2 release. Moreover, a reduction 
'CaL has been 
reported in the heart in the presence of halothane (Ikemoto et at 1985). 
Following the triggered release of Ca2t 
 from the SR. cytosolic free Ca 2 increases, leading 
to the binding of Ca 2 with the troponin-C complex, which, results in the sliding of actin 
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and myosin over each other, and subsequent contraction. These processes have the 
potential to be altered by changes in pharmacological environment and alterations in the 
pathological state (Morgan et at, 2000). It has also been reported that myofilament 
sensitivity to Ca2*  is altered in the normal rat heart in the presence of halothane (Harrison 
a at 1999). Therefore, changes in myofilament sensitivity may contribute to cardiac 
contractile abnormalities in the diabetic heart and may be attenuated by halothane. 
During surgical procedures, the concentration of plasma halothane ranges between 0.05 
and 0.7 mmol I ' (Davies ci at 1972). It has been reported that, two times minimum 
alveolar concentration (MAC)(2) concentration in the rat is 0.6 mmol I (Rithalia c/ at 
2001). Therefore, in this study, a clinically relevant concentration ofhalothane (0.6 mmol I 
) has been employed to characterise the effects of halothane on the diabetic heart 
compared to age-matched control. The diabetic heart is characterised by an alteration or 
disruption of contractility that is underpinned by changes in Ca 2 homeostasis. The 
intracellular mechanisms underlying the changes in cardiac function in the presence of 
halothane in the diabetic heart are not fully understood. It is hoped that changes associated 
with inotropic effects of halothane in normal and diabetic myocytes may provide a greater 
understanding of the underlying mechanisms of dysfunction in the STZ-induced diabetic 
heart. 
The aim of this study was to investigate the effects ofa clinically relevant concentration of 
halothane on isolated ventricular myocytes from age-matched control and STZ-induced 
diabetic hearts. Specifically this study has investigated the effects of halothane on: (I) 
'CaL, 
voltage dependence of contraction, inotropy an lusitropy, stimulated Ca 2 ' transient and 
myofllament sensitivity for Ca 2t 
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6.2 	 Results 
In all figures, unless otherwise stated, relate to 8-12 weeks STZ-induced diabetic 
ventricular myocytes and age-matched controls. In a number of tissues it is established that 
membrane Ca 2 conductance decreases progressively over time and is mainly due to 
artificially perfusing cells as thus washing away of molecules that are important in 
maintaining the function of channels, which can result in a loss of 
'Cal. (Kameyama et aL 
1997). This process is known as "run-down". Rundown was assessed in a number of 
experiments, and it was shown there was no significance difference between the 'CaL  in 
control and STZ-induced myocytes following wash off periods compared to time-tested 
controls. Cell volume (V) was measured by using a formula based on the observations of 
Satoh c/ al. (1996), that the shape of a rat ventricular myocyte is an elongated ellipse, of 
which the volume is equal to 54% of the volume ofa block. This is defined as the length X 
Width X Depth. Depth was calculated as a prediction of the cell width. Therfore, the 
formula was; V =L X W X (W/W:D) X 5.4 X 10 4 p1 tm 3 or V =L X W2/2667 pV' 
Mm 3 .Cell volume in ventricular myocytes obtained from control beans were not 
significantly different to those obtained from STZ-induced diabetic hearts, respectively. 
Control 15.2 ± 0.8 p1, (n=9) and STZ 14.9 ± 0.31 p1, (n=9). 
LI- 
a 
a 
a 
0 
Figure 6.1. Membrane capacitance (pF) measured in control and STZ-induced diabetic 
ventricular myocytes: Control 102.7 ± 5.64 pF, (iv=9) and STZ 100.6 ± 2.09 pF,(n9). 
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0.3 nA 
50 ms 
(c) STZ 
(a) Control 	 (b) Control plus Halothane 
II .!_1J iii CTTTTi I ''iii ii',,,, 
50 ms 
(d) STZ plus Halothane 
SOms 	 SOms 
Figure 6.2. Typical chart traces Of/C a.L following a test pulse of 0 my from a holding 
poteial of —40 my in (a) control and (c) STZ-induced ventricular myocytes and the 
effects of halothane (0.6 mM) on 
'CLL in (b) control and (d) STZ-induced myocytes at 
room temperature. Traces are typical of 8-10 cells from taken from 3-4 rat hearts. 
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6.2.1 Current function 
Figure 6.2. shows typical 'CaL  traces obtained from either in (a) age-matched control, (b) 
age-matched control plus halothane, (c) STZ-induced or (d) STZ-induced plus halothane 
myocytes. The (pk  of 'Ca,L  was not significantly (P>0.05) altered between control and STZ-
induced diabetic myocytes in the absence or presence of halothane (Table 6.1.). 
Table 6.1. The effects of 8-12 weeks STZ-induced diabetes and halothane on 
the time to peak of the 'Ca,L  compared to age-matched controls in isolated 
ventricular myocytes patched clamped in whole cell configuration at room 
temperature. 
Time to peak of the 'CJ.L  (msec) 
Control 	 7.97±0.97(9) 
STZ 
	
9.25±1.35(9) 
Control plus halothane 	 10.3 1±0.79(9) 
STZ plus halothane 	 8.91±0.91(9) 
Data are means ± S.E.M. Number in parenthesis indicates number of cells. 
Control Vs. STZ was compared using Student's independent samples (test. 
Control Vs Control plus halothane (0.6 mM) and STZ Vs. STZ plus halothane 
(0.6 mM) was compared using a paired / test. 
6.22 Current Amplitude 
Figure 6.3. Shows the peak 'Ca. L amplitude (difference between the peak 'CaL and the 'Ca,L 
at the end of the depolarising pulse) in age-matched control and STZ-induced diabetic 
ventricular myocytes in the presence and abscence of halothane (0.6 mM). The amplitude 
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-1 
Ll 
CL 
of peak 'Cal. was significantly (P<0.05) reduced in STZ-induced myocytes (-3.03 ± 0.19 
pA/pF, n =9 Vs. -4.87 + 0.32 pA/pF, n 9) compared to age-matched control, respectively. 
Following the application of halothane (hal), peak 
'Cal. amplitude was significantly 
(P<0.05) to -3.24 ± 0.29 pA/pF, n =7 in control myocytes and to -1.81 + 0.23 pA/pF, n 
in STZ-induced diabetic myocytes (Figure 6.2.). 
CNT 	 CNT hal 	 STZ 	 STZ hal 
Figure 6.3. The effect of halothane (hal, 0.6 mM) on the mean voltage dependence 
oflcai . in control-CNT (b) and STZ-induced diabetic (c) ventricular myocytes. 
Respective control for each group (either control (b) or STZ (c)) is shown for 
comparison. Data shown are mean ± SEM. Statistical significance showing control 
(n8) vs. control plus halothane (n=8) and STZ (n=7) vs. STZ plus halothane (n=7) 
compared using paired (testis represented by p 
 <0.05. 
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6.23 Currenttl voltage relationship 
Figure 6.4. shows the 'Ca,L voltage relationship in (a) control versus STZ, (b) control 
versus control plus halothane and (c) STZ versus STZ plus halothane. The 
'Ca,L  was 
significantly (P<0.05) reduced throughout voltage ranges (0 my and 40 my) in STZ-
induced myocytes when compared to age-matched controls (Figure 6.4.a). However, there 
was no significant difference in 'Ca,L between control and STZ-induced myocytes in the 
presence of halothane. In age-matched control myocytes, 'CaL was further reduced at 
voltages between 10 my and 40 mV in the presence of halothane (Figure 6.4.b). Halothane 
also significantly (P>0.05) reduced the ICa,L further in STZ-induced myocytes at 10 my 
test pulse, but in contrast did have not any significant effect at all other voltages (Figure 
6.4.c). 
(a) 
Membrane potential (my) 
-30 	 -20 	 -10 	 0 	 10 	 20 	 30 	 40 	 50 
LI- 
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a 
0) 
-3 U, 
E 
o - C 
C-) 
s'i 
-6 
Figure 6.4.a. Mean voltage dependence of 'CaL. plotted as current density (pA/pF) 
for test potentials beween —30 and + 50 mV between control-CNT and STZ-
induced diabetic ventricular myocytes at room temperature. Data shown are mean 
± SEM. Statistical significance showing CNT (n=7) vs. STZ (n=7) were compared 
using independent nest. *P <0.05. 
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Figure 6.4. Mean voltage dependence of 'CaL plotted as current density (pA/pF) for 
test potentials beween —30 and + 50 mV in (b) control-CNT and (c) STZ-induced 
diabetic ventricular myocytes, pre and post application of halothane (ha!) at room 
temperature. Data shown are mean ± SEM. Statistical significance showing CNT 
(n7) vs. CNT plus hal (n=7) and STZ vs. STZ plus hal (n=7) were compared using 
paired Itest. *]) <0.05. 
6.2.4 Voltage dependence of contraction 
Figure 6.5. shows the effect of halothane on the voltage dependence of contraction in 
8-12 weeks STZ-induced and age-matched control myocytes at room temperature. 
Contraction was examined in these cells by measuring the amplitude of contraction in 
relation to resting cell length elicited at each test voltage (my) step in the 'CaL  /voltage 
data. Contraction was significantly (P<0.05) greater in control myocytes compared to STZ-
induced myocytes at all test potentials. Following the application of halothane (0.6 mM), 
the amplitude of contraction significantly decreased between - 10 mV and - 50 my 
potentials in control myocytes. Moreover in STZ-induced diabetic myocytes, following the 
application of halothane also resulted in a significant reduction in the amplitude of 
contraction at —20 mV. 0 my and +10 mV potentials. Furthermore, contraction was 
significantly decreased at test potentials between —20 and + 10 my when comparing 
control myocyte with STZ-induced myocytes in the presence of halothane. 
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Figure 6.5. Mean voltage dependence of contraction plotted as percentage of resting cell 
length for test potentials between —30 and + 50 my in control-CNT and 8-12 weeks STZ-
induced diabetic ventricular myocytes, in the absence and presence of halothane (hal) at 
room temperature. Data shown are mean ± SEM. Statistical significance was analysed (see 
commentary) CNT (n=7) vs. STZ (n7) were compared using independent ttest. CNT 
(n=7) vs. CNT plus hal (n=7) and STZ vs. STZ plus hat (n=7) were compared using paired 
(test. 
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6.2.5 Contraction 
Figure 6.6. shows (a) original fast time based chart recordings of contraction, (b) 
'pk of 
contraction and (c) contraction as percentage remaining following the application of 0.6 
mM halothane in ventricular myocytes isolated from age-matched control and STZ-
induced diabetic. Figures 6.7 and 6.8 show (a) original fast time based chart recordings and 
the (b), lpk of contraction and t decay of contraction (c) in age-matched control and STZ-
induced cardiomyocytes in the absence and presence of 0.6 mM halothane. The results 
show that the tpk of myocyte shortening was significantly (P<0.01) prolonged in STZ 
myocytes (137.2 ± 4.1 msec, n =32) compared to control (105.5 ± 2.0 msec, n 31) 
(Figure 6.6.a). However, 'pk of contraction were significantly (Pc0.01) reduced in control 
(105.5 ± 2.0 msec, n =31 V.s 94.6 ± 2.4 msec. n =31 ) (Figure 6.7.b) and STZ-induced 
(137.2 ± 4.1 msec, n =32 Vs. 119.3 ± 3.4 msec. ii =32)(Figure 6.8.b) myocytes in the 
absence and presence of halothane, respectively. 1-lalothane significantly (P<0.01) reduced 
amplitude of contraction in both control (from 100% to 65.9 ± 2.7%, n =31) and STZ-
induced (from 100% to 40.9 ± 3.2 %, n =32) myocytes. This reduction in contraction was 
significantly (Pc0.01) greater in STZ-induced myocytes compared to control (Figure 
6.6.c). The decay was not significantly altered between control and STZ-induced 
myocytes in the presence of halothane, but was significantly (Pc0.01) decreased in control 
(46.5 ± 2.1 msec, n =31 Vs. 42.5 ± 2.0 msec, n =31) (Figure 6.7.c) and STZ-induced (48.6 
± 1.8 msec, n =32 Vs. 45.1. ± 1.9 msec, n =32,) (Figure 6.8.c) myocytes before and after 
the application of halothane. respectively. 
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Figure 6.6.a Representative fast lime-base recordings of contraction in 
electrically stimulated (I Hz) rat ventricular myocyles. superfused with NT 
containing 0.6 mM halothane at 35-37 °C, from (i) STZ-induced diabetic 
compared with (ii) control rats. (b), fpk of contraction and (c), conlraction as a 
percentage remaining after the application of halothane. Data shown are mean ± 
SEM. Numbers within bars represent number of cells. Statistical significance 
showing control vs. STZ, independent samples / test is represented by **P <0.01. 
Frames in (a) are typical of3 I control myocytes and 32 STZ treated myocytes. 
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Figure 6.7. (a) Representative fast time-base recordings of contraction in 
electrically stimulated (I Hz) rat ventricular myocytes, superfused with either 
normal Tyrode (NT) alone (Pre) or containing 0.6 mM halothane (Post) at 35-
37°C, from age-matched control rat hearts. (b) tpk  of contraction and (c), i relax. 
Data shown are mean ± SEM. Numbers within bars represent number of cells. 
Statistical significance showing Pre Vs Post application of halothane using paired 
t test is represented by ttP <0.01. 
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Figure 6.8. (a) Representative fast time-base recordings of contraction in 
electrically stimulated (1 Hz) rat ventricular myocytes, superfused with either 
NT alone or NT containing 0.6 mM halothane at 35-37 °C, from STZ-induced 
diabetic rat hearts. (b) !pk of contraction and (c), i Data shown are mean ± 
SEM. Numbers within bars represent number of cells. Statistical significance 
showing Pre Vs. Post application of halothane using paired t test. **p 
 c 0.01. 
Frames in (a) are typical of32 STZ-treated such myocytes. 
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6.2.6 Calcium 
Figure 6.9. shows typical chart recordings of Ca 2 transient in ventricular myocytes taken 
from age-matched control and STZ-induced diabetic rat heart superfused with either NT 
solution alone or NT solution containing 0.6 mM halothane. Figure 6.10. shows (a) the 
amplitude of Ca2 transient measured in ratio units, (b) tpk  of Ca24 transient (ms) and (c), 
t decay of Ca 2 
 transient in the absence and presence of halothane in ventricular 
myocytes isolated from age-matched control and STZ-induced diabetic rat hearts. The 
resting level of [Ca 24J (measured as basal ratio units) was not (P>0.05) significantly 
affected by the application of halothane in control and STZ-induced cardiac myocytes. The 
amplitude of Ca24 
 transient was significantly reduced in both age-matched control (Pc0.01) 
(0.507 ± 0.078 ratio units, n =13, Vs 0.374 ± 0.054 ratio units, n =13) and STZ-induced 
(P<0.05) myocytes (0.513 ± 0.061 ratio units, n 13. Vs 0.437 + 0.058 ratio units, n =13), 
in the absence and presence of halothane, respectively (Figure 6.1O.a). However, there was 
no significant (P>0.05, paired test) difference between the amplitude of Ca 24 in age-
matched control and STZ-induced myocytes in the absence and presence of halothane 
(Figure 6.I0.a). The 'pk  of Ca2 transient was not significantly (P>0.05) altered in STZ 
myocytes (74.7 ± 6.5 msec Vs. 68.3 ± 5.4 msec, n = 13) and age-matched control (66.0 ± 
2.8 msec Vs. 61.4 ± 3.4 msec, n 13) myocytes in the absence and presence of halothane 
(Figure 6.10.b). Moreover, there is no significant (P>0.05, paired test) difference between 
the tpk of Ca24  transient in age-matched control and STZ-induced myocytes either before 
or after the application of halothane (Figure 6.10.b). In contrast, the t decay of Ca24 
transient was significantly (P<0.01) longer in STZ-induced cardiac myocytes (148.4 ± 10.2 
msec Vs. 160.5 ± 9.93 msec, n =13) and control myocytes (104.8 ± 4.5 msec Vs 109.0 ± 
4.0 msec, n =13), in the absence and presence of halothane, respectively (Figure 6.10.c). 
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However, the application of halothane did not significantly (P>0.05) alter the Idecay of 
Ca2 transient the results obtained in the absence and presence of halothane (Figure 6.1 0.c). 
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Figure 6.9. Effect of 0.6 mM halothane on Ca 2 transients (I Hz) in control and 
STZ-induced ventricular myocytes perfused at 35-37 °C. Traces are typical of 13 such 
myocytes from at least 4 rats per group. (a) Control superfused with NT alone and 
control superfused with NT containing halothane, (b) STZ superfused with NT and 
STZ superfused with NT containing halothane (c) Control superfused with NT alone 
and STZ superfused with NT and (d) Control superfused with NT containing 
halothane and STZ superfused with NT containing halothane. 
156 
Control E?221 STZ (a) 1 0.8 C 
3 
0 
(V 
0.6 
C 
a 
C., 
C 
2 
E 0.4 
3 
a 
(V 
a 
0 
0.2 
3 
0. 
E 
0 
PRE 	 POST 
Halothane application 
(a) 
100 
I., 
E 
C 
.2 76 
&0 
C 
2 
E 
3 
50 
(V 
U 
m 
a 
0. 
2 25 
a 
E 
I- 
0 
PRE 	 POST 
Halothane application 
Figure 6.10. Effects of halothane on the (a) amplitude of Ca2t  transient and (b) the 
tpk of Ca 2+ transient from ventricular myocytes taken from age-matched control 
(open) and STZ-induced (hatched) diabetic rat hearts perfused at 35-37 °C with (a) 
Control with NT, (b) STZ with NT, (c) Control with 0.6 mM halothane and (d) STZ 
with 0.6 mM halothane. Data shown are mean ± SEM. Numbers within bars represent 
number of cells. Statistical significance showing NT alone vs. NT plus halothane 
treatment halothane (paired t test) and control i's. STZ, ( independent samples / 
test).*P <0.05 and **P <0.01. 
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Figure 6.10. (c) Effects of halothane on the ¼ decay of Ca 2 transient from 
ventricular myocytes taken from age-matched control (open) and STZ-induced 
(hatched) diabetic rat hearts perfused at 35-37 °C with (a) Control with NT, (b) STZ 
with NT, (c) Control with 0.6 mM halothane and (d) STZ with 0.6 mM halothane. 
Data shown are mean ± SEM. Numbers within bars represent number of cells. 
Statistical significance showing NT alone vs. NT plus halothane treatment halothane 
(paired t test) and control vs. STZ, (independent samples / test). ** <0.01. 
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6.2.7 MyoJilament calcium sensitivity 
Previous reports have suggested that during the final phase of relaxation, cardiac 
myofilaments come into a quasi-equilibrium state with [Ca -] i (Spurgeon ci al. 1992) 
Therefore, plotting myocyte cell length against the ratio of emitted fura-2 fluorescence 
during the final phase of relaxation of a contraction may provide an index of Ca 2 
sensitivity of the myofilaments. 
The relationship between the magnitude of cell length and analogous fura-2 fluorescence 
ratio from age-matched control and STZ diabetic rats hearts in the absence and presence of 
halothane are shown in table 6.2. Figure 6.11 .a and Figure 6.1 2.a 
Slope of regression Mm/fura-2 fluorescence ratio 
Control 	
-5.0 10.6 pim/fura-2 fluorescence ratio, n = 13 
STZ 	
-13.5 ± 3.6 pm/fura-2 fluorescence ratio, n 6 * 
Control plus halothane 	
-3.7 ± 0.5 ttm/fura-2 fluorescence ratio. n =13# 
STZ plus halothane 	
-9.0 ± 2.3 Rm/fura-2 fluorescence ratio, n =6 # 
Table 6.2. The slope of regression during the final phase of relaxation in ventricular 
myocytes obtained from age-matched control and STZ-induced diabetic rat hearts 
following 8-12 weeks treatment in the absence and presence of halothane (0.6 mM). Data 
are means ± S.E.M. Number in parenthesis indicates number of cells. Control Vs. STZ in 
the absence and presence of halothane (0.6 mM) was compared using Student's 
independent samples i test. * P<0.05. Control and STZ before and after the application of 
halothane (0.6 mM) was compared using paired nest. # Rc0.05. 
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Figure 6.11. Effects of halothane on myofilament Ca 2 sensitivity in stimulated (I Hz) 
cardiac myocytes from age-matched control rat heart perfused at 35-37 °C. (a) 
Relationship between cell length and ratio obtained during perfusion of NT solution and 
NT solution plus halothane (0.6 mM) and (b) relationship between the cell length and of 
fluorescence ratio during the final relaxation phase obtained in myocytes perfused with 
NT or NT plus halothane. Data in b are fitted with a regression line. Traces are typical 
observations from 13 such myocytes from at least 4 hearts. 
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Figure 6.12. Effects of halothane on myofilament Ca 2 sensitivity in stimulated (I Hz) 
cardiac myocytes from STZ-induced rat heart perfused at 35-37°C. (a) Relationship 
between cell length and ratio obtained during perfusion of NT solution and NT solution 
plus halothane (0.6 mM) and b relationship between the cell length and of fluorescence 
ratio during the final relaxation phase obtained in myocytes perfused with NT or NT 
plus halothane. Data in bare fitted with a regression line. Traces are typical observations 
from 13 such myocytes from at least 4 hearts. 
fl 
6.3 	 Discussion 
6.3.1 'Ca.L  amplitude and tpA 
This study has reported that the tpk of 'Ca,L  was not significantly affected by either the 
diabetic state or by the application of halothane. This would imply that the 
'pk  of 'Ca,L  does 
not have a role to play in the downstream characteristics reported in halothane-induced 
inotropic changes in the heart (1-lousmans c/at, 1988). The 'Ca,L  amplitude of the cell is 
indicative of increased 'Cal. and therefore is of direct significance to the influx of Ca 2 
i into the cell. Increased Ca 2+ 
 influx may lead to ncreased triggering ofCa release from 
the SR (Bers, 2002). This study has reported that in STZ-induced diabetic myocytes, the 
amplitude of 
'CaL is significantly less than that of controls, moreover, the application of 
halothane further reduced the peak amplitude of the 
'CaL  in control and STZ-induced 
diabetic myocytes. This reduction in peak 'Cal, amplitude was more pronounced in 
halothane treated diabetic myocytes compared to control. A reduction in the 
'CaL  has been 
reported in the following the application of halothane in normal heart (Ikemoto c/at 1985; 
Bosnjal ci at 1991). A halothane—induced decrease in 'CaL will lead to a reduction in SR 
content and may lead to a reduction in the fractional release of Ca 2 from the SR. 
Reduced SR Ca 2 release may ultimately contribute to a decrease in the amplitude of 
contraction. 
6.3.2 Current voltage relationship 
This study also investigated the relationship between 
'OLL and voltage in the diabetic heart 
in the presence of halothane. The 
'Ca.L was significantly reduced in all voltage ranges (-10 
mV to 50 mM) in diabetic myocytes compared to control. Moreover, in the presence of 
halothane, the 'CaL was further reduced in control myocytes (0 my to 50 my) and diabetic 
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myocytes (10 my). Diabetes, therefore, in respect of the JOEL  voltage relationship reduces 
the 'Ca,. at test potentials associated with the opening of the L-type Ca 2 channel. This may 
result in a decrease in Ca2t  influx into the cell and contribute to a decrease in trigger Ca 2 
needed to initiate Ca 2 release from SR. Moreover, reduced SR Ca 2 release may lead to 
reduced amounts of Ca2* 
 available for contraction. Following the application halothane, 
'Ca,L was also significantly reduced in both control and STZ-induced myocytes, which 
suggest the diabetic state may act synergistically with halothane. 
6.3.3 Voltage dependence of contraction 
The dependence of voltage on the amplitude of contraction was studied in the STZ-induced 
diabetic myocytes in the absence and presence of halothane. In this series of experiments 
the results show that STZ-induced diabetic myocytes displayed significant reduction in the 
amplitude of contraction at all test potentials tested compared to age-matched control 
myocytes. Moreover, myocyte shortening was further reduced in diabetic and control 
myocytes in the presence of halothane. This would suggest that the process by which a 
voltage test pulse causes the contraction is disrupted by the diabetic state and by the 
application of halothane. The reduction in contraction occurs because of a reduction in the 
amount of Ca2t 
 released from the SR or by a reduction in the myofilament sensitivity to 
Ca 2t It has been reported that halothane reduces the peak 'CaL  amplitude. This would 
therefore imply that a reduction in Ca2t 
 influx results in a decreased amount of trigger Ca2t 
and a subsequent decrease in SR Ca 2+ 
 release and contraction. Moreover, it has been 
reported in this study that the application of halothane reduces the amplitude of contraction 
in control and STZ-induced diabetic myocytes. 
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In contrast, it has been reported within this study that the amplitude of contraction is 
significantly increased in the STZ-induced diabetic heart compared to that of control in 
electrically cells. One possible reason for these apparent changes in results may lie with the 
properties of the diabetic Ap. In the myocardium the height and duration of the Ap greatly 
correlates to the strength and amplitude of contraction (Fabiato ci at 1985). Moreover, 
Bouchard & Giles, (1995), showed that increased Ap duration resulted in a two-fold 
decrease in the peak 
'CaL , but an increase in the Ca 2 transient and the amplitude of 
contraction. In the diabetic heart it has been reported that the Ap duration is significantly 
longer than age-matched controls (Shimoni ci at 1994; Magyar ci al. 1992; Jourdan & 
Feuvray, 1993). An increase in Ap duration in an STZ-induced diabetic myocyte, will be 
associated with a decrease in the 'CaL but an increased flux of Ca 2t The increase in Ca 2 
influx may in turn compensate for any reduction in Ca 2 influx via 'Cal,  that would be 
notable in voltage clamped myocytes. This would neutralise differences between control 
and diabetic myocytes and would result in a similar amount of trigger Ca 2 for both groups. 
Consequently, this may lead to a similar release of Ca 2 from the SR. This is in agreement 
with results detailed within chapter 5. An increase in contraction, in the electrically 
stimulated myocytes in the absence of any relative (compared to control) changes in Ca 2+ 
 
released from the SR is likely to be due to a change in the myofilament sensitivity for 
Ca2 . In the patch clamped myocyte, however, the Ap is not a factor due to the voltage 
clamp protocols. Therefore in these cells, reduced JCa.i.  would lead to a reduction in Ca 
influx and subsequent reduction in trigger Ca 2t This may contribute to a reduction in SR 
Ca2+ release and a subsequent reduction in contraction that has been reported in this study 
in STZ-induced myocyte. 
6.3.4 Contraction 
In the diabetic state it has been reported that contractile function is significantly altered 
(Choi ci at, 2002). Moreover, other reports suggest that halothane has a negative inotropic 
effect on the normal heart (Harrison c/aL, 1999). This study has investigated the effects of 
halothane on the STZ-induced diabetic heart. Although halothane was found to 
significantly depress the amplitude of contraction in both control and STZ-induced 
myocytes, the reduction in the amplitude of contraction was significantly greater in 
diabetic myocytes compared to age-matched controls. This interesting observation suggests 
that either the release of Ca 2 from the SR during stimulation is decreased (this may be due 
to either less influx of Ca 2 from the cellular medium) or myofilament sensitivity to Ca 2 
is reduced. Either or both would bring about a decrease in contraction. Moreover, 
halothane significantly decreased the ipk and idecay of contraction in the diabetic heart, an 
observation that has been reported in the normal heart too (Housmans ci at 2000). A 
change in the tj'k  of contraction may be a consequence of a change in RyR sensitivity for 
trigger Ca 2 . Interestingly, in the diabetic heart it has been reported that the ipk is increased 
(Howarth c/ at 2001). This suggests that STZ-induced diabetes affect cardiac myocytes 
contractility in opposing way with respect to halothane. In this study halothane reversed 
the increased contraction and the Ipk of contraction that has previously been reported in the 
diabetic heart (Howarth ci at, 2001). 
6.3.5 Calcium 
It has been reported in chapter 6 in this study that an alteration in contraction induced by 
halothane is likely to be caused by a change in Ca 2 homeostasis within the cell. Therefore, 
this study has investigated the effect of halothane on electrically stimulated (1 Hz) Ca 2 
transients in control and STZ-induced myocytes, and has demonstrated that halothane can 
significantly reduce the amplitude of Ca 2 ' transient in both control and STZ-induced 
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cardiac myocytes. The application of halothane itself, therefore is likely to account for the 
reduction in the amplitude of Ca2*  release in stimulated myocytes. The reduction in Ca 2 
may be attributable to a number of factors including, the reduction in trigger Ca 2 through 
'Ca,L (which has been reported in this study) or a reduction in SR Ca 2 content or fractional 
release. SR Ca2 content has been reported to be reduced by halothane in normal rat 
ventricular myocytes (Davies et at, 2000). In the present study, it has been shown that the 
peak amplitude of 'CaL  is reduced by halothane. Therefore, it is acceptable to suggest that a 
decrease in 'Ca,L  and therefore Ca 2 influx leads to a reduction in SR Ca 2 release in the 
presence of halothane. The tpk  and tx decay of Ca 2 transient were not significantly 
altered by halothane in control and STZ-induced diabetic myocytes. It is therefore likely 
that in the STZ-induced diabetic heart, halothane has no significant effect on either Ca 2 
efflux or Ca2 uptake during diastole. 
6.3.6 Myofilament sensitivity 
The results in this study have shown that the slope of regression during the final phase of 
relaxation in STZ-induced myocytes was significantly increased compared to age-matched 
controls. Therefore, this study is the first to suggest that the sensitivity of the cardiac 
myofilaments to [Ca 2 ']1 in the STZ-induced diabetic hearts is significantly increased 
compared to that of controls. We have thus far reported that within electrically stimulated 
STZ-induced diabetic myocytes, the amplitude of contraction is significantly increased 
compared to that of control. In contrast, this study has shown that the fractional release and 
total release of Ca2F 
 from the SR is not changed between control and diabetic myocytes. 
Therefore, the results from Ca 2 and contraction studies have reported that a similar 
increase in [Ca 2 ']1 is mirrored by greater contraction in the diabetic heart. The results in 
this study therefore suggest that the underlying mechanism that controls this change in 
MIS 
contraction within the diabetic heart is an increase in the sensitivity of the myofilaments 
for Ca2*  in myofilaments. In contrast, following the application ofhalothane, ventricular 
myocytes obtained from both age-matched control and STZ-induced diabetic hearts 
reported a significant reduction in the slope of regression. This would suggest that 
halothane directly decreases the sensitivity of the myofilament to [Ca 24]. This is in 
agreement with Harrison et at (1999) who reported that halothane induced a reduction in 
myofilament sensitivity in myocytes from a normal heart. The activity of the cardiac 
myofilaments is controlled by cross bridge cycling of actin and myosin. Moreover, a 
change in the affinity of Troponin-C for Ca 2 is a primary reason for changes in 
myofilament sensitivity. Within the diabetic heart it has been reported that the expression 
of the MHC is switched from the active a-MI-IC to the less active 3-MHC isoform 
(Golfman et at 1999; Depre c/at 2000b; Pierce & Dhalla, 1981) which, has been reported 
as a factor in cardiac dysfunction (Brouty-Boye C! al. 1995). It may be that an alteration in 
MI-IC isoform and Troponic-C affinity for Ca 2 is altered by the diabetic state and may 
contribute to an increase in myofilament Ca 2 ' sensitivity, which ultimately is responsible 
for an increase in the amplitude of contraction that has been reported in this study 
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Chapter 7 
General discussion and final 
comments 
This study was developed principally to examine the underlying cellular mechanism(s) that 
are associated with contractile dysfunction in an experimentally-induced model of type-I 
diabetes in the rat heart. A stable model of type-I diabetes mellitus was induced in male 
Wistar rats by a single i.p. injection of STZ (60mg Kg") (Howarth etal. 2001). The STZ-
diabetic heart was characterised by hyperglycaemia, hypoinsulinaemia and changes in 
osmolarity. Further more total cardiac Ca 24, Cu2 , Zn2 and Fe2 , following 2 months STZ-
treatment were significantly elevated compared to controls. Therefore, as well as changes 
in blood chemistry the diabetic heart is characterised by an alteration in specific cation 
imbalance. It is suggested these changes may contribute and lead to an alteration in heart 
function that has been reported in STZ-induced diabetes. To assess the relative 
contributions of particular parameters within the heart, cardiac myocytes were isolated 
from ventricular heart tissue, using an enzymatic method to produce single 
cardiomyocytes. In some experiments, the volatile general anaesthetic, halothane was 
applied to myocytes. Halothane is known to alter specific properties of F-C coupling in 
cardiac myocytes from normal hearts (Housmans & Murat, 1988), although very little is 
known about its effects on the diabetic heart. 
Although contractility studies had been reported in human and animal models with 
diabetes, there appeared to be degree a degree of contradiction regarding results 
experimental design. Initial studies therefore focussed on measuring contraction. In 
ventricular myocytes taken from the STZ-induced diabetic rat following 4 weeks, 8-12 
weeks, 5 months and 10 month of STZ-treatment, reported significant increases in the 
amplitude of contraction compared to control. Moreover, the tpk of contraction was 
significantly longer following 4 and 8-12 weeks and 5 months of STZ-treatment. 
However, in the 10-month STZ4reated heart, the t,,k of contraction was not significantly 
altered. Interestingly, the t relax was significantly longer following 10 months of STZ-
treatment but appeared similar to age-matched controls following 4, 8-12 weeks and 5 
months treatment of STZ. These time-dependent changes in the chronic (10 month STZ-
induced) model of diabetes may be indicative of a some underlying compensatory process 
that is instigated within the heart to secure its integrity. Following the application 
halothane, the amplitude of contraction was depressed in both control and STZ-induced 
myocytes, but this was significantly more pronounced in the diabetic cells. Moreover the 
time coarse of contraction was also effected by the application of halothane in the diabetic 
heart, suggesting that the diabetic heart is more susceptible to the actions of halothane. In 
a separate study, it was shown that high glucose (25 mM) increased the amplitude of 
shortening, the rate of contraction and the rate of relaxation in control, but not in STZ-
induced diabetic myocytes, showing that the diabetic heart may be more acclimatized to 
the increase in glucose. 
An increase in contraction is a consequence of increased SR Ca 2 release and/or increased 
myofilanient Ca 2 sensitivity. A change in Ca 2 influx via 'Ca.I.  has been shown to alter the 
SR load and fractional Ca 2 release (Bouchard el at 1995). Therefore, 'Ca,L  and the voltage-
dependence of contraction was measured in the STZ-induced diabetic myocytes. The peak 
amplitude of 'Ca.L  was found to be significantly decreased in STZ-induced myocytes 
compared to age-matched controls. Moreover, following the application of halothane 
application was further reduced the 'Ca,L  in control and STZ-induced diabetic myocytes. 
The voltage-dependence of contraction was found to be decreased in STZ-myocytes 
compared to control, thus opposing the results that been obtained in electrically stimulated 
myocytes. In voltage-clamped myocytes, the depolarising pulse is identical. Reduced 
'CaL 
in the STZ-induced myocytes will therefore result in a decrease in Ca2t 
 influx. Reduced 
Ca2 influx will lead to a decrease in SR Ca 2 ' load and reduced Ca 2 release from the SR. It 
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is therefore likely that a reduction in SR Ca 2 release in voltage clamped myocytes from 
STZ-induced diabetic hearts makes a major contribution in reducing the amplitude of 
contraction. In electrically stimulated myocytes, however, changes in Ap duration may 
influence changes in the open probability of the L-type Ca 24 channel (Sah ci aL2003). The 
open probability of the L-type Ca 2 channel is dictated in part by the membrane potential. 
At more positive potentials there is an increased possibility of L-type Ca 24 channel 
opening. In normal rat myocytes, large 
'OLL spikes have a rapid membrane repolarisations 
that, consequently have a rapid phase within the more positive potential and are therefore 
likely to restrict the open probability and channel activation, as well as accelerating the 
channel deactivation (Bers, 2002). Moreover it has been shown that in normal rat 
myocytes, prolonging the AP leads to a reduction in peak 
'Cal.,  but an increase in Ca24 
influx release (Bouchard ci at 1995). Increased Ca 2 leads to an increased SR load and 
release and contributes to a positive inotropic effect. In the diabetic heart it is well 
established that the Ap duration is prolonged because of a decrease in f 0 (Shimoni el at 
1994; Magyar ci at 1992) It is therefore suggested that in electrically stimulated STZ-
induced myoeytes, prolonged Ap duration leads to a smaller 
'Ca,!, but increased probability 
of L-type Ca2* 
 influx. Increased trigger Ca 24 is likely to act on the SR and may contribute 
to the changes in Ca 2 release. 
To ascertain if changes in contractile function are partly due to alterations in trigger Ca 24 
influx, Ca 2 ' measurements were taken in the control and diabetic heart. In this study, basal 
resting Ca 2 ' was increased in the diabetic heart, suggesting that increased NaVCa 2t 
exchanger, possibly through increased [Na +]i could reduce the rate f Ca 2 efflux. The 
amplitude and the 
'pk of the Ca 2 transient through electrically stimulated myocytes or 
caffeine-induced release were not altered by the diabetic state, suggesting that triggered 
Ca24 release from the RyR's and fractional Ca 2 ' release is not deranged in STZ-induced 
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diabetes. These results show that a similar amount ofCa2* 
 release released fromthe SR in 
control and diabetic myocytes have different effects on contraction and is therefore likely 
that myofilament Ca2* 
 sensitivity may play a role in the alteration in contraction within the 
STZ-induced diabetic heart. It was also observed that the decay of the Ca2t 
 transient in 
both caffeine-induced and electrically stimulated myocytes appeared significantly longer in 
STZ-induced diabetic myocytes. A prolonged decay that was observed in the STZ-induced 
myocytes in the presence of caffeine is an indirect measure of the speed of Ca 2 efflux 
from the cell. In order to ascertain if the prolongation in Ca 2+ 
 decay was partly or 
principally due to the Na/Ca 2texchanger. NiCk was employed to block this mechanism 
during a caffeine-induced Ca2t release. In the presence of NiCl2, Ca2t 
 efflux in age-
matched control myocytes was similar to that seen in diabetic myocytes. Moreover, NiC1 2 
did not significantly alter the amplitude of Ca 2t release in the diabetic myocytes. This 
suggests that the NaVCa 2
-exchanger, but not the PMCA, contributes to a longer decay in 
Ca2t transient in the diabetic heart. 
Myouilament Ca2t sensitivity was assessed by simultaneous measurement of contraction 
and Ca2t. 
 Plotting cell length with [Ca 2 '] generated in the final phase of relaxation 
provided an index of myofilament Ca2t sensitivity (Sturgeon ci aL 1992). In STZ-induced 
myocytes myofilament Ca2t sensitivity was significantly increased compared to controls. 
Therefore, in the STZ-induced diabetic myocytes, increased contraction in the absence of 
increased [Ca 24]1 (compared to control) is primarily due to an increase in myofilament Ca 2 ' 
sensitivity. It is this overriding observation that underpins the differences between the 
diabetic heart and control within this study. It has been reported that changes in the cross-
bridge cycling due to an alteration in MHC isoform (that has been reported in the diabetic 
heart, (Schaffer ci aL, 1989a)) may underpin the change in myofilament Ca 2t sensitivity 
that has been demonstrated in this study. In the presence of halothane, myofilament Ca2t 
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sensitivity was significantly decreased in both control and STZ-induced myocytes. 
Therefore, it is suggested that decreased in myofilament sensitivity in the following the 
application of halothane is the overriding mechanism by which contraction is depressed to 
a greater degree in the diabetic heart. Although a change in expression is a likely candidate 
for explains the perturbation of myofilament Ca 2 in diabetes, it is unlikely that the 
transient application of halothane would manipulate the filaments in such a manner. It is 
therefore suggested that direct action of halothane reduces the affinity of troponin-C for 
Ca2 , and in doing so reduces contraction to a greater degree in the diabetic heart. 
7.1 	 Final conclusion 
This main focus of this study has looked at the effects of STZ-induced diabetes on isolated 
ventricular myocytes. The results of the study have shown that a decrease in 'caL  led to an 
increase in the amplitude of contraction in electrically stimulated STZ-induced myocytes 
compared to controls and this was primarily due to an increase in myofilament sensitivity 
for Ca2 and not due to an increase in Ca 2 release from the SR. Moreover, the prolonged 
decay in Ca 2 ' effiux following electrically stimulated and caffeine induced Ca 2 release in 
STZ-induced diabetic myocytes is in part due to dysfunctional Na/Ca 2texchanger. It is 
suggested that prolonged Ap duration primarily through reduced Its. may lead to increased 
Ca2 influx albeit a reduced 'CaL.  Increased Ca 2 influx through 'Ca,L may overcompensate 
for a decrease in SERCA function (that has been reported in the diabetic heart, Misra c/ aL 
1999) and may lead to a similar SR Ca 2 load and release in both diabetic and control 
myocytes. Following SR Ca2 release it is suggested that the increased myofilament Ca 2 
sensitivity in STZ-induced myocytes leads to an increase in contraction that has been 
reported in this study. 
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In voltage clamped myocytes from STZ-induced hearts, however, that are not influenced 
by the Ap, decreased 'Cat,  may lead to a reduction in Ca 2 influx through 'CaL,  leading to a 
reduction in trigger Ca 2 and subsequent SR Ca 2 release. Reduced Ca 2 release from the 
SR, may not be compensate for by the increase in myofilament Ca 2 sensitivity in the 
diabetic heart, and may ultimately lead to a reduction in the amplitude of contraction that 
has been reported in this study. 
It has also been shown that, following the application of halothane, the 
'CaI,  Ca2 transient 
and amplitude of contraction were significantly more decreased in STZ-induced myocytes 
compared to that of control. It is suggested that reduced myofi lament Ca 2 sensitivity in the 
presence of halothane contributes to the changes in contraction. However, it is also likely 
that another mechanism such as fractional Ca 2 ' release and/or SR Ca 2 load may also be 
affected by the actions of halothane in the diabetic heart. 
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Chapter 8 
Appendix 
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8.1 	 Solutions 
8.1.1 [co/a/ion solution 
The composition of the physiological salt solution used during the cell isolation procedure 
was (in mM) 130. NaCl (VWR, 102415-R), 5.4, KCI (VWR, 1019842); 1.4. MgC1 2 (VWR, 
220933-M); 0.4, Nal-12PO 4 
 (VWR, 102494-C); 5, HEPES (Sigma, H-3375); 10, glucose; 
20, taurine (Sigma, 1-0625); 10, creatine (Sigma C-0780) and 0.75 Cal set to pH 7.3 
(Orion pH meter, 920-A) with 4 M NaOH (VWR. 10252). 
& 1.2 Normal Tyrode (NT) solution 
The NT solution used to perfuse cells during experiments contained (in mM) 140, NaCl; 5, 
KCI; I. MgCl2.61-120 (VWR, 101494-V); 10, glucose; 5, FIEPES; I. CaCl2, set to pH 7.4 
with 4 M NaOH. 
& 1.3 Patch pipette solution 
Patch pipette solution contained (in mM) 120 mM, CsCl2 (Sigma, C-301 I); 8, K2ATP 
(Sigma A-8937); 5, glucose; 10, NaCl; 8, MgCl 2 ; 10 I-IEPES set to pH 7.2 with CsOH 
(Sigma, C-85 IS). 
8.1.4 Halo/kane solution 
Halothane was made up by adding 132.5 .xl stock solution halothane to 2.37 ml of stock 
DMSO. A 60 p1 portion of this mixed solution was then added to 50 ml of NT (I mM 
Ca2 ) to give a final halothane concentration of 0.6 mM. All solutions were freshly 
prepared using either Milli-Q or Millipore grade water. 
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